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The studies presented in this thesis represent an attempt to 
characterise some aspects of the abnormalities of somatomedin physio-
logy in protein-energy malnutrition. 
A suitable bioassay to study somatomedin was found in that of 
Van den Brande and Du Caju (1974) which makes use of uniform discs 
of cartilage punched from slices of immature porcine costal carti-
lage. The handling of the cartilage discs was made easy by the 
specially designed incubation rack. Preincubation increased sensi-
tivity of the cartilage, and post incubation with radioactive 
tracer reduced the potential interference of varying sulphate con-
tent of assay samples. Serum samples were subjected to formal mul-
tipoint parallel line bioassay and daia analysed by a computer pro-
gramme designed to examine such assays. The bioassay was found to 
be sensitive to a concentration of serum of 5% and to have an index 
precisiori of less than 0.30 (and usually less than 0.20). 
An experimental model of protein-energy malnutrition (Stead 
and Brock) 1972) was adopted which made use of weanling rats fed 
semi-synthetic diets (ad lib) containing either 4% casein (to pro-
duce malnutrition) or 20% casein (to produce wellnourished age-
matched controls). The diets were isocaloric and provided known 
and adequate amounts of vitamins, minerals and trace elements. Un-
treated weanlings were used as additional weight-matched wellnouri-
shed controls. The protein deficient diet produced a syndrome in 
the rats which had many features in common with human protein-energy 
malnutrition: failure to gain weight, failure of linear growth, 
hypoproteinaemia, hypoalbuminaemia and periportal fatty infiltra-
tion of the liver. 
Histologically the epiphyseal growth plates of long bones (es-
pecially that of the upper tibia) were found to be narro1-: and inac-
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tive in malnourished animals. The cartilagenous ground substance 
of malnourished cartilage was found to stain normally by a variety 
of histochemical techniques~ The incorporation of 35 so4 into car-
tilage, 
3Sso 4, 
24 hours after the intraperitoneal administration of Naz 
was found to be reduced in protein malnourished animals, 
autoradiography being used to examine long bones and scintillation 
counting for costal cartilage. 
Serum somatomedin activity was found to be reduced to nearly 
hypopituitary levels in protein malnourished animals. There was 
no evidence for the presence of an inhibitor 1n mixing experiments 
andcbse response curves of protein malnourished and costal sera 
were parallel. Growth hormone was found to be normal by radio-
immunoa~say and in this respect the situation in the rat differs 
from that in man where the growth hormone levels are elevated. 
Nevertheless this represents a situation not dissimilar to that in 
humans in that the somatomedin activity is inappropriately low for 
the level of growth hormone present. Hypoinsulinaemia was confir-
med in this model of experimental protein malnutrition and this may 
be a factor responsible for the reduced somatomedin activity. The 
administration of pharmacological doses of growth hormone (from 
species known to be biologically active in the rat) failed to stimu-
late weight gain, linear growth, tibial width or serum somato-
medin activity. 
When the cartilage of malnourished and age-matched control 
animals was examined in an in vitro incubation system both were 
found to incorporate 35 S04 similarly under serum-free conditions 
and to be equally stimulated in the presence of normal rat serum, 
while serum from malnourished animals was poorly stimulating to 
both types of cartilage. These observations suggested that an end 
organ resistance of cartilage to somatomedin's action was not a 
iii 
major factor in the reduced growth rate, narrow epiphyses and redu-
ced in vivo incorporation of 35S04 in protein-energy malnutrition. 
An isolated in situ liver perfusion technique based on that of 
Hems, Ross, Berry and Krebs (1966) was developed to study the gene-
ration of somatomedin by the livers of malnourished and wellnouri-
shed animals. The viability of the liver preparation was determi-
ned as being satisfactory by the following criteria: macroscopic 
appearance, histological appearance, perfusate flow rate, bile 
secretion rate, normal wet/dry weight ratios of perfused livers, 
oxygen consumption, adequate and linear gluconeogenesis from lac-
tate and, in a slightly modified system, sensitivity to glucagon-
induced glycogenolysis in the physiological range. The livers of 
protein malnourished animals were found to generate less somatomedin 
activity than control livers in the absence of hormonal stimulus or 
when stimulated by growth hormone, insulin, or a combination of 
growth hormone and insulin. The slightly greater relative sensiti-
vity of protein malnourished livers to insulin may be an indication 
of the importance of insulin in the maintenance of normal somatome-
din activity (in vivo, protein malnourished animals were noted to 
be hypoinsulinaemic). The reduced liver generation of somatomedin 
activity by the livers of protein malnourished animals may be a 
mechanism whereby the low serum somatomedin activity in this condi-
tion occurs. Reduced somatomedin generation itself may represent a 
non-specific effect of deranged liver function or an adaptive homeo-
static mechanism by means of which the direct actions of growth hor-
mone might be made possible without concomitant stimulation of grow-
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·. SCOPE N~D OBJECTIVES 
"He who has begun has half done. Dare to be wise; Begin" 
Horace 
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In the last quarter of the 20th century malnutrition remains a 
major problem for a majority of the population of our planet. The 
problem is especially one for the under-developed or Third World 
countries. Unbridled population growth, increasing shortages of 
resources of all types, the advance of deserts into previously ara-
ble land on every contin~nt and poor and increasingly expensive dis-
tribution of food reserves, all give little reason for optimism. 
The University of Cape Town Medical School has been in th~ unusual 
position of having sophisticated technology and skilled staff avai-
lable to study protein-energy malnutrition which is a disease all too 
frequently encountered in the Cape peninsula. Professor J.F. Brock 
and his coworkers were responsible for defining many of the clinical 
and biochemical abnormalities of protein-energy malnutrition. The 
endocrine adjustments and abnormalities which occur in this condi-
tion have been studied in considerable detail by Professor B.L. 
Pimstone and this thesis represents the work done to explore some of 
the endocrine changes which may be responsible f~r failure of linear 
growth in protein-energy malnutrition and the mechanism whereby 
these changes occur. Specifically these changes are those which 
are related to somatomedin (growth hormone dependent sulphation fac-
tor). Because the cartilagenous end-organ (the site of action of 
somatomedin), and the liver, which is .a major site of somatomedin 
generation, are not readily accessible to study in man, it was 
decided to use a rat mode l of protein-energy malnutrition. 
Chapter 2 reviews the literature on somatomedin and related 
growth factors. 
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Chapter 3 discusses the bioassay of somatomedin activity and 
describes the methodology and validation of the bioassay which was 
used to explore the problems of somatomedin in protein-energy malnu-
trition. 
Chapter 4 deals with animal models of protein-energy malnutri-
tion, the relevance of such models to the human syndrome and the 
reasons for choosing the rat model of Stead and Brock (1972). The 
diet, animals (protein malnourished and control) and the morpholo-
gic and biochemical characterisation of the model are fully recorde~ 
Chapter 5 describes the histological and histochemical features 
of growth cartilage as well as the 35so4 incorporation in vivo in 
protein-energy malnutrition. 
Chapter 6 deals with the measurement of somatomedin activity in 
the serum of protein malnourished rats and the failure to demonstra-
te obvious inhibitors. Growth hormone and insulin, both of which 
have a role in somatomedin generation, were also measured by radio-
immunoassay and the relationships between growth hormone, insulin 
and somatomedin activity are discussed. 
Chapter 7 describes the behaviour of cartilage from protein 
malnourished and control rats in an in vitro incubation system with 
special emphasis on the responsiveness of such cartilage to normal 
and protein malnourished serum. 
Chapter 8 covers a discussion of the role of the liver in the 
generation of somatomedin activity and the suitability of liver per-
fusion systems, the development and validation of a liver perfusion 
system and its uses in studying the generation of somatomedin acti-
vity by the livers of protein malnourished and control animals in 
response to growth hormone and insulin. 
Chapter 9 provides a summary of the main conclusions reached 
in this study. 
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CHAPTER TWO 
REVIEW OF THE LITERATURE 
"Listening to both sides of a story will convince you that there 
is more to a story than both sides" Frank Tyger 
The purpose of this review is to provide a comprehensive but 
not exhaustive survey of the literature of somatomedin including an 
introductory coverage of those areas which are the special brief of 
this thesis. The literature relating to the bioassay of somatomed~, 
the production of experimental models of protein-energy malnutrition, 
cartilage histology, serum somatomedin and cartilagenous end-organ 
sensitivity in protein-energy malnutrition and somatomedin genera-
tion by the isolated perfused liver is dealt with in greater depth 
in the separate chapters on these subjects. 
A Introduction 
The very name "growth hormone" or "somatotropin" implies that 
this hormone acts directly on skeletal tissue to cause growth and 
this was long held to be one of its major functions (Becks, Simpson, 
Evans, Ray, Li and Asling, 1946). In a search for an improved in 
vitro bioassay for growth hormone Salmon and Daughaday (1956) per-
formed a series of experiments which to this day provide the basis 
for the somatomedin hypothesis of growth hormone's action on skele-
tal tissue and all subsequent work in this field. It was found 
that utilising the incorporation of 35 S04 into hypophysectomised rat 
costal cartilage as the bioassay preparation, hypophysectomised rat 
serum (which would be free of growth hormone) was less stimulatory 
to 35S04 incorporation than normal rat serum but that the addition 
of growth hormone to hypophysectornised rat serum would not result in 
. further stimulation. In contrast to the in vitro situation the ad-
ministration of growth hormone in vivo to hypophysectomised rats res-
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tored the ability of serum from these animals to stimulate 35 S04 in-
corporation. The initial name given to this stimulatory activity 
was "sulphation factor" but when it was found that sulphation factor 
activity was but one action (see Table 2.1), the more all embracing 
term ''somatomedin" was coined (Daughaday, Hall, Rab en, Salmon, Van 
den Brande and Van Wyk, 1972). This term indicates by "somato" 
the relationship to somatotropin or growth hormone, and by "medin" 
that it is the mediator for growth hormone's action on skeletal 
tissue. 
The somatomedin hypothesis ~hich resulted from the work of 
Salmon and Daughaday (1956) states that growth hormone does not act 
directly to cause growth of tissues (especially skeletal tissue) but 
stimulates the generation of secondary factor(s) known as somato-
medin(s) which acts on peripheral tissue to cause growth. For over 
20 years this has remained only an hypothesis, in that in spite of 
a large body of supportive evidence direct proof in the form of 
growth stimulat~on by a somatomedin preparation in a hypophysecto-
mised animal has been lacking. In 197 _8, however, almost certain 
_proof of the hypothesis has been provided by the demonstration of 
highly significant somatic growth in Snell dwarf (hereditary hypo 
somatotrophic) mice by a somatomedin preparation from human serum 
(Van Buul, Dumoleijin, Korteland, Van de Klundert and Van den Brande 
1978). 
B The bioassay of somatomedin 
Somatornedin(s) has diverse biological actions which are shown 
in Table 2.1. All of these biological actions have potential use 
b . b t . 1 h . d d 35 S04 . as 1oassays u most pract1ca tee n1ques epen on 1ncorpor~ 
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tion into hypophysectomised rat costal cartilage ( H Methyl thymidine 
. . b d . d . 1 1 . 1 f 3 S S.O 4 1ncorporat1on may e eterm1ne sirnu taneous y or 1n pace o 
TABLE 2.1 
METABOLIC EFFECTS OF SOMATOMEDIN (modified from Daugbaday, 
Phillips and Herington, 1975) 
(A) Stimulation of:-
1. Cartilage 
i) Chondroitin sulphate synthesis - 35s sulphate 
. . a-f 1ncorporat1on 
/ii) Chondromucoprotein synthesis - 14c leucine 
. . afg in corpora t1on 
iii) Collagen synthesis - 14c proline converted to 
collagen 14c hydroxyproline 
iv) RNA synthesis - 3H uridine incorporation f 
v) DNA synthesis - 3 fij H thymidine incorporation 
2. Other tissues 
i) Protein synthesis in muscle - 14c leucine 
incorporation 
ii) Glucose oxidation in adipose tissue (NSILA)k 
iii) HeLa cell growth in tissue culture 1 
iv) DNA synthesis in human glial cells - 3H thymidine 
incorporation° 
v) DNA synthesis in chick embryo fibroblasts - 3H 
thymidine incorporation P 
vi) In vitro growth of human serum fibroblasts q 
(B) Inhibition of:-
1. Glycerol release in epinephrine stimulated epididymal fat 
pads m 
2. 125 I insulin binding to adipocytes, chondrocytes and 
liver cell membranes. 
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Clin. Endocrinol. Metab. 40, 62. 
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but provides less precision) (Daughaday, Phillips and Herington, 
1975), 35 so4 incorporation into cartilage of chick embryo pelvic 
rudiments (Hall, 1970) or 35 so4 into porcine costal cartilage (Van 
den Brande and Du Caju, 1974) (Se e also Table 3.1). Bioassays are 
subject to non-specific stimulation and also to inhibitors which may 
interact with the somatomedin present to give reduced values 
(Daugh aday, Phillips and Herington, 1975). 
There are as yet no international standards for serum or for a 
purified somatomedin preparation, each laboratory using its own 
reference serum, usually a pool (of variable size) obtained from 
normal subjects, with a nominal potency of 1 U/ml. This situation 
makes the direct comparison of data between different laboratories 
difficult (Beaton, 1976). 
C Somatomedin activity in health 
i) The effect of age on somatomedin activity 
Reports on somatomedin levels in cord blood and materna l serum 
and the changes occurring in early life vary greatly. Somatomedin 
activity of cord blood has been reported as being equal to that of 
maternal serum (Daughaday, Salmon and Alexander, 1959; Chesley, 
1962; Hintz, Seeds, Johnsonbaugh, 1974) or higher (Tata, Du Caju, 
Prevot and Rappaport, 1975). Cord blood levels of somatomedin A 
(by radio receptor assay) and somatomedin B (by radioimmunoassay) 
however are lower than maternal blood levels (Svan, Hall, Ritzen, 
Takano and Skottner, 1977) as is bioassayable non-suppressible insu-
lin-like activity-soluble (NSILA-S) (Franklin, Pepperel, Burger and 
Came ron, 1978). Similar low levels have been observed with an 
NSILA competitive protein binding assay (Heinrich, Draznin, Johnson 
and Schalch, 1978) and a somatomedin bioassay (Ashton, Matheson, 
Vesey and Franclsi 1978). Tata, Du Caju, Prevot and Rappaport 
1 1 
(1975) have reported a rise in somatomedin activity from very low 
levels in the newborn to the normal adult range by the fourth day 
of life and a fall between 23 days and 15 months. Conversely, 
most workers have shown that after the first months of life a slow 
rise in somatomedin activity occurs, reaching adult levels by four 
to eight years of age (D aughaday, Salmon and Alexander, 1959; 
Almqvist, Ikkos and Luft, 1961; Almqvist and Rune, 1961; Kogut, 
Kaplan and~imizu , 1963; Van den Brande and Du Caju, 1973). A 
similar rise has been observed for somatomedin C by radio receptor 
assay (D'Ercole, Underwood and Van Wyk, 1977) and radioimmunoassay 
(Furlanetto, Underwood, Van Wyk and D'Ercole, 1977) from hypopitui-
tary levels in the newborn to near adult levels over a similar time 
span. 
No correlation between birth weight or labour stress and cord 
blood somatomedin activity could be found by Giordano, Foppiani, 
Minute and Perroni (1976) or with somatomedin A (radio receptor 
assay) and somatomedin B (radioimmunoassay) (Svan, Hall, Ritzen, 
Takano and Skottner, 1977). In contrast Gluckman and Brinsmead 
(1976) found somatomedin activity to correlate positively with 
birth weight, length and head circumference, independently of 
gestational age. NSILA has also been found to correlate with 
birth weight and gestational age (Heinrich, Draznin, Johnson and 
Schalch, 1978) as has somatomedin activity (Ashton, Matheson, Vesey, 
and Francis , 1978). A number of conditions characterised by foetal 
hypopituitarism are associated with normal or only slightly reduced 
foetal size at birth (Blizzard and Alberts, 1956; Reid, 1960). 
Somatostatin levels in cord blood do not correlate with growth hor-
mone (Gluckman and Brinsmead, 1976; Giordano, Foppiani, Minute and 
Perroni, 1976), but placental lactogen (somatomammotropin) is 
equipotent with growth hormone in causing weight gain in hypophysec-
12 
tomised rats, binds to growth hormone receptors in the liver with 
high affinity (Chan, Robertson and Friesen, 1976) and has been im-
plicated in the generation of foetal somatomedin activity (Hurley, 
D'Ercole, Handwerger, Underwood, Furlanetto and Fellows, 1977). 
Foetal somatomedin activity has not been systemically studied in 
-._) 
man, but in the rat, in spite of high growth hormone and insulin 
levels, somatomedin activity was scarcely detectable until birth 
after which it rose to adult levels within 11 days (Stuart, Lazarus, 
Moore and Smythe, 1976). Beaton (1976) found a progressive rise in 
somatomedin activity in the rabbit from prenatal to pubertal ani-
mals. In children, Hall and Filipsson (1975) have shown a corre-
lation between dental maturity and growth rate with somatomedin A. 
Daughaday (1971) reported no change in somatomedin activity at the 
time of puberty while Rothenberg, Hintz and Van Camp (1977) found a 
significant increase in girls in late puberty. The changes with 
age described above have not been specifically related to puberty. 
Somatomedin activity persists into old age (Almqvist and Rune, 1961). 
That growth should be most rapid at times that somatomedin ac-
tivity of serum is low is apparently paradoxical but the explanation 
lies in the sensitivity of the cartilage of young animals to the 
stimulus of somatomedin. Dziewiatkowski (1954) showed that the 
ability of the rat to incorporate 35 so4 into the cartilage fell with 
age, Herbai (1970) found the incorporation of 35so4 into .costal 
cartilage in the mouse to correlate with weight gain in the prece-
ding week. In an elegant longitudinal study Beaton (1976) has 
shown that incorporation of 35S04 and thymidine into rabbit costal 
cartilage is related to the growth velocity of the animal from 
which they were ' taken. 
Cartilage responsiveness to stimulation by somatomedin is 
greatest in young animals (Phillips, Herington and Daughaday, 1974) 
l 3 
(but cartilage from the foetal r a t was riot stimulated by human se-
rum) (Heins, Garland and Daughaday, 1970) while the cartilage res-
ponsiveness in foetal and post-natal rabbits was related to growth 
velocity (Beaton, 1976). 
ii) Somatomedin activity in pregnancy 
Early reports suggest that somatomedin was unchanged by preg-
nancy (Chesley, 1962; Daughaday, Salmon and Alexander, 1959; Hintz, 
Seeds and Johnsonbaugh, 1974), while Tata, Du Caju, Pr~vot and 
Rappaport (1975) and Giordano, Foppiani, Minuto and Perroni (1976) 
reported low somatomedin activity in pregnancy falling to hypopitui-
tary levels after delivery. Reduced somatomedin A (by radio · recep-
tor assay) and increased somatomedin B (by radioimmunoassay) have 
been found by Svan, Hall, Ritzen, Takano and Skottner,(1977). 
NSILA-S (by bioassay) has been found to rise progressively 
during pregnancy and to fall from high levels at delivery (2.49 U/ 
ml) to normal within 48 hours ( 1. 10 U/ml) (Franklin, Peppe rel, 
Burger and Cameron, 1978). 
iii) Circadian variation 
Daughaday, Salmon and Alexander (1959) were unable to show 
significant circadian variation. A suggestion of cyclical varia-
tion, inversely related to plasma cortisol concentration has been 
reported (Du Caju and Van den Brande, 1976). In the intact animal 
the incorporation of 35 so4 (Simmons, 1968) and the mitotic irtdex 
(Simmons, 1964) of the epiphyseal growth cartilage of mice have been 
shown to have a significant diurnal variation. 
iv) Except for the special circumstances which obtain in preg-
nancy sexual dimorphism of somatomedin activity have not been repor-
ted (Daughaday, Salmon and Alexander, 1959; Almqvist and Rune, 
1961; Van den Brande, Van Buul, Heinrich, Van Roon, Zurcher and 
Van Steirtegem, 1975). 
D Somatomedin activity in disease 
14 
Somatomedin activity has been measured in a wide variety of 
disease states, especially those in which there are growth· abnor-
malities. The findings fall into three broad groups, that in 
which growth hormone and srimatomedin are concordant, that in which 
low somatomedin activity is associated with an inappropriately ele-
vated growth hormone level and finally where somatomedin is normal 
or elevated in the face of low or absent growth hormone levels (see 
Table 2.2). 
i) Conditions associated with concordance of growth hormone 
and somatomedin 
a) Conditions associated with low or absent growth hormone levels: 
Hyposomatotropism due to isolated growth hormone deficiency, 
panhypopituitarism or hypophysectomy is associated with low somato-
medin activity (usually in the range 0.20 - 0.40 µ/ml) (Daughaday, 
Salmon and Alexander, 1959; Hall, 1970), and the administration of 
exogenous growth hormone results in the restoration of serum somato-
medin activity (Hall and Olin, 1972; Schimpf£, Donnadieu, Gourmelen 
and Girard, 1974). The therapeutic response to exogenous growth 
hormone in children with growth hormone deficiency, as measured by 
gro~th velocity, has been shown to correlate well with the serum 
somatomedin activity (Hall and Olin, 1972; Schimpf£, Donnadieu, 
Gourrnelen and Girard, 1974). After intravenous administration of 
growth hormone (1 mg) an increase of somatomedin activity was de-
tectable within three hours (Hall, 1971), while after subcutaneous 
or intramuscular injections the increase was detectable within six 


































































































































































































































































































































































































































































































































































































































































































































































































and complete normalisation of scrum somatostatin requires two to 
four days of continuous growth hormone therapy (Daughaday, 1975). 
Children suffering from psychosocial dwarfism or the emotional-dep-
rivation short stature syndrome, who have retarded skeletal matura-
tion, short stature and who show catch-up growth when hospitalised 
or when home circumstances improve, have been shown to have low 
growth hormone levels and somatomedin activity which return to 
normal in the phase of catch-up growth (Van den Brande, Van Buul, 
Heinrich, Van Roon, Zurcher and Van Steirtegen, 1975; Powell, 
Brasel and Blizzard, 1967). The mechanism for the depressed grow-
th hormone levels in this syndrome remains obscure. 
b) Conditions associated with elevated growth hormone levels: 
In acromegaly, somatomedin activity is usually elevated but 
there is poor correlation between the immunoreactive growth hormone 
levels and somatomedin activity (Yde, 1969). There is a fair 
correlation between the clinical assessment of disease activity and 
somatomedin (Stuart and Lazarus, 1975). 
c) Conditions associated with normal growth hormone and normal 
somatomedin activity with a disorder of growth: 
A number of conditions associated with short stature fall into 
this group: Turner's syndrome in which growth hormone is normal 
or slightly elevated (Saenger, Schwartz, Wiedemann, Levine, Tsai 
and New, 1976), African pygmies (Daughaday, 1969) and pseudohypo-
parathyroidism (Urdanivia, Mataverde and Cohen, 1975). It is pos-
tulated that short stature in these conditions is due to an end-
organ resistance to somatomedin at cartilage level. Proof of this 
hypothesis requires the demonstration of resistance to exogenously 
administered somatomedin in vivo or the failure of cartilage to bind 
1 b 11 d t d . t d t t d" b 35 S04 t k a e e soma ome in, or o respon o soma ome in y up a e 
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in vitro. 
Soto's syndrome or cerebral gigantism is characterised by a 
typical facies, advanced skeletal maturation, rapid and excessive 
growth from birth, large hands and feet, mental retardation and 
dilated cerebral ventricles, and has been found to have normal or 
low normal somatomedin activity and normal growth hormone levels 
(Van den Brande and Du Caju, 1973; Saenger, Levine, Wiedemann, 
Schwartz and New, 1976; Lecornu, 1973) . The mechanism for the 
excessive growth in .this syndrome remains undetermined. 
ii) Conditions associated with low somatomedin activity in 
the presence of elevated or normal growth hormo,ne levels 
There exists a number of clinical situations in which the nor-
mal relationship between growth hormone and somatomedin no longer 
obtains. 
Laron's dwarfism is a syndrome characterised by the phenotypic 
features of growth hormone deficiency but grossly elevated immuno-
reactive growth hormone levels and low somatomedin activity (Laron, 
Pertzelan and Mannheimer, 1966). The condition is especially com-
mon in Jews of Asiatic origin but has been reported in other groups; 
the inheritance appears to be as a Mendelian recessive trait. 
Although the initial hypothesis was that the syndrome resulted from 
biologically inactive growth hormone, serum growth hormone from 
patients was found to behave identically to human growth hormone on 
electrophoresis and immunologically (Eshet, Laron , Brown and Arnon, 
1973; Elders, Garland, Daughaday, Fisher, Whitney, and 
Hughes, 1973) and to bind normally in a growth hormone radio recep-
tor assay (Jacobs, Sneid, Garland, Laron and Daughaday, 1976) . Th e 
exogenous administration of growth hormone even in large doses could 
not increase serum somatomedin (Daughaday, Laron, Pertzelan and 
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Heins, 1969; New, Schwartz, Parks, Landpy and Wiedemann, 1972) 
nor does ~rowth hormone induce nitrogen and phosphorus retention, 
calcium excretion, lipolysis or skeletal growth (Laron, Pertzelan, 
Karp, Kowadlo-Silbergeld and Daughaday, 1971). The hypothesis of 
Daughaday and Garland (1972) is that there is an end-organ resis-
tance to growth hormone, not only for its direct effects (e.g. 
lipolysis) but also for the induction of somatomedin generation. 
Liver disease, especially cirrhosis, has been found to be 
associated with high growth hormone levels and low somatomedin acti-
vity (Wu, Grant, Hambley and Levi, 1974; Stuart and Lazarus, 1975). 
Children with type VI glycogen storage disease (phosphorylase defi-
ciency) have growth retardation with normal growth hormone and low 
soma tomedin which does not rise after the administration of exoge-
nous growth hormone in pharmacological doses (Levine, Wiedemann, 
Saenger, Schwartz and New, 1976). 
The growth failure occurring in children with severe renal 
disease is associated with normal or elevated growth hormone levels 
and low somatomedin activity (Stuart and Lazarus, 1975; Saenger, 
Wiedemann, Schwartz, Korth-Schutz, Lewy, Riggio, Rubin, Stenzel and 
New, 1974). In those cases where treatment by dialysis or tr~ns-
plantation resulted in improved growth rate, serum somatomedin ac-
tivity was found to increase. Children treated with glucocorticohls 
have normal growth hormone levels and low somatomedin activity with 
poor growth (Elders, Wingfield, McNatt, Clarke a~d Hughes, 1975). 
Glucocorticoids may act to reduce somatomedin generation (Hill, 
Francis, Conroy and Ashton, 1977; Mosier, Jansons, Hill and 
Dearden, 1976) and to reduce 35so4 uptake into cartilage in vitro 
(Keret, Schimpf£ and Girard, 1976; Mosier, Jansons, Hill and 
Dearden, 1976). Alternate day glucocorticoid therapy has been 
found to improve growth rate in children and somatomedin activity 
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has been found to be normal on the day in which glucocorticoids are 
not administered (E Ide rs, Wing£ ie ld, McN a tt, Clarke and Hughes, 19 7 5 ). 
The doses of hydrocortisone administered for the treatment of con-
genital adrenal hyperplasia have no effect on somatomedin activity 
(Rappaport and Prevot, 1977). 
Oestrogens have been used to treat acromegaly since they reduce 
hypercalciuria, hydroxyprolinuria, the increased radiocalcium bone 
accretion rate and hyperphosphataemia in spite of the fact that 
growth hormone levels are unchanged or even elevated. The mecha-
nism for these effects is a reduction of somatomedin activity 
(Wiedemann and Schwartz, 1972; Saenger, Schwartz, Wiedemann, Levine, 
Tsai and New, 1976). Exogenously administered glucagon has been 
found to reduce serum somatomedin without an effect on growth hor-
mone levels (Binoux, Schimpf£ and Donnadieu, 1977). 
Protein-energy malnutrition in which growth failure is a major 
feature is associated with grossly elevated non-suppressible grow-
th hormon~ levels (Pimstone, Wittmann, Hansen and Murray, 1966; 
Pimstone, Barbezat, Hansen and Murray, 1967) and in general growth 
hormone levels are higher in kwashiorkor than marasmus (Pimstone, 
/ 
Barbezat, Hansen and Murray, 1967). Somatomedin activity is redu-
ced in protein-energy malnutrition and returns to normal with re-
feeding, as does the growth hormone (Grant, Hambley, Becker and 
Pimstone, 1973; Van den Brande and Du Caju, 1973; Hintz, Suskind, 
Amatayakul, Thanangkul and Olson, 1978). Frequently the dose res-
ponse of serum from children with untreated protein malnutrition is 
not parallel to that of normal serum (Grant, Hambley, Becker and 
Pimstone, 1973) and this may be due to an inhibitor (Van den Brande 
and Du Caju, 1973); with recovery parallelism of the dose reponse 
returns. 
Many of the above clinical situations are in keeping with a 
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postulated feedback loop in which som~tomedin activity may act at 
pituitary or hypothalamic level to inhibit growth hormone secretion 
(Cha:hinov and Daughaday, 1976). 
iii) Conditions associated with normal or increased somatomedin 
activity in the presence of reduced or absent growth 
hormone levels 
A variety of factors other than growth hormone may operate to 
induce somatomedin activity generation. 
Catch-up growth can occur in children following surgery for 
craniopharyngioma, in the absence of immunore active growth hormone 
in the serum, whilst normal somatomedin activity is found (Kenny, 
Guyda, Wright and Friesen, 1973; Finkelstein, Kream, Ludan and 
Hellman, 1972; Costin, Kogut, Phillips and Daughaday, 1976). 
Similar results have been reported with hypothalamic tumours other 
than craniopharyngiomas (Kenny, Iturzaeta, Mintz, Drash, Garces, 
Susen and Askari, 1968). Elevated prolactin has been postulated 
as the cause for the normal somatomedin activity (Kenny, Iturzaeta, 
Mintz, Drash, Garces, Susen and Askari, 1968) and ovine and rat 
prolactin have been shown to stimulate the generation of somato-
medin activity from the isolated perfused rat liver (Francis and 
Hill, 1975; Hill, 1977). It seems more likely however that the 
hyperphagia which may result from hypothalamic injury in such cases 
causes hyperinsulinism which stimulates somatomedin generation 
(Kenny, Guyda, Wright and Friesen, 1973; Costin, Kogut, Phillips 
and Daughaday, 19 76). Insulin has been shown to have growth pro-
moting effects (Salter and Best, 1953) and to stimulate somatomcdin 
generation by the isolated perfused rat liver (Daughaday, Phillips 
and Mueller, 1976). Simple obesity is another situation in which 
growth hormone levels tend to be low, insulin levels high and 
somatomedin ac tivity normal (Van den Brande and Du Caju, 1973). 
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Patients with the clinical features of active acromegaly with 
normal growth hormone and insulin levels but elevated somatomedin 
activity have been reported (Hoffenberg, Howell, Epstein, Pimstone, 
Fryklund, Hall, Schwalbe and Rudd, 1977). Hypophysectomised rats 
infested with the spargana stage of the cat tapeworm (Spirometra 
mansonoides) grow in spite of the total absence of growth hormone. 
This phenomenon is due to the elaboration of a "worm factor" or 
I 
pherocercoid growth factor by the worms (Garland, Ruegamer and 
Daughaday, 1971). The factor appears able to induce most of the 
metabolic effects of growth ho rmone (Steelman, Morgan, Cuccaro and 
Glitzer, 1970) including an increase in ornithine decarboxylase 
(Sogani , Matsushita, Mueller and Raben, 1972). That the pherocer-
coid growth factor induces somatomedin in a similar way to growth 
hormone is suggested by the decrease in pituitary content of growth 
hormone of rats infested with spargana (Garland and Daughaday, 1972) 
and that Jhe factor displaces 125 1-labelled human growth hormone 
from receptors on liver cell membranes (Tsushirna, Friesen, Chang and 
R_aben, 1974). After several weeks antibodies are produced in the 
infested rat which block the biological effects of the worm factor 
and inhibit further somatomedin activity generation and further 
growth ceases (Daughaday, 1971). 
E The site of origin of somatomedin activitz 
i) The presence of somatomedin activity in body fluids 
Apart from the original observation of somatomedin being pre-
sent in serum (Salmon and Daughaday, 1957) and being purified from 
outdated human plasma (Hall, Takano, Fryklund and Sievertsson, 1975; 
Van Wyk , Underwood, Baseman, Hintz, Clemmons and Marshall, 1975), 
somatomedin activity has also been found in cerebrospinal fluid 
(Beaton, Sagel and Distiller, 1975), lymph (Cohen and Nissley, 1975), 
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amniotic fluid (bioassayable, Bala and Smith, 1976; somatomedin C 
by radio rec~ptor assay, cfochinov, Ma riz, Hajek and Daughaday, 
1977), urine (somatomedin B by radioimmunoassay, Yalow, Hall and 
Luft, 1975a), and aqueous humor (unpublished personal observations). 
ii) The presence of somatomedin activity in tissue 
Somatomedin differs from other hormones in that no tissue con-
tains more than plasma itself. Aqueous extracts of muscle, live.r 
and brain have been shown to stimulate the sulphation of chick car-
tilage (Hall and Bozovic, 1969). 
iii) The role of the liver in the generation of somatornedin 
activity 
Considerable evidence has accumulated indicating that the 
liver is a major site for the generation of somatomedin activity. 
Partial hepatectomy in the rat results in a fall in serum somato-
medin activity (Uthne and Uthne, 1972). Chronic liver disease is 
associated with reduced serum somatomedin activity (Wu, Grant, 
Hambley and Levi, 1974; Giordano, Foppiani, Minuto, Perroni and 
DiCicco, 1975), and a positive transhepatic gradient of somatomedin 
activity has been demonstrated in the dog (Schimpf£, Donnadieu, 
Glasinovic, Warnet and Girard, 1976). In vitro somatomedin acti-
vity has been generated by a variety of liver ·preparations including 
crude microsomal fractions (Ifall and Uthne, 1971) and the isolated 
perfused rat liver (McConaghey and Sledge, 1970). Less somatomedin 
activity is released from the livers of hypophysectomised than in-
tact animals (McConaghey, 1972) and growth hormone stimulates soma-
tomedin release from the perfused liver (McConaghey and Sledge, 
1970; Phillips, Herington, Karl and Daughaday, 1976). 
Insulin (Daughaday, Phillips and Mueller, 1976) and prolactin 
(Francis and Hill, 1975; Hill, 1977) are other stimulants for 
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hepatic release of somatomedin. A cloned rat liver cell tumour 
grown in culture releases a somatomedin-like peptide into the 
medium (Smith and Temin, 1974). While the liver is probably th~ 
major site of somatomedin generation, the kidney may play a role 
as somatomedin activity has beeri found to be generated in an jsola-
ted perfused rat kidney system (McConaghey and Dehnel, 1972). 
iv) Somatomedin activity in plasma occurs as a high molecular 
weight complex in which the small molecular weight somatomedin is 
associated with a protein MW> 50000 daltons (Van den Brande, Van 
Wyk, Weaver and Mayberry, 1971). The carrier protein is presumably 
of liver origin in that somatomedin activity generated by isolated 
perfused rat livers occurs as a large molecular weight complex 
(Dehnel, McConaghey and Francis, 1974). The binding to plasma 
proteins may account for the long half life of serum somatomedin 
activity, 3-4 hours in the rat (Daughaday, 1971) and~ 12 hours in 
man (Almqvist and Falkheden, 1961). 
F The isolation and characterisation 6f s6matom~dihs and other 
growth factors 
i) Introduction 
The availability of suitable bioassay systems enabled workers 
to follow the concentration of growth factors through purification 
procedures. As somatomedin activity is not concentrated in any 
organ, serum and plasma were the starting materials chosen ' and 
initial purification procedures were applied to small volumes of 
serum (normal human, acromegalic human and rat). Somatomedin 
activity was found to be retained by dialysis tubing (Salmon and 
Daughaday, 1958) and similar fi11dings were reported with membrane 
ultrafiltration giving an exclusion point of 50,000 daltons (Van 
Wyk, Hall, Van den Brande and Weaver, 1971). The high molecular 
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weight of somatomedin has been found to be due to its association 
with binding proteins (Hall, Takano, Fryklund and Sievertsson, 1975; 
Van Wyk, · Underwood, Baseman, Hintz, Clemmons and Marshall, 1975; 
Froesch, Schlumpf, Heimann, Zapf, Humbel and Ritschard, 1975), and 
some of these binding proteins themselves have been shown to be 
growth hormone dependent (Zapf, Kaufmannand Froesch, 1977; Zapf 
and Froesch, 1978; Draznin, Schalch, Heinrich and Schlueter, 1978; 
Enberg, Fryklund and Hall, 1978). Acid-ethanol extraction or 
heating, with or without gel chromatography, resulted in the dis-
sociation from binding proteins and purification of somatomedin by 
up to 100 to 500 fold but with the low recoveries only very small 
amounts of the material were isolated. It was only when blood 
fractions r~presenting starting material equivalent to several tons 
of out-dated plasma were subjected to industrial scale preparative 
technology that highly purified somatomedins were isolated in any 
meaningful quantity. 
ii) Peptides with cartilage-stimulating properties 
a) Somatomedin A 
-
Large scale purification of modified Cohn fraction IV derived 
from out-dated human plasma was undertaken using the embryonic 
chick caitilage bioassay to monitor the concentration of somatomedin 
activity. Initial purification schemes consisted of acid-ethanol 
extraction, Sephadex G-75 gel chromatography, Dowex SO W-X8 ion 
exchange chromatography and high-voltage paper electrophoresis at 
pH 6.5, 3.6 and 2.0, resulting in a 1 to 2 million-fold concentra-
tion of activity with a recovery of 0.10% (Hall, 1972). More re-
cent schemes involved acid-ethanol extraction, Sephadex G-75 and 
G-50 .gel chromatography, cellulose column electrophoresis at pH 7. S 
and pH 5.0 and final Sephadex G-50 gel chromatography (Sievertsson, 
... 
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Fryklund, Uthne, Hall and Westermark, 1975). The purified material 
is a neutral peptide having an isoelectric point of 7.1-7.5 and mole-
cular weight of 7,600. Gel electrophoresis revealed two bands, 
equipotent in the bioassay and having somewhat different amino acid 
compositions (Sievertsson, Fryklund, Uthne, Hall and Westermark, 
1975; Fryklund, Uthne and Sievertsson, 1974). 
A peptide with not dissimilar properties has been isolated from 
bovine plasma (Liberti, 1975). 
b) Somatomedin C 
Commencing with Cohn fraction IV, but using the rat costal 
cartilage bioassay to monitor the purification process, and follo-
wing a somewhat different purification scheme, a basic peptide with 
an isoelectric point of 8.4-9.2 and molecular weight of 7,600 has 
been isolated. The purification scheme consisted of acid-ethanol 
extraction, gel chromatography on Sephadex G-75 and G-50, conti-
nuous isoelectric focusing between pH 3-10 and pH 7.0-10, SP 
Sephadex chromatography, Sephadex G-50 gel chromatography, prepa-
rative gel electrophoresis (pH 2.3 in 6M urea) and final Sephadex 
G-50 chromatography. A peptide isolated from rat plasma has simi-
lar properties (Chochinov, Mariz and Daughaday, 1977; Daughaday, 
Mariz, Daniels, Jacobs and Rubin, 1978). 
c) Non-suppressible insulin-like activity-soluble (NSILA-S) 
When insulin bioactivity of serum was measured by the conver-
sion of 14c-U-glucose into 14co2 or the incorporation of 14c-U-glu-
cose into glycogen in rat diaphragm in the presence of an excess of 
anti-insulin serum, 90-95% of the insulin-like activity in the 
· serum remained and the term non-suppressible insulin-like activity 
(NS I LA) was applied to this activity (Froesch, Bilrgi, MUller, Humbel, 
Jakob and Labhart, 1967). The NSILA activity wa s found to reside 
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in a variety of different proteins. NSILA-S is the term applied 
to those fractions which are soluble in acid-ethanol (Froesch, 
Schlumpf, Heimann, Zapf, Humbel and Ritschard, 1975). Large scale 
purification from out-dated human plasma of Cohn fr_ac tion I I I was 
by _means of acetone extraction of lipids, acid ethanol extraction, 
Sephadex G-75 gel chromatography, CM cellulose and DEAE ion ex-
change chromatography, Sephadex G-50 gel chromatography and final 
CM cellulose ion exchange chromatography. This resulted in a 
270,000 fold concentration of the peptide and on polyacrylamide gel 
electrophoresis this was found to have two major components, both 
bioactive. The amino acid composition of the material has been 
determined (Froesch, Schlumpf, Heimann, Zapf, Humbel and Ritschard, 
1975; Rinderknecht and Humbel, 1976), and the amino acid sequen-
ces and secondary structures have been found to show considerable 
homology with proinsulin. This has resulted in the new term 
insulin-like growth factor (IGF) being applied to the peptides. 
The two peptides IGF-I and IGF-II have been shown to have slightly 
different stimulatory potencies in rat fat pad, rat costal carti-
lage and chick cartilage assays (Humbel and Rinderknecht, 1977). 
Another major NSILA component is that which is insoluble in 
acid ethanol (NSILA-P) (Jakob, Hauri and Froesch, 1968; Poffenbarger, 
1975). This material has a molecular weight of> 100,000 and may 
be a major fraction of the total NSILA activity of serum. 
d) Multiplication-stimulatory activity (MSA) 
Calf serum or tissue culture medium in which a cloned liver 
cell tumour (derived from a buffalo rat) was cultured, has been 
shown to contain factors which stimulate the multiplication of 
chick embryo fibroblasts in culture. Calf serum was subjected to 
ion exchange chromatography on Dowex 50 W-X8, Biogel P-100 chroma-
tography and preparative polyacrylamide gel electrophoresis irhich 
resulted in an 8000-fold concentration of activity (Pierson and 
Temin, 1972). The same process was used to concentrate MSA from 
serum-free rat liver cell tumour conditioned medium. The major 
component of MSA has a molecular weight of 10,000 but no clearcut 
isoelectric point (Smith and Temin, 1974). 
iii) Tissue growth factors not related to cartilage growth 
a) Somatomedin B 
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An acidic fraction from the initial electrophoretic step in 
the preparation of somatomedin A was found to stimulate thymidine 
uptake into human glia-like cells and human foetal lung fibroblasts 
but to have no sulphation factor activity (Uthne, 1973). Further 
purification by electrophoresis at pH 5 and Sephadex G-50 chromato-
graphy yielded a peptide with a molecular weight of 5,000 of known 
amino acid composition (Sievertsson, Fryklund, Uthne, Hall and 
Westermark, 1975). The full amino acid sequence of 44 amino acids 
has been determined and shows considerable homology with certain 
protease inhibitors. The physiological reasons for a protease 
inhibitor which is under partial growth hormone control is as yet 
not known (Fryklund, Skottner and Forsman, 1978). 
b) Nerve growth factor (NGF) 
A polypeptide extracted from the submandibular gland of the 
mouse was found to stimulate the outgrowth of nerve fibre processes 
from chick sympathetic ganglia in culture and in vivo (Levi-
Montalcini and Angeletti, 1968). A structurally similar peptide 
-has been isolated from cobra venom (Cohen, 1959). Both peptides 
show structural homology with proinsulin (Hogue-Angeletti, Bradshaw, 
and Frazier, 1975). NGF has not been shown to have sulphation fac-
tor activity (Hambley, Howell and Grant, 1974). 
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c) Epidermal growth factot (EGF) 
An extract of male mouse submandibular gland has been isolated 
which causes precocious eyelid opening and tooth eruption in new-· 
born mice (Cohen, 1962). The factor is a polypeptide, molecular 
weight 6045, and is a single chain of 53 amino acid residues and 
has been shown to stimulate amino acid uptake, protein synthesis 
and RNA synthesis of cell cultures of ectodermal origin, as well 
as to stimulate the growth of fibroblasts in culture. Like NGF 
the material is present in periductal cells and is stimulated by 
testosterone (Cohen, Carpenter and Lembach, 1975). Urogastrone, 
an inhibitor of gastric acid secretion and a stimulator of mucosal 
proliferation, has been isolated from human urine and shown to have 
a structure closely homologous to EGF (Gregory, 1975). 
d) Granulocytosis-inducing ~factor was the third peptide derived 
from mouse submandibular gland and stimulates the proliferation of 
granulocyte precursors in culture (Angeletti, Salvi, Capani and 
Frati, 1965). 
e) Fibroblast growth factor (FGF) 
Extracts of pituitary glands or brain have yielded a peptide, 
molecular weight 13,000, which stimulates growth or a variety of 
cells in culture: 3T3 cells, mouse and human fibroblasts, Y1 
adrenal cells, 16 myogenic cells, foetal calf myoblasts, human 
amniotic cells and early passages of rat chondrocytes. The prepa-
ration was free of known pituitary hormones and proteases 
(Gospodarowicz, Rudland, Lindstrom and Benirschke, 1975). 
f) Erythropoietin stimulates the proliferation of erythrocyte pre-
cursors both in vivo and in vitro (Gordon, 1971) and is under par-
tial growth hormone control (Peschle, Rappaport, Sasso, Gordon and 
Condorelli, 1972). Liver, spleen and kidney appear to be the 
main sites of synthesis; 
g) Thymic growth factors 
A variety of factors have been extracted from calf thymus 
which include thymosin, thymopoietin I and II and a number of other 
less well characterised factors. These factors stimulate the pro-
liferation and immunocompetence of lymphocytes and other components 
of the immune system (White and Goldstein, 1975). 
h) Relaxin 
A factor isolated from porcine corpora lutea which relaxed .the 
pubic symphysis of oestrogen primed guinea pigs was termed relaxin. 
It has been shown to have homology with proinsulin (James, Niall, 
Kwok and Bryant-Greenwood, 1977; Schwabe and McDonald, 1977). In 
spite of a major locus of its action being skeletal tissue, sulpha-
tion factor activity of the peptide has not yet been examined 
(Niall, personal communication, 1977). 
iv) Comparison of biological actions of growth factors 
(Table 2. 3) 
Four well defined peptides meet the criteria which make them 
true somatomedins: somatomedin A, . somatomedin C, NSILA-S (IGF-I 
and II) and MSA. The first three are all of similar molecular 
weight and are derived from human plasma where they are bound to a 
high molecular weight protein. All are bioactive in the rat, pig 
and chick cartilage assays except NSILA-S which appears to have no 
activity in the porcine cartilage assay (Hall, Takano, Fryklund and 
Sievertsson, 1975; 
and Marshall, 1975; 
and Morell, 1975). 
Van Wyk, Underwood, Baseman, Hintz, Clemmons 
Froesch, Zapf, M.euli, Mader, Waldvogel, Kaufmann 
MSA has mitogenic effects on chick fibroblasts, 
sulphation factor activity and NSIL activity (Moses, Nissley, 
Rechler, Short and Podskalny, 1978). Fibrobl~st growth is stimu-





















































































































































































































































































































































































































































































and Marshall, 1975) and NSILA-S (Froesch, Zapf, Meuli, Mader, 
Waldvogel, Kaufmann and Morell, 1975) but probably not somatomedin 
A (Wasteson, Westermark and Uthne, 1975). The two components of 
NSILA-S (IGF-I and II) whilst both having NSILA, sulphation and 
mitogenic activity, have them in slightly different proportions 
(Zapf, Schonle and Froesch, 1977). Somatomedin A (Hall, Takano, 
Fryklund and Sievertsson, 1975) and somatomedin C (Van Wyk, 
Underwood, Baseman, Hintz, Clemmons and Marshall, 1975) both have 
NSILA properties. There is evidence that the action of somatome-
dins is associated with an inhibition in adenylate cyclase activity 
I 
of their target tissues (Hall, Takano, Fryklund and Sievertsson, · 
1975; Froesch, Zapf, Meuli, Mader, Waldvogel, Kaufmann and Morell, 
1975; Tell, Cuatrec~sa~, Van Wyk and Hintz, 1973). 
In vivo somatomedin A injected into hypophysectomised rats was 
found to increase tibial epiphyseal width and incorporation of amino 
acids into diaphragmatic muscle (Uthne, 1975) and to stimulat~ sul-
phation of skin and cartilage (Fryklund, Skottner and Forsman, 1978). 
14 In the intact rat NSILA-S stimulates the incorporation of C-U-glu-
cose into the glycogen of diaphragmatic muscle and the lipids of 
adipose tissue. The hypoglycaemic effects of NSILA-S is more pro-
longed than that of insulin (Froesch, Schlumpf, Heimann, Eigenmann 
and Zapf, 1975) and there is evidence to suggest that NSILA-S acts 
via a receptor distinct from that of insulin to activate the same 
glucose transport mechanism as insulin itself (Meuli and Froesch, 
19 7 7) . 
G Receptor binding of somatomedins and radioreceptor assays 
The availability of well characterised purified somatomedins 
opened the door for the study of the interaction of these peptides 
with cell membranes. Radioreceptor assays using radioiodinated 
somatomedins or insulin binding to receptor sites on cell surfaces 
from various tissues have been developed. In broad outline, 
NSILA-S, somatomedins A and C and MSA bind to their own receptor(s) 
with high affinity as well as to insulin receptors with lower affi-
nity. Growth promoting effects may be mediated by . the former and 
the insulin-like effects by the latier (which at physiological con-
centration is of minor importance). The binding and radioreceptor 
assays for non-somatomedin growth factors (EGF, NGF, FGF, etc.) 
lie outside the scope of this review. 
Somatomedin A 
125 r-Somatomedin A binds specifically to membranes prepared 
from various tissues of rat and monkey including lung, kidney, 
liver, thymus, brain, spleen, pancreas, heart and fat (Takano, 
Hall, Fryklund and Sievertsson, 1976), cartilage and human placenta 
(Hall, Takano, Fryklund and Sievertsson, 1975). Placental membranes 
have been used as a ligand in a radioreceptor assay which is not 
completely specific in th at similar concentrations of somatomedin A 
or C (Hall, Takano, Fryklund and Sievertsson, 1975) or IGF-I and 
IGF-II (Hall, Brant, Enberg and Fryklund, 1978) will displace 
125 1-
Somatomedin A bound to the membranes as will very high concentra-
tions of insulin. No data on displacement by MSA have been repor-
ted. 
Somatomedin C 
125 I-Somatomedin C binds to membranes from rat liver, embryo-
nic chick cartilage, human placenta, liver, lung, kidney, brain, 
muscle and thymus (Van Wyk, Underwood, Baseman, Hintz, Clemmons and 
Marshall, 1975; Hintz, Clemmons, Underwood and Van Wyk, 1972). 
U . 1 t 1 b ~. d d 125 1 S d. C sing p acen a mem ranes as 1gan an - omatome 1n as tracer, 
a radioreceptor assay has been developed. Crossreaction occurs 
with somatomedin A, MSA and with insulin in very high concentratio1~ 
.) .) 
but not with the non-somatomedin growth factors NGF and EGF (Van 
This Wyk, Underwood, Baseman, Hintz, Clemmons and Marshall, 1975). 
radioreceptor assay has been used to monitor the isolation of a 
somat omedin C-like peptide from amniotic fluid (Chochinov, Mariz, 
Hajek and Daughaday, 1976). 
NSILA-S (IGF) 
125 I-NSILA-S binds to rat adipose tissue, rat liver, chick 
embryo fibroblasts and transformed human lymphocytes (Froesch, Zapf, 
Meuli, Mader, Waldvogel, Kaufmann and Morell, 1975; Magyesi, Kahn, 
Roth, Neville, Nissley, Humbel and Froesch, 1975; 
Waldvogel, Schalch and Froesch, 1975). Impure preparations of 
somatomedin A and C, insulin and proinsulin poorly displace 125 r-
NSILA-S from liver cell membranes while MSA is almost as potent as 
NSILA-S its elf. 
In addition to its receptors on cell membranes NSILA-S has a 
highly specific high affinity serum binding protein which has been 
utilised as a ligand for a radioligand assay (Zapf, Waldvogel and 
Froesch, 1975). 
MSA 
125I-MSA binds to rat liver membranes, chick embryo fibroblasts, 
transformed human lymphocytes (Rechler, Podskalny and Nissley, 1976) 
and human placental membranes (Chochinov and Daughaday, 1977). MSA 
and NSILA-S are equipotent in their ability to displace each other 
from liver cell membranes but are poorly displaced by insulin (Zapf, 
Mader, Waldvogel, Schalch and Froesch, 1975; Rechler, Podskalny and 
Nissley, 1976). 125 I-MSA bound to chick embryo fibroblasts and 
plac ental membranes is easily displaced by insulin while 125 r-MSA is 
even more re adily displaced from transformed human lymphocytes by 
insulin than by MSA itself, indicating that these cells havi only 
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insulin receptors of low affinity and no high affinity MSA receptors 
(Rechler, Podskalny and Nissley, 1976). 
H Radioimmunoassay of Somatomedins 
The development of radioimmunoassays for the somatomedins, was 
dependent on the availability of pure or semi-pure somatomedin pre-
parations for the immunisation of suitable animals to generate anti-
sera of adequate specificity and titre, for radioiodination to pro-
duce a label and for standards. Radioimmunoassay with its poten-
tial for specificity, sensitivity and the ability to deal with 
large numbers of samples, offers enormous advantages in the study 
of somatamedin and will be a major area of study in the years to 
come. 
i) Somatomedin A (Hall, Brant, Enberg and Fryklund, 1978) 
A radioimmunoassay has recently been developed for somatomedin 
A using an antibody raised in chickens, human somatomedin A label-
led with 125 r by the chloramine-T method as tracer and highly puri-
fied human somatomedin as standard; bound from free tracer was 
separated by polyethylene glycol (or charcoal). The assay was not 
completely specific in that it crossreacted with insulin-like growth 
factor (IGF-I and IGF-II). 
ii) Somatomedin C (Fur:lanetto, Underwood, Van Wyk and D'Ercolc 
197 7) 
A radioimmunoassay for this peptide has been developed using an 
antiserum raised in rabbits to a human somatomedin C - ovalbumin 
complex, chloramine-T iodinated human somatomedin as label (5,800 
U/mg, 90% pure, < 1 part per 10,000 immunoreactive insulin) and a 
pool of normal human serum from three healthy adult males as stan-
dard with an arbitrary value of 1 U/ml; bound from free tracer was 
\. 
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separated by double antibody precipitation. Because of competition 
between serum binding proteins and antibody, the dose-response 
curves for standard serum and purified somatomedin C were not para-
llel under equilibrium conditions of assay. This non-parallelism 
could be overcome by a non-equilibrium assay procedure. The anti-
serum bound 70% of the label at 1:10,000 dilution and had a Ka of 
4.6 x 10 10 litres/mole. There was no crossreactivity with pitui-
tary hormones or MSA. There was slight crossreactivity with insu-
lin at very high concentrations and somatomedin A crossreacted 3% 
on a weight basis. NSILA was not tested. 
In normal humans radioassayable somatomedin Crose dramati-
cally from birth (0. 38 U/ml) to four years (1. 30 U/ml) after which it 
was fairly constant (adults 1.50 U/ml). In acromegaly mean levels 
I 
were 6.28 U/ml while in hypopituitarism mean levels were 0.2 U/ml, 
the difference between these two being greater than with any other 
assay of somatomedin. 
Sera from dog, baboon, guinea pig, lamb and chicken were all 
found to produce parallel displacement in the assay, rat serum and 
-
purified rat somatomedin caused non-parallel displacement, while 
fish serum produced no displacement. 
iii) Somatomedin B (Yalow, Hall and Luft, 1975b) 
This peptide was the first of the somatomedin ~roup to be mea-
sured by radioimmunoassay. The assay makes use of an antiserum 
raised in guinea pigs to a human somatomedin B - guinea pig albumin 
conjugate, human somatomedin B iodinated by the chloramine-T tech-
nique as tracer and highly purified human somatomedin Bas standard. 
I 
Bound tracer was separated from free by a precipitating second anti-
body or by uncoated charcoal. 
Somatomedins A and C and NSILA-S did not crossreact in the 
assay. The assay was able to discriminate between acromegalic 
) 
(19.3 + 2.3 µg/ml) and hypopituitary (6.6 ~ 0.5 µg/ml) sera and a 
fall in serum somatomedin B could be demonstrated after the success-
ful treatment of acromegalics. Immunoreactive somatomedin B was 
only present in the sera of monkeys and man and not of guinea pig, 
mouse, rat, cow, dog, sheep, pig or rabbit. 
Low serum somatomedin B levels have been reported 1n liver and 
renal disease (Eversmann, Glockner, Gottsmann, Weidl and Werder, 
1977). Radioimmunoassayable somatomedin B has been detected in 
urine (Yalow, Hall and Luft, 1975a). 
iv) Rat somatomedin (Daniels, Mariz and Daughaday, 1917) 
An as yet unperfected assay has been reported using an anti-
body raised in rabbits to rat somatomedin, a tracer of chloramine-T 
labelled rat somatomedin and rat somatomedin standards. There was 
no crossreaction with human somatomedin A and C, human insulin, 
proinsulin or NSILA-S. The assay cannot yet be applied to unex-
tracted rat serum due to problems with competition from serum pro-
teins for tracer. Extracts of hypophysectornised serum contained 
20% of the immunoreactive material of normal serum (100%), whilst 
serum from rats bearing growth hormone secreting tumours contained 
1000%. 
v) NSILA-S (Reber and Liske, 1976) 
A radioimmunoassay for this peptide using an antiserum raised 
in rabbits against human NSILA-S, chloramine-T radioiodinated 
highly purified human NSILA-S as label and highly purified human 
NSILA-S as standard; bound from free tracer was separated by the 
second antibody precipitation method. The assay was sensitive to 
30 pg/tube. Insulin, glucagon and growth hormone did not cross-
react in the assay but NSILA related growth factors were not exa-
mined. 
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vi) NSILA-P (Poffenbarger, 1978) 
A radioirnrnunoassay for this peptide has been reported using an 
antibody raised in rabbits to human NSILA-P. The assay does not 
crossreact with NSILA-S (IGF-I and II) sornatornedin C or MSA 
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CHAPTER THREE 
THE BIOASSAY OF SOMATOMEDIN ACTIVITY 
"And in a glas he hadde pigges bones" Geoffrey Chaucer 
A Introduction 
i) General and statistical considerations 
The diverse actions of somatomedin on a variety of tissues has 
been shown in Table 2.1. A practical bioassay making use of one or 
more of these actions was required. Such an assay had to provide 
acceptable sensitivity, precision and reproducibility for a reaso-
nable expenditure of time, effort and money. A large number of 
assay syst~ms have been described which lay claim to these ideals 
(see Table 3. 1). 
Bioassays have the great advantage of measuring a physiologica~ 
as distinct from an immunological or chemical, property of a hormone 
but often lack precision. Non-specific stimulation must be rigo-
rously guarded against and inhibitors may interact to give reduced 
values (which may of course represent the biologically relevant net 
activity). Because of interassay variability in the responsiveness 
of the bioassay preparation and the techniques in handling it, a 
standard must be assayed on each occasion. Standard and unknown 
sample are assumed to be qualitatively similar but may differ 
quantitatively from each other. Thus standard and. unknown should 
dilute in parallel for valid potency ratios to be calculated. The 
absence of an international reference standard of either serum or a 
purified somatomedin preparation (Bangh am, 1976, personal communi-
cation) has resulted in each laboratory using its own reference 
standard (usually a pool of "normal" . human serum) and makes compari-






































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































The usual treatment of assay data is to express the assay res-
ponse (e.g. 35 so4 incorporation) as a function of the logarithm of 
dose of somatomedin (serum), to select linear portions of the dose-
response lines for standard and unknowns, and to calculate the 
least square regression lines of these dose responses. Only if 
the dose response regression lines of unknowns are linear and 
parallel to those of the standard to within an acceptable probabi-
lity limit (usually arbitrarily chosen asp< 0.05) can a valid po-
tency ratio be calculated. The potency ratio is derived from the 
horizontal distance between the least square regression lines of 
standard and unknown, the precision being expressed as confidence 
or fiducial limits. 
The index of precision or residual mean square per slope (A) 
for the standard provides a general idea of the reliability of a 
bioassay. When the A of an assay is 0.3 - 0.4, it will provide 
semi-quantitative data on large differences in potency ratios, 
while with A of 0.2 - 0.3 more quantitative data on smaller diffe-
rences can be obtained. A more detailed discussion of the statis-
tics of parallel dose-response bioassays based on the work of Finney 
(1964) appears in Appendix C. 
ii) An appraisal of commonly used somatomedin bioassays 
a) Hypophysectomised rat _costal cartilage bioassays: Such 
assays were the first for somatomedin and they have evolved little 
since that of Salmon and Daughaday (1957). The major advantage of 
such assays is their sensitivity, 0.5% serum or less, (Daughaday, 
Phillips and Herington, 1975) (see Table 3.1) but they show a high A. 
A number of techniques have been applied to improve the index of 
precision including a single rat source of cartilage (Wiedemann and 
Schwartz, 1972) which suffers from the defect that each rat only 
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provides enough cartilage for the determination of a standard and 
one (or at most two) unknown sera. The use of a serine-free buffer 
(Daughaday, Salmon and Alexander, 1959) increases the precision of 
the assay at the expense of a potential loss of specificity, in 
I 
that serine even in the absence of serum stimul a tes 35 S04 incorpora-
tion. Other amino acids which have been shown to stimulate rat 
cartilage are glycine, glutamini, threonine and valine (Koum~ns, 
and Daughaday, 1963; Almqvist, 1961; Salmon and Daughaday, 1958; 
Bostrom, Roden and Westermark, 1955). Chick cartilage was found to 
be stimulated by glutamine and serine (Hall, 1970). Homocysteine 
which stimulates cartilage may be responsible for the skeletal ab-
norma lity of homocysteinuria (Dehnel and Francis, 1972). All these 
amino acids and a large range of other amino acids are present in 
the incubation and dilution media advised for somatomedin assays, 
the concentrations being similar to those found in normal human 
serum (Daughaday and Reeder, 1966; Hall, 1970, Van den Brande, Du Caju, 
197 4 ; Phillips, Herington and Daughaday, 1974). To date no attem-
pts have been made to adjust amino acid composition of media to that 
of t h e serum of the species or condition being assayed (Van den 
Brande, Kootte, Tielenburg, van der Wilk and Huyser, 1974; Shapiro 
and P i ms t one-, 1 9 7 7) . As in most assays serum is considerably dilu-
ted, any changes in amino acid composition probably do not result 
in significant effects providing the diluting medium contains ade-
quate concentrations of stimulatory amino acids. The glucose added 
to all assay media provides a source of energy and substrate for 
mucopolysaccharide synthesis (Herington, Adamson and Bornstein, 
1972). 
When comparing 35 S04 to 3H Methyl-thymidine incorpor a tion 
th 1 tt . 11 f d t b ·t· 35 S04 e a er 1s genera y oun o e as sens1 1ve as incorpora-
tion but to have consistently greater~ values (see Table 3.1). In 
/ 
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general, the high sensitivity and low precision of the hypophysec-
tomised rat costal cartilage assays makes them best suited to the 
monitoring of somatomedin purification or production by isolated 
organ or tissues (Daughaday, Phillips and Herington, 1975). 
b) Intact-rat costal cartilage bioassays: Such assays 
using intact male rats age d 21-27 days fasted for 48 hours were 
originally described by Almqvist (1961) and improved by Yde (1968) 
and Alford, Bellair, Burger and Lovett (1972). All use a serine 
free buffer (with its potential lack of specificity) and provide a 
sensitivity similar or slightly less than that of hypophysectomised 
I 
rat costal cartilage, with A values of 0.3 or less. The use of 
intact rats is advantageous in that they are more readily available, 
cost far less and more easily maintained than hypophysectomised rat~ 
The assay of Alford, Bellair, aurger and Lovett (1972) is interes-
ting in that the cartilage is dissolved by papain and the mucopoly-
saccharide precipitated on filter paper strips by acid-ethanol before 
counting; which allows the re-use of scintillation fluid (scinti-
llation fluid can be a major expense in somatomedin bioassays). 
c) Embryonic chick pelvic cartilage bioassays: Adamson and 
Anast (1966) noted that serum stimulated 35so4 incorporation into 
the pelvic rudiment s of chick embryos. Hall (1970) used such 
pelvic rudiments for the bioassay of somatomedin. This assay pro-
vides a sensitivity as low as 2.5% serum with A values of 0.3 or 
less, in addition embryonated hens' eggs can be obtained at rela-
tively low cost, the tissue preparation is not difficult and the 
resultant cartilage fragments are uniform in size, shape and 
weight for a given embryonic age. Such assays are considered satis-
factory for the monitoring of somatomedin purification an~ for 
clinical studies (Daughaday, Phillips and Herington, 1975). 
43 
(d) Porcine costal cartilage bioassays: Such assays have 
been described by Van den Brande and Du Caju (1974) and Phillips, 
Herington and Daughaday (1974) and have the advantage that a single 
animal provides the cartilage for the assay of 8 or more unknown 
sera. Other advantages are the fact that the uniform discs punched 
out of the porcine cartilage do not have to be individually weighed 
and a A value less than 0.3 is consistently achieved. In spite of 
this high precision, the assay is less sensitive in that it does 
not respond to serum concentrations less than 5%. The assay of 
Van den Brande and Du Caju (1974) uses a phosphaline buffer and 
examines the incorporation of 35 S04 and/or 3H thymidine while 
Phillips, Herington and Daughaday (1974) using 35 so4 incorporation 
and a Tris-HCl-amino acid buffer claim ~ steeper and more consistent 
dose response curve and omit the preincubation step. This assay is 
particularly suited for the assay of large numbers of samples. 
(e) Bioassays using cartilage from other sources: A variety 
of other cartilagenous tissues have been used, these include; 
hypophysectomised puppy cartilage (Fujisawa, 1964) which is not 
practical because of the complex surgery required, the limited 
availability and cost of laboratory dogs; monkey costal cartilage; 
human neonatal articular cartilage (Van den Brande, Kootte, 
Tielenburg, Van der Wilk and Huyser, 1974) and immature ovine cos-
tal cartilage (Daughaday, Phillips and Herington, 1975). All com-
pare unfavourably with the porcine costal cartilage assay in that 
tissue is either not easily available (man and monkey) or results 
are less satisfactory (lamb cartilage). An assay using normal 
immature rabbit costal cartilage (Bala, Hankins and Smith, 1975) 
makes use of only one animal per assay and provides satisfactory 
sensitivity and precision. 
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(f) Bioassays utilising cell cultures: Isolated chick pel-
vie rudiment chondrocytes have been used by Garland, Lottes, Kozak 
and Daughaday (1972). This provides an assay sensitive to as low 
as 0.5% serum and having a A value less than 0.4, but many sera arc 
I 
inhibitory unless heat treated (S6°C for 30 minutes) and it has not 
been found to consistently distinguish normal from hypopituitary 
serum. The main potential use of this assay is in the isolation of 
somatomedin-rich fractions from plasma. 
Uthne (1973) used thymidine incorporation into a culture of 
human glia-like cells obtained from a brain biopsy to monitor the 
purification of a stimulatory serum fraction which came to be known 
as somatomedin B. Wasteson, Uthne and Westermark (1973) have used 
35so4 incorporation into a culture of human foetal fibroblasts and 
have shown this to be stimulated by serum or somatomedin-rich plasma 
fractions. 
Reasons for choosing the porcine costal cartilage bioassay 
for the present study: 
The porcine costal cartilage assay of Van den Brande and Du 
Caju (1974) was chosen because it provided adequate sensitivity with. 
good precision, there was no need for large numbers of hypophysec-
tomised animals which were unobtainable locally and which are very 
expensive to import and travel extremely badly. In addition, the 
assay used cartilage discs of very uniform weight, individual 
weighing of cartilage fragments (a very tedious process) was not 
required and the Cape Town Municipal Abattoir was within 5 minutes 
drive of the laboratory and was known to be highly cooperative in 
assisting with medical research. 
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B Methodology 
i) Source of cartilage 
The costal cartilages (and sternum) from ribs 4 to 8 bilate-
rally were obtain~d from young pigs, weight 30-40 Kg, age 140-190 
days. The pigs were slaughtered at the Cape Town Municipal Aba-
ttoir and due to the excellent cooperation of this institutidn, the 
cartilages could be excised within 20-30 minutes of the moment of 
death (i.e. as soon as the animals were bled and eviscerated). 
ii) Transport of cartilage 
The block of tissue including the costal cartilages was placed 
in a large sterile screw-cap jar of sterile saline kept at 4-6°C in 
an insulated container. The transit time from abattoir to labora-
tory was 5-7 minutes. Although transport in cold saline was used 
routinely it was found that transport at ambient temperature provi-
ded identical results. 
iii) Preparation of cartilage 
(a) On arrival at the laboratory the block of tissue was rin-
sed in 6 changes of sterile saline (at least 3 litres), placed in 
a sterile tray and with sterile instruments the muscle and connec-
tive tissue dissected from the costal cartilages. The perichon-
dium was left intact, the 2 cm adjacent the costochondral junction 
and the 1 cm adjacent the sternocostal joint were excised and dis-
carded. (b) The cleaned cartilage segments were sliced into 2mm 
tl1ick slices (at right-angles to the long axis of the cartilage) 
with a razor blade guillotine (Fig. 3.1). (c) From the slices of 
cartilage uniform discs of cartilage were punched using a Trucut 
(Travenol Laboratories Inc., Deerfield, Illinois) biopsy needle, 
the tip of which was ground off square and sharpened. This needle 
was held in the chuck of a Minimat lathe/drillpress and punching was 
Fig. 3.1 Razor blade guillotine 
Rigid single edge razor blades are held 
2 mm apart in a hinged frame. This 
mechanism made it possible to cut 
uniform 2 mm sli~es of cartilage. 
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carried out under saline in a perspex chamber (Fig.3.2). From each 
slice of cartilage one to six discs of cartilage were punched, and 
expelled from the needle by pressure on the ground-down stillet 
(Fig. 3.3). Cartilage discs were punched out about 2 mm from the 
edge of the slice and from each other. (d) The saline was drained 
from the punching chamber and the cartilage discs (~ 300) placed in 
I 
a sterile beaker with SO ml of incubation medium. This was incub a-
ted (covered with sterile plastic film) for 20 hours at 37°c in a 
non-shaking incubator. The incubation medium was that described 
by Daughaday and Reeder (1966) and is essentially a Krebs . phospho-
saline buffer supplemented with amino acids, dextrose and antibio-
tics (Penicillin, Streptomycin and Kanamycin). Full details of 
the composition and method of preparation of this medium are provi-
ded in Appendix B. 
iv) Incubation of cartilage with test substances (e.g. serum) 
(a) The cartilage discs were incubated in a specially designed 
rack with a standard and unknown (Fig. 3.4 and Fig. 3.5). As can 
be seen from the figures, the cartilage discs were confined to the 
perforated teflon tubes which rest in pots containing the serum di-
lutions. The dilutions usually used were 40, 20, 10, 5 and 2.5% 
or 40, 20, 10 and 5%, the volume being 1 ml and each concentra-
tion being made up in triplicate. The rack could thus accommodate 
6 unknowns and 1 reference standard as 10 point symmetrical assays, 
or 7 unknowns and 1 reference standard as 8 point symmetrical 
assays. In each case at least 3 tubes were filled with incubation 
medium only (0% serum). 30 to SO discs were kept in the beaker in 
incubation medium for later determination of the weigl1t of cartilage 
discs. (b) After 46 hours of incubation with dilutioris of unknowm 
and standards the rack holding the perforated tubes was removed from 
Fig. 3.2 Minimat lathe/drillpress with modified 
biopsy needle held in the chuck and 
perspex chamber clamped in place. 
The . cartilage discs were punched out 
under saline in the perspex chamber. 
48 . 
Fig. 3.3 Slices of cartilage with the cartilage 
discs punched from them by the modified 
biopsy needle (visible with its stillet 
at the upp e r right of the photograph). 
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Fig. 3.4 Incubation rack: Perforated teflon 
tubes (above) fit into teflon pots 
(below). When in place the clearance 
between the tubes and the bottom of 
the pot is 1 mm. 
so 
Fig. 3.5 Incubation rack and perspex bath for 
simultaneous incubation of all 
cartil age discs in the same 
35 S04 
containing medium. The rack of 
perforated teflon tubes (above) is 
lowered into the perspex bath (below). 
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the rack holding the pots of samples. The lower l to 
1/3 of the 
perforated tubes were lowered into a perspex bath containing sterile 
normal saline, agitated for 30 seconds, removed and gently shaken 
free of residual saline. The perspex bath was then filled with 
I 
incubation medium containing Na2 35 so4 2 µCi/ml (carrier-free Na2
35 so~ 
The Radiochemical Centre, Amersham, U.K.) (Fig. 3 . 5). The perfora-
ted tubes were 1 mm from the bottom of the bath and the_ volume of 
medium was such as to completely submerge the cartilage discs. This 
incubation was maintained for 4 hours. (c) The rack containing the 
perforated tubes with their cartilage discs was transferred to a 
stainless steel bath fitted with a siphon which automatically filled 
and emptied the bath. After an initial rinse with tap water at 
room temperature the cartilage was killed by the addition of water 
at 80-90°C. This was retained for 10 minutes after which repeated 
filling and emptying of the bath was carried out over the next 30 
minutes to rinse off all unincorporated Na2
35 S04 . In 5 consecutive 
assays the radioactivity of the effluent wash was measured and found 
to be background after 7-9 exchanges. A period of 30 minutes pro-
vided at least 20 changes of wash water (Fig . 3 . 6) . 
v) Preparation of cartilage discs for counting 
The 2 discs from each perforated tube were shaken out into 25 
ml glass scintillation counting vials (Packard) each containing 0.5 
ml 23M Formic Acid (Merck, Darmstadt) . The vials were then 
loosely capped with polyethylene-lined caps (metal foil-lined caps 
were subject to corrosion) and heated to so 0 c for 60-90 minutes in 
an oven, which resulted in complete dissolution. After cooling, 
Instagel (Packard) 10 ml was added to each tube, and after vigo-
rous mixing the tubes placed in~ cool dark place for 4 hours before 
35 S04 was determined by liquid scintillation counting. The 30-50 
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Number of changes of washing water 
Removal of unincorporated Naz 
35S04 from incubation 
rack containing cartilage fragments by washing in 
siphoning rinsing bath. Graph shows CPM 
35 so4/ml 
washing water with each change (mean~ SD> n = 5). 
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riment were washed in 3 changes of absolute alcohol over 12 hours 
and then 2 changes of ether (! hour each) to dehydrate them. Indi-
vidual discs were then weighed to the nearest 0.1 mg on a Metler 4 
place digital balance. The mean dry weight of these represen,tative 
samples of cartilage discs from each batch was 1.8-1.9 mg with a 
coefficient of variation from 5-7% on a sample of 8 consecutive 
assays. Later mean weight of cartilage discs was determined simply 
by weighing en masse and dividing by the number of discs weighed. 
vi) The 35S04 in samples was determined by liquid scintillation 
counting with a Packard Tricarb Z650 appropriately set for 35 s 
(Appendix B). 
vii) The somatomedin potency ratios were calculated using a 
Hewlett-Packard 9810 desk computer with plotter number and extended 
memory facilities. The programme listing was kindly provided by 
Dr. L. Phillips, Northwestern University College, U.S.A., and a 
full description of the programme is found in Appendix C. Essen-
tially it provides a log-log transformation of the incorporation of 
35 so4 and serum t t· ·th th 1· · d d concen ra ion, w1 e 1near1se ose response 
line plotted by the computer, the linear portion is selected by eye 
and subjected to analysis. The programme provides for tests of 
linearity (95% confidence level), linear regression on the line and 
the index of precision (A). The standard and unknown are then 
compared, and parallelism, heteroscedasticity, Finney's g and 
potency ratio with 95% confidence limits calculated. The statis-
I 
tics used were those for symmetrical bioassays (Finney, 1964) and 
are described in detail in Appendix C. 
viii) Standard sera 
In the absence of international reference preparations or even 
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international reference sera, use was made of a pool of serum made 
up of 30 ml of serum from 30 normal adult males (aged 20-48) who 
were clinically in good health and normal for height and weight. 
For rats, a pool of serum from 60 normal fed adult male rats was 
used. In both cases the blood was allowed to clot at 4°C, the 
serum separated by centrifugation (2000g for 30 min at 4°C), the 
sera pooled, aliquoted and frozen at -20°c until use. 
C Validation of the bioassay (Methods and Results) 
The method described in Section B above was used routinely to 
determine serum somatomedin activity. A number of experiments were 
carried out to validate and optimise the assay. 
i) 35 To prove the uptake of S04 was an active process 
(a) Temperature dependence. Pairs of cartilage discs prepa-
red as above were incubated with and without normal human serum at 
' 
a concentration of 40% in triplicate (volume 1mD in 6 ml plastic 
test tubes at 4, 17, 25, 30, 37, 40 , 45, 55 and so 0 c. Fig . 3 . 7 
~hows that both serum-free and 40% normal human serum stimulated 
35 S04 t k h . . h h . 1 . 1 up a e were at t eir maximum at or near t e p ys10 ogica 
temperature of 37°c and that the stimulation by serum was clearly 
greatest at 37°c. 
(b) Cartilage discs which were first killed by 5 minutes 
boiling in incubation medium failed to take up 
35 so4 above back-
ground, either with or without 40% normal serum . 
() T th t 35 S04 t k d d c o prove a up a ' e was energy epen ent. Carti-
lage discs were incubated at 37°c with and without 4% normal human 
serum and dinitrophenol (Merck~ Darmstadt) at a variety of concen-
trations. Dinitrophenol uncouples oxidative phosphorylation and 
Effect of Temperature on
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The effect of temperature on basal (0% normal pooled 
human serum) and stimulated (40% normal pooled human 
) 35so · · · · · 1 serum 4 incorporation into porcine carti age 
discs in vitro. Incorporation with or without serum 
is greatest at 37°c as is the stimulatory effect of 
serum. The point designated 100°C is cartilage discs 
boiled for S minutes and then subjected to incubation 
at 37°c. The graph shows mean! SEM, n = 3). 
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Fig. 3.8 shows that both stimulated and unstimulated 
35
S04 incor-
poration was to a large extent dependent on oxidative phosphoryla-
tion. 
(d) To show that 35 S04 incorporated into cartilage was in 
the form of large molecular weight mucopolysaccharides. Cartilage 
discs were prepared as described above and incubated either in 
serum-free medium or with pooled normal rat serum or pooled nor-mal 
human serum at a concentration of 40%. At the end of the assay 
procedure (after the washing step) instead of dissolving the carti-
lage in formic acid, a papain solution was used (0.5 mg/ml papain 
(Boehringer Mannheim) 2.0M cy.steine and 2mM EDTA in 0.1M phosphate 
buffer at pH 6.5). Twenty cartilage discs from serum stimulated 
and serum-free incubations, were incubated with 1 ml papain solu-
tion at 50°C with agitation for 16 hours, which resulted in com-
plete dissolution. An aliquot of the papain digest from stimula-
ted and unstimulated cartilage was run on a Sephadex G100 gel fil-
tration column (0.9 x SO cm) in 0.1M phosphate buffer (pH 6.5). In 
both instances the 35 S04 eluted as a high molecular weight form 
(see Fig. 3.9). 
When aliquots of the papain digest were further incubated with 
testicular hyaluronidase (0.5 mg/ml) (Boehringer Mannheim) at 37°c 
for 8 hours, all the 35S04 eluted as small molecular weight form 
(see Fig. 3.9). 
This method for the determination -Of the molecular weight of 
35so4 mucopolysaccharides in cartilage has been used by Alford, 
Bellair, Burger and Lovett (1972) for rat cartilage, and the resul-
ts for porcine cartilage are very similar. 
ii) To prove that the age of the pigs providing the cartilage 
was compatible with adequate sensitivity 
Effect of Dinitrophenol on In Vitro 35so4 
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Fig. 3.8 The effect of dinitrophenol on 35 S04 incorporation 
into porcine costal cartilage discs in vitro. 
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35 The stimulation of uptake of S04 by 30% normal human serum on 
cartilage discs from a number of pigs of ages from 6 weeks to 2 
years is shown in Fig. 3.10. This confirms the findings of others 
that age is the most important factor in determining cartilage sen-
sitivity to sulphation factor. Al though the very young animals 
provided the most sensitive cartilage it was not practical to use 
them and pigs aged 6-9 months were used routinely. 
iii) To prove that the area of cartilage chosen for the assay 
. f 1 . . 35 S04 . t. was uni orm y responsive in incorpora ion 
Three blocks of tissue were obtained· as described in Section B. 
(a) Samples of cartilage discs were obtained from the central por-
tions of ribs 4 to 8. There was no significant difference at any 
rib level in the incorporation of 35 S04, either unstimulated or 
stimulated with 40% serum. (b) Cartilage discs obtained from 
slices from the costochondral junction to the sternum were examined 
for basal uptake (serum free). Fig. 3.11 shows a far greater in-
corporation of 35 so4 into discs prepared from the area within 20mm 
of the costochondral junction while discs from the rest of the 
cartilage had a uniform uptake. (c) Discs prepared from the mid-
portionsof costal cartilages 4 to 8 were punched from the periphery 
(2mm from the surface), intermediate (4mm from the surface) and 
centre of the cartilage slices. There was no statistical differe-
nee between the three areas, either basally or stimulated by 40% 
normal human serum. 
iv) To prove that the sulphation factor measured with the 
porcine costal cartilage assay is growth hormone dependent 
(a) Serum was obtained and assayed from patients with panhypo-
pituitarism, isolated growth hormone deficiency (with and without 
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EFFECT OF AGE ON SENSITIVITY 
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Fig. 3.10 The sensitivity to stimulation by 30% normal 
pooled human serum of porcine costal cartilage 
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growth hormone treatment), untreated active acromegaly, treated 
acromegaly (treated with radiation, transsphenoidal hypophysectomy, 
transfrontal hypophysectomy or combined surgery and irradiation) and 
clinically normal persons. The findings of these assays is shown 
j 
in Fig. 3.12 which shows that serum somatomedin activity is low in 
panhypopituitarism and isolated growth hormone deficiency, and 
responds to growth hormone treatment, that it is elevated in acro-
megaly and reduced in some treated cases of acromegaly~ 
(b) Great difficulty was experienced in obtaining hypophysec-
tomised rats. A pool of hypophysectomised rat serum obtained from 
rats kindly hypophysectomised by Mr. D. de Wit of the State Vaccine 
Institute, Cape Town, was obtained and found to have a low somato-
medin activity (0.19 U/ml, 95% confidence limits 0.09-0.30) and 
absent serum radioimmunoassayable rat growth _hormone (no trace of 
pituitary tissue in the pituitary fossa). There were insufficient 
animals for growth hormone therapy to fully test growth hormone de-
pendence in the rat but in view of the studies on man, the data 
available on the rat and the fact that the assay has been fully va-
lidated in the past on many occasions, growth hormone dependency 
was considered to be proven. 
v) Reproducibility of somatomedin level results by the 
porcine costal cartilage bioassay 
Two secondary pools of rat serum were prepared, each consis-
ting of serum from 8 normal adult fed rats which were prepared in 
the same way as the primary rat standard, aliquoted and frozen at 
-zo 0 c. The secondary pools were measured against the primary rat 
standard on 6 occasions over a period of 15 months. Over the 
period studied there was a high degree of reproducibility in the 
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'TABLE ·3. 2 




Potency Ratio Potency Ratio 
(~ 95% Confidence (~ 95% Confidence 
limits) limits) 
1. 11 (0.98 - 1 . 2 2) 0.84 (0.68 - 0. 9 8) 
1. 2 3 ( 1 • 0 8 1 . 35) 0. 81 (0.65 - 0.96) 
1. 14 (0. 99 - 1 , 2 8) 0.80 (0. 6 4 - 0.96) 
1.01 (0.90 - 1 . 1 2) 0.90 (0.77 - 1 . 0 2) 
1. 09 (0.94 - 1 . 2 5) 0.83 (0.68 - 0. 9 7) 
1. 15 ( 1 . 0 1 - 1 • 30) 0. 86 (0. 71 - 1 . 01 ) 
Serum somatomedin activity of aliquots deep frozen (-20°C) 
rat serum pools (8 normal adult male rats each) against 
the primary normal fed adult male rat standard (pool of 60) 
on 6 occasions over 15 months (the first within 1 week of 
bleeding). 
vi) The precision of the porcine costal cartilage assay 
The indices of precision obtained for sulphation factor acti-
vity are similar to those reported by others (Van den Brande and Du 
Caju, 1974; Beaton, 1976). (See Table 3.3). 
TABLE 3.3 
MEAN INDEX OF PRECISION FOR THE 
CARTILAGE BIOASSAY (35S04 
Assay of Human serum: reference standard 
· unknown samples 




Mean l ). 
0.18 
0. 19 















The assay was found to be able to readily discriminate between 
serum-free medium and 5% normal pooled serum which represents by 
definition 0.05 U/ml somatomedin activity and was in keeping with 
that reported by others (Van den Brande and Du Caju, 1974; Phillips, 
Herington and Daughaday, 1974). 
D Discussion 
In validating this porcine costal cartilage bioassay for somato-
medin, it has been shown to conform to the characteristics of por-
cine costal cartilage in the hands of other workers (Van den Brande 
and Du Caju, 1974; Phillips, Herington and Daughaday, 1974; Beaton, 
1976). 
Sulphate uptake alone was used because of its greater precision, 
the lower cost, and the fact that there is an excellent correlation 
between somatomedin activity when measured either as sulphation or 
thymidine factor. There is no evidence that somatomedin activity 
of serum has dissociated sulphation factor and thymidine factor acti-
vities. 
6 7 . 
The uniformity of basal and stimulated sulphate uptake by the 
cartilage discs from areasof tissue used has been proven. The up-
take of sulphate has been shown to be an active temperature and 
35 energy dependent process in which the S sulphate .is incorporated 
into a high molecular weight mucopolysaccharide macromolecule. 
The growth hormone dependence of the factor bioassayed has been 
shown. This is a prerequisite for all somatomedin bioassays (Van 
Wyk, Underwood, Hintz, Clemmons, Voi,na and Weaver, 1974; Daughaday, 
Hall, Raben, Salmon, Van den Brande and Van Wyk, 1972). 
An adequate degree of reproducibility and an acceptable index 
of precision and sensitivity were obtained with this assay and it 
was considered suitable for further use in investigating somatomedin 
levels in experimental protein energy malnutrition. 
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CHAPTER FOUR 
EXPERIMENTAL PROTEIN MALNUTRITION 
"All flesh is Grass". The prophet Isaiah 
A Introduction 
i) Human clinical protein-energy malnutrition: 
This presents a highly heterogenous spectrum, varying in age 
of onset, duration and severity. Concomitant vitamin and miner~l 
deficiencies and water and electrolyte imbalance frequently-occur, 
while presentation to medical attention is all too often precipita-
ted by intercurrent infections and infestations. Protein deficie-
ncy of energy remains however the central core of the syndrome of 
protein-energy malnutrition, ranging from kwashiorkor to marasmus 
(Trowell, Davies and Dean, 1954). The diversity of the syndrome 
and the fact that withholding adequate food intake while non-thera-
:, peu_tic investigations and experiments are conducted is ethically 
unjustifiable, making an animal model of protein malnutrition 
highly desirable (Kirsch, Saunders and Brock, 1968). 
ii) Animal models of protein malnutrition: 
The perfectly valid animal model would simulate all the clini-
cal and biochemical parameters of human malnutrition, avoid vita-
min, mineral, water and electrolyte imbalances, infections and 
infestations, while being uniform in severity and age of onset. 
No such model exists. The problems have been reviewed by_ Kirsch, 
Saunders and Brock (1968). 
Larger animals such as the pig (Mccance and Widdowson, 1966; 
Platt, Heard and Stewart, 1964), the dog (Platt, Heard and 
Stewart, 1964) and the monkey (Deo, Sood and Ramalingaswami, 
1965; Follis, 1957) have the disadvantages of high cost, slow 
breeding and the need for large scale animal housing which limits 
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the numbers of animals that can be studied. Rat models (Mccance 
and Widdowson, 1966; Kirsch, Brock and Saunders, 1968; Edozien, 
1968; Sidransky and Verney, 1970; Enwonwu and Sreebny, 1970; 
Stead and Brock, 1972) have the advantages of low cost, ease of 
breeding and housing and the availability of large numbers of ani-
mals for adequate statistical analysis of data. 
Rats on low protein diets reduce food intake (Harper, 1959) 
which may be overcome by intragastric force feeding at the expense 
of high mortality (Sidransky and Verney, 1970) or "meal" feeding to 
reduce the anorexic effect (Stead and Brock, 1972; Padwaldesai, 
Ninj oor, Ramakrishnan, Sawant, Kum ta and Sreeni vasan, 19 69) . Al-
ternatively the reduced intake can be accepted, in that although 
reduced, it remains appropriate for body weight and weight loss 
does not occur (Stead and Brock, 1972). 
iii) The choice of an animal model: 
The model of Stead and Brock (1972) was chosen because it is 
produced in early weaned rats fed a low protein diet ad lib, a 
situation not dissimilar to that in human protein energy malnutri-
tion. A variety of endocrine aspects of this model had been pre-
viously studied in this laboratory and it was thus familiar, high-
ly characterised and much detailed endocrine and metabolic data was 
was available. Le Raith and Pimstone (1973) using a meal fed varia-
tion, demonstrated a lowered exchangeable calcium pool and bone 
calcium accretion rate associated with poor calcium absorption and 
undermineralised bone. Kalk and Pimstone (1974) showed a low in-
testinal calcium binding protein but normal vitamin D metabolism. 
Abnormal glucose tolerance and poor insulin secretion was found 
(Weinkove, Weinkove and Pimstone: 1976) similar to that in human 
protein-energy malnutrition (Becker, Pimstone, Hansen and 
Hendricks, 1971). 
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The isolated in situ perfusion of livers from these animals has 
been used to investigate insulin degradation (Sacks, Pimstone, 
Waligora, Peires, Weinkove and Saunders, 1977). 
B Methodology 
i) Breeding colony: 
Albino rats of the Wistar strain were used. 
inbred over many years is extremely homogeneous. 
This strain, 
Fertile females 
were introduced into a large (50 x 27 x 20 cm) plastic cage with 
several adult males and remained there until obviously pregnant. 
Each female was then placed in a separate plastic cage (40 x 25 x 
23 cm) until deliv~ry, only litters of 6-9 were used. All adults 
had continuous access to tap water and standard rat cubes (Epol 
Feeds, Cape Town), fresh shredded paper bedding was provided 
twice weekly. 
ii) Dietary regime: 
Unsexed weanling rats (i.e. fed maternal milk and just begin-
ning to eat scraps of standard rat cubes) aged 21 days, weighing 
28-38g were housed in mesh-bottomed (to prevent coprophagia) stain-
less steel cages (30 x 15 x 15 cm) at a density of 2-3 per cage 
(225-150 cm2 floor surface/animal). All animals were kept in an 
air-conditioned room at 18-20°C, 40-60% humidity and a 12-hour 
light/dark cycle was provided by overhead fluorescent lighting and 
an automatic time switch. The rats were allowed free access to 
tap water and one of two diets: 20% protein in the form of cow's 
milk casein or 4% casein supplemented with 0.2% DL Methiopine 
(this prevents specific methionine deficiency; methionine being 
the first limiting amino acid in casein (Harper, 1959)). Both 
diets are isocaloric and provide known and adequate amounts of 
vitamins and minerals (Harper, 1959) (See Tables 4.1 and 4.2). 
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TABLE 4. 1 
DIETARY COMPOSITION FOR THE EXPERIMENTAL MODEL OF 
















4% Casein Diet .20% Casein Diet 
(g/Kg diet) (g/Kg Diet) 
40.0 200.0 
855.0 69 7. 0 
c.40. 0 40.0 
10.0 1 0. 0 
40.0 40.0 
10. 0 10.0 
3.0 3.0 
2.0 
90 mesh (South African Milk 
Board 
(Glucose and Starch Products, 
Cape Town) 
Vereeniging Consolidated Mills, 
Vereeniging) 
(Marine Oil Refineries, Hout 
Bay) provides 4000 ID . Vitamin 
A and 2000 IU Vitamin D per 
Kg diet 
Provided as all a tocopheryl 
acetate (Merck, Darmstadt) 
(BDH, Poole, England) 
(BDH, Poole, England) 
TABLE 4. 2 
VITAMIN MIXTURE (Harper, 19 59) 
Inositol 
Ascorbic Acid 



























MgS04 • 7H20 
Fe(C6HsOH) ·6H20 
CaHP04 · 2H2 0 
MnS04•4H20 











0. 16 0 





All constituents were reagent grade and were ground to a very fine 
uniform powder and stored in airtight glass containers at 4°c. 
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Animals from each litter were allocated at random to the die-
tary regimes, those fed the 20% protein diet acted as "age matched" 
adequately protein nourished controls for the protein malnourished 
rats fed the 4% protein diet, while untreated weanlings acted as 
"weight matched" controls. Animals were marked by staining the 
fur on crown, back, belly or tail with picric acid. All blood 
sampling, tissue analyses, histology and liver perfusions were 
carried out on animals which had been fasted overnight (free access 
to water continued) for 14 to 16 hours in clean cages. 
C Validation of nutritional status of the rat model 
I The following parameters were determined for confirmation of a 
protein malnourished state: 
i) Body weight: Animals were weighed to the nearest O.Sg 
twice weekly between 09.00 and 11.00 hours. 
ii) Body length: Animals were measured under light ether 
anaesthesia at the beginning and end of the period on the 
experimental diet. (a) Total length (nose to tail-tip 
and (b) tail length (vent to tail-tip) were measured. 
iii) Total serum protein was determined on serum obtained at 
the end of the experimental period by aortic puncture 
under light ether anaesthesia by the method of Lowry, 
Rosebrough, Farr and Randall ( 1951) (See Appendix B). 
iv) Serum albumin was determined by the method of Doumas, 
Watson and Biggs (1971) (See Appendix B). 
v) Liver fat content was measured by the decrease in weight 
of the dried liver after extraction with petroleum ether 
(b.p. 40°-6o 0 c) (Hazlewood and Nichols, 1969) (See 
Appendix B). 
vi) Liver histology was carried out on 10 µm frozen sections 
of tissue fixed in 10% buffered formalin and stained with 
oil red O in iso-propanol (Lillie and Ashburn, 1943) and 
Mayer's Haemalum. 
vii) Wet and dry weights of livers. Livers were weighed 
immediately after sacrifice and again after drying at 
I 
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100°c for 24 hours and the wet:dry weight ratio calculated 
II Results 
i) Body weight: Animals fed the 4% protein diet failed to 
gain weight during the experimental period while those fed 
the 20% protein diet gained weight steadily (see Fig. 4.1). 
ii) Body length: There was no significant growth in total or 
tail length in the animals fed the 4% protein diet while 
those fed the 20% protein diet increased by over 50%. 
(See Table 4.3 and Fig. 4.2). 
iii) Total serum protein and serum albumin were significantly 
lower in the 4% protein fed rats than those fed 20% pro-
tein or in weanlings (see Table 4.3). 
iv) Liver lipid was greatest in the 4% protein fed rats and 
liver histology confirmed the characteristic periportal 
fatty infiltration only in these animals (see Fig. 4.3 
and Table 4.3). 
v) Liver wet:dry weight ratio was significantly greater in 
the 4% protein fed rats than those fed 20% protein or in 
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DAYS ON DIET 
The effect of 20% and 4% protein diets on 
weight gain 
Rats on 20% protein diet (solid line) 
gain weight steadily while those on 4% 
protein diet (dashed line) fail to gain 





















































































































































































































































































































































































































































































































































Fig. 4.2 General appearance of the three types 
of experimental animals. Animals fed 
a 4% protein diet for 25 days from 
weaning fail to grow. Yellow marks 
























































































































































































































































































































































































































































































































































































































































































































































































D Discussion and Conclusions 
i) After 25 days of free access to the diet containing 4% 
protein the rats developed a syndrome characterised by many of the 
features of protein-energy malnutrition in humans. The features 
were: failure of weight gain and linear growth, hypoproteinaemia 
and albuminaemia and fatty infiltration of the liver. These fin-
dings were in keeping with others using this model (Stead and Brock, 
1972; le Roi th and Pimstone, 1973; Weinkove, Weinkove and Pimstone, 
1976; Sacks, Pimstone, Waligora, Peires, Weinkove and Saunders, 
1977) and is a reflection of its high degree of reproducibility. 
ii) Oedema was not a feature of the syndrome and occult accu-
mulation of water has been excluded by dilution studies with tritia-
ted water (Weinkove, Weinkove and Pimstone, 1976). Oedema has also 
not been found in other rat models of malnutrition (Ramalingaswami 
and Deo ~ 1968; Widdowson and Mccance, 1957). The short period of 
protein deprivation (25 days) may be a factor, in that after 15 
weeks on a pure cassava diet (Schnieden, Hendrickse and Haigh, 1958) 
rats developed weight loss, a fall in serum albumin from 4.2 to 1.2 
g/100 ml and a rise in total body water from 69.9 to 77.4%. 
iii) Food intake was not measured but is known to be reduced 
in animals fed 4% protein diet, the intake is however sufficient 
to maintain constant body weight which excludes simple starvation 
(Stead and Brock, 1972). Equal food intake can only be achieved 
by highly unphysiological force feeding with resultant high morta-
lity (Sidransky and Verney, 1970). 
iv) In spite of the problems of producing pure protein depri-
vation (Weinkove, 1974; Kirsch, Saunders and Brock, 1968) and the 
difficulties of extrapolating any animal pathological states to 
humans, it was considered that the syndrome produced by feeding a 
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4% protein diet was one of protein malnutrition; not too dissimi-
lar to that observed in humans, and warranted use in this study . 
CHAPTER FIVE 
IN VIVO 35so4 I NCORPORATION I NTO CARTILAGE AND CARTILAGE 
HISTOLOGY AND HISTOCHEMISTRY 
"As thou knowe st not what is the way of the spirit nor 
how the bon e s do arow ..... " . .. Ecclesiastes 11.5. 
A Introduction 
i) A failure of linear growth is a striking feature of pro-
tein energy malnutrition (Berridge and Prior, 1954; Trowell, 
Davies and De an , 1 9 5 4) . The linear growth of long bones, which is 
/ 
the main contributor to height in man, occurs at the epiphyses 
(Davies and Coupland, 1967) and abnormal, narrow epiphyses have 
been noted in protein-energy malnutrition (Higginson, 1954). 
ii) Much of the emphasis on the study of the skeleton in pro-
tein malnutrition has been directed towards calcium and bone meta-
bolism rather than to that part of the skeleton especially relevant 
to growth, namely the epiphyseal cartilage (Higginson, 1954; Platt 
and Stewart, 1962; Deo, Sood and Ramalingaswami, 1965; Jha, Deo 
and Ramalingaswami, 1968; Adams and Berridge, 1969; Dickerson and 
John, 1969; le Roi th and Pimstone, 1973). When cartilage has 
been studied it has frequently been that of the costochondral junc-
tion rather than that of the long bones and only in the case of Deo 
et al (1965) have special cartilage stains been tised (PAS-Alcian 
b 1 ue) . 
iii) The incorporation of 35so4 into the mucopolysaccharides of 
cartilage reflects a functional balance between three factors: the 
intrinsic growth activity of the cartilage (and other tissues), 
its modification by humeral factors and the dilution of the radio-
active tracer in the freely exchangeable sulphate pool of the body. 
Thus the in vivo incorporation of 35so4 into cartilage was chosen 
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as an overall functional indicator of cartilagenous activity in the 
state of protein malnutrition in the rat. It has been shown that 
in growing rats within 24 hours of an intraperitoneally administe-
red dose of Naz 35so4, most of the 
35 so4 present in cartilage is 
I 
incorporated in the mucopolysaccharides of the matrix and very 
little is free (Dziewiatkcwski, 19 5 4; Dziewi atkowski, Di Ferr ante,. 
Bronner and Okinaka, 1957; Bostrom, 1952). The in vivo incorpo-
ration of 35 so4 into cartilage matrix is influenced by changes in 
hormonal milieu, especially hypophysectomy (Dziewia~owski, 1964). 
iv) A detailed morphometric, histological and histochemical 
study of the epiphyses and costal cartilages was made to correlate 
functional activity, fl d b 35S . . as re ecte y 04 incorporation, epiphy-
seal plate width, histological parameters of epiphyseal activity 
and the nature of the matrix. Much of the previous work on carti-
lage in malnutri~ion concentrated on the costochondral junction and 
confirmation of the finding in long bone epiphyseal plates was re-
quired. The choice of the upper tibial epiphyseal plate for de-
tailed study was because of its uniformity which in the rat has 
made this the site of choice for the study of epiphyseal growth, 
as in the bioassays of growth hormone (Evans, Simpson, Marx and 
Kibrick, 1943; Greenspan, Li, Simpson and Evans, 1949). 
B Methodology 
i) Administration of 35S04: Saline control (250 µl) or 
35 
carrier free Naz S04 (The Radiochemical Centre, Amersham, U.K.) 
was administered by intraperitoneal injection in dose? of 0.1, 
1.0, 2, 5, 10 µCi/g body weight to 5 animals of each type (20% 
protein fed, 4% protein fed and weanlings) in 250 µl of sterile 
saline. All animals were housed in mesh-bottomed stainless steel 
cages and all contaminated excreta collected and disposed of. 
After 24 hours, animals were sacrificed by exsanguination under 
light ether anaesthesia. 
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ii) Serum sulphate was determined on 8 animals of each type by 
j 
the method of Kleeman, Taborsky and Epstein (1956), in which the 
serum was deproteinized with uranylacetate, which simultaneously 
removed phosphate. The sulphate in the protein-free supernatant 
was precipitated as benzidine sulphate and the benzidine in the pre-
cipitate quantitated by photometric measurement after reaction with 
B Naphthoquinone 4 sulphonate. (For detailed methodology see 
Appendix B). 
iii) Quantitative measurement of 
35 so4 incorporation into cos-
tal cartilage: The rib cages of the rats were dissected by the 
method of Herbai (1970) (Fig. 5.1) in which the whole rib cage was 
removed, dipped into boiling water and the ribs stripped of muscle 
and divided into lateral, middle and medial segments. The seg-
ments from left and right sides were pooled (except for the left 
seventh rib which was reserved for sectioning). After drying at 
so 0 c for 12 hours the cartilage segments were weighed on a microtor-
tion balance, dissolved in 500 µl 23M formic acid at so 0 c for 1 
hour and counted by liquid scintillation counting in 10 ml of Insta-
gel (Packard, USA). 
iv) Preparation of bony tissue for histology, histochemistry 
and autoradiography: The tibiae with intact knee and ankle joints 
were dissected free of most attached muscle. In the case of some 
animals the humerus with intact shoulder and elbow joints and the 
7th rib including the costochondral junction were similarly dissec-
ted. All tissues were immediately placed in 10% formalin with 
0.5% cetylpyridinium chloride (Engfeldt and Hjertquist, 1967) for 
24 hour fixation. (This has been shown to elute the smallest amount 
of 35so4containing mucolysac
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Fig. 5.1 Dissection of the rat anterior thoracic 
wall (based on that of Herbai (1970) for 
the mouse). 
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Tissue was decalcified in Gooding and Stewart's Medium (Culling, 
1974) for 72 hours. The decalcified long bones were bisected 
(equal numbers in the sagittal and coronal planes), dehydrated in 
graded alcohols, cleared in xylol and embedded in paraffin wax. 
I 
Multiple sections (where possible serial sections) 8 µm thick were 
cut with a Jung sliding microtome and dewaxed in xylol and graded 
alcohols. 
v) Semiquantitative macroautoradiography (a modification of 
the method of Dziewiatkowski, 1951). Sections of long bones and 
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ribs 8 µm thick were air dried for 24 hours after dewaxing and then 
placed in direct contact with the emulsion of Kodak Ortho Process 
Film 4154, thick, cut into strips 20 x 60 mm. The film was held 
in place by means of a clean microscopic slide and a rubber band at 
each end. After periods ranging from 5 to 40 days the film was 
developed for 5 minutes in Kodak D19 developer, washed for 30 
seconds in 1% acetic acid and fixed in Amphix (Maybaker, Cape Town) 
diluted 1:4 for 20 minutes, rinsed in tap water for 30 minutes and 
distilled water for 1 minute, then dried and mounted, emulsion 
uppermost, on clean microscopic slides. All work with film while 
sensitive was carried out under low intensity light filtered with a 
Kodak No. 1 Safelight filter. After autoradiography, the tissue 
sections could be used for histological staining. The importance 
of unlabelled controls to exclude spurious images on the film due 
to direct chemical action has been stressed (Dziewiatkowski, 1951). 
vi) Histological and histochemical staining (see Appendix A 
for detailed methodology): The following techniques were used: 
Mayer's haemalum and eosin for routine cellular morphology; the 
resorcin-crystal violet and picro-fuchsin method of Sweet (1968) 
stains chondroitin sulphate pale blue and keratosulphate pink; 
Toluidine blue 0.25% in Michaelis' veronal acetate-HCl buffer for 
metachromasia (Culling, 1974), Alcian blue 8GX 1% in 0.1M HCl 
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(pH 1.0) for sulphated mucopolysaccharides; Alcian blue 8GX 1% in 
0.5M acetic acid (pH 2.5) for carboxyl and sulphate groups of muco-
polysaccharides (Culling, 1974); Alcian blue 8GX 1% in 0.1M aceta-
te buffer (pH 5.7) with MgCl2 at 0.1, 0.7 and 1.0M according to 
the critical electrolyte concentration technique of Quintarelli, 
Scott and Dellovo (1964) for differentiating acid from sulphated 
mucopolysaccharides. Some sections were subjected to ovine testi-
cular hyaluronidase digestion prior to staining with Alcian blue 
8GX 1% in 0.1M HCl (Culling, 1974). All sections were dehydrated 
in graded alcohols, cleared in xylol and mounted in Depex (GT Gurr, 
U.K.). 
vii) Measurement of tibial length and epiphyseal width: Tibial 
lengths were measured to the nearest mm with a transparent rule on 
stained mounted sections, from the centre of the tibial plateau to 
the upper articular surface of the ankle mortice. The width of 
the upper tibial epiphysis in its central half was measured at 5 
equidistant points by an eyepiece micrometer on at least 5 sections 
from the tibia of each animal (see Fig. 5.2). All sections and 
autoradiographs were assigned a random number and examined and 
measured without the observer having any knowledge of which group 
of animals they came from. 
C Results 
i) Serum inorganic sulphate: 
There was no significant difference in the sulphate content of 
the sera from the three groups of experimental animals. (See Table 
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Points of measurement of the tibial 
epiphyseal width . Width was measured 
by eyepiece micrometer at 5 equidistant 








· SERUM SULPHATE LEVELS 
Mean Serum Sulphate (µg/ml) + SEM 
4% Protein diet (n = 8) 63.0 + 3.5 
20% Protein diet (n = 8) 60.4 + 2. 7 
Wean lings (n = 8) 62.7 + 3. 1 
Unpaired Student's t test 
p > 0.5 for all groups 
ii) The incorporation of 
35 S04 into costal cartilage: The 
'\r 
following features were demonstrated: Incorporation of 
35 S04 was 
lowest at all doses in the 4% protein fed rats, the 20% protein 
fed rats (age-matched, 
3SSO . . 4 incorporation, 
wellnourished controls) had an intermediate 
while the rapidly growing younger weanlings 
(weight-matched controls) had the greatest incorporation. 
differences were significant (see Fig. 5.3). 
These 
iii) The regional distribution of 35 S04 incorporation into 
costal cartilages: This confirms the findings of Herbai (1970). 
For all three groups of animals the highest incorporation occurred 
in the lateral segments which includes the costochondral junction 
and was lowest in the medial segment. The total incorporation per 
unit cartilage weight was slightly higher in the upper than the 
lower ribs (probably because the costochondral junction area made 
up a larger fraction of the total) (Table 5.3). The ratio between 
the lateral and middle and medial segments was significantly lowest 
in the 4% protein fed rats relative to age and weight-matched 
controls (see Tables 5.2 and 5.3). 
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Fig. 5.3 Incorporation of 35so4 into costal 
cartilage in vivo of weanling, 20% 
protein fed and 4% protein fed rats, 
24 hours after intraperitoneal 
injection of Naz 35so4 0.1 to 10 µCi/ 
gm body weight. 
Each bar represents mean+ SEM for 
5 animals. 
** p < 0.001 (4% vs 20%) 
* p < 0.05 (4% vs 20%) 
.... p < 0.001 (4% vs Weanling) 
.. p < 0.05 (4% vs Weanling) 


































































































































































































































































TABLE S. 3 
INCORPORATION OF 35 so 4 I NTO COSTAL 'CARTILAGE 
AT DOSE 1 JJCi/g 'B ODY WEIGHT (n = S) 
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(Similar results were obtained at other dose levels) 
Mean CPM/mg dry cartilage (whole cartilage) 
Rib . No. 4% Protein Diet 20 % Prot e in Diet Weanling 
3 1 , 180 5,840 16,270 
4 9 3'4 5,430 14,380 
5 814 4,550 12,140 
6 - 76 2 3,810 11,720 
7 701 3,210 11,010 
iv) Semiquantitative macroautoradiography of long bone epiphy-
ses and costochondral junctions: The incorporation of 35so 4 into 
epiphyses of long bones as demonstrated by this method confirmed 
the quantitative findings in costal cartilages. There was a 
striking decrease of 35S04 in the sections of tissue from 4% pro-
tein fed rats, this applied especially to the epiphyseal but also 
to the articular cartilage, bone periosteum and joint capsule. 
In the case of costal cartilages the maximum incorporation was in 
cartilage adjacent to the costochondral junction in all groups of 
animals but again was least in the malnourished animals. Unlabel-
led control sections produced no spurious images on the film (see 
Fig. 5.4). 
v) Micrometry of tibial epiphyseal width: The upper tibial 
epiphyses of the 4% protein fed rats were significantly narrower 
than age or weight-matched controls, both absolutely, or if ex-
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Panels D & G 
Panels E & H 
Panels F & I 
Autoradiographs of sections after 
t 
administration of Naz 35so4 (1 µCi/g 
body weight) 24 hours before sacrifice. 
Weanling (weigh~matched control) marked 
uptake of 35S04 into epiphyses. 
4% Protein fed (protein deficient) poor 
uptake of 35so4 into epiphyses. 
20% Protein fed (age-matched control) 
good uptake of 35 S04 into epiphyses. 
The identical sections from which the 
autoradiographs were made stained with 
Alcian Blue at pH 1.0. 
Photomicrographs of the upper tibial 
epipysis of the stained sections. 
Weanling (weight-matched control) 
with very wide active epiphysis. 
4% Protein fed (protein deficient) 
with inactive epiphysis. 
20% Protein fed (age-matched control) 
with active epiphysis. 
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. TABLE . S. 4 
UPPER TIBIAL EPI"PHYS"EAL . WIDTH 
4 % Protein Diet · ·z-0%· ·Prote·in Di et Weanlings 
Tibial epiphyseal 
width (µm) 202 + 46 36 7 + 5 2 - 5 78 + 40 
' Ratio of epiphyseal 
width to tibial 
length (µm/mm) 9.4 + 1.9 14.2 + 2.4 28.2 + 2.3 
(Mean ~ SEM) (n = 20) 
Similar results were found for lower tibial, lower femoral, 
upper humeral and lower humeral epiphyses but the variance of micro-
metric measurements were far greater, confirming the uniformity of 
the upper tibial epiphyses as an area for study. 
vi) Histological features: The narrowing of the epiphyseal 
plate in the 4% protein fed animals was due to a diminution in the 
thickness of all zones, resting, proliferating, maturing and de-
generating cartilage. The proliferating zone was most severely 
affected. The osteoid tissue and osteoblasts were atrophic. The 
cartilage cells were small, flattened with frequent pyknotic nu-
clei. The metaphyseal trabeculae were narrow and poorly branched. 
There was poor vascular invasion of the metaphyseal-epiphyseal 
junction (see Fig. 5.5). 
vii) Histochemistry of cartilage matrix: There was no signi-
ficant difference in the staining properties of the matrix of the 
cartilage from the three groups of animals, when studied by the 
methods detailed above suggesting that the acid and sulphated muco-
polysaccharides are qualitatively similar but quantitatively less 





























































































































Fig. 5.6 Sections of tibial epiphyses stained with 
Sweet's resorcin-crystal violet and picro-
fuchsin method. 
(a) Weanling (weight-matched control) 
(b) Epiphysis of 20% protein fed (age-matched 
control) 
(c) Articular cartilage from same 20% protein 
fed rat tibial section to show contrast 
in staining of epiphyseal and articular 
cartilage 
(d) 4% Protein fed. 
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Fig. 5.6 Sweet's stain 
(a) 
Weanling (weight-matched control) 
(b) 
Epiphysis of 20% protein fed (age-matched control) 
Fig. 5.6 Sweet's stain (continued) 
(c) 
Articular cartilage from same 20% protein fed rat tibial 
section to show contract in staining of epiphyseal and 
articular cartilage 
(d) 






























































































































Fig. 5.8 Autoradiographs of sections of tibial epiphyses 
from rats administered Naz 35so4 1.0 µCi/g body 
weight 24 hours before sacrifice. Sections 
were subsequently stained with Alcian blue 8GX 
at pH 1.0 for sulphated mucopolysaccharides. 
Note the concordance between the labelling with 
35so4 and the staining with Alcian blue 8GX. 
(a) Weanling (weight-matched control) 
(b) 20% Protein fed (age-matched control) 


















































































































Fig. 5.9 Section of tibial epiphyses stained by the 
critical electrolyte technique using Alcian 
I 
blue 8GX at pH 5.7 with MgC12 at 0.1 and 1.0M. 
(a) Weanling (weight-matched control) at 0.1M 
MgClz 
(b) Weanling (weight-matched control) at 1.0M 
MgC12 
(c) 20% Protein fed (age-matched control) at 
0.1M MgClz 
(d) 20% Protein fed (age-matched control) at 
1.0M MgC12 
(e) 4% Protein fed at 0.1M MgClz 
(f) 4% Protein fed at 1.0M MgClz. 
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Fig. 5.9 Critical electrolyte technique 
Weanling (weight-matched control) at 0.1M MgClz 
(b) 
Weanling (weight-matched control) at 1.0M MgClz 
106 
Fig. 5.9 Critical electrolyte technique (continued) 
(c) 
20% Protein fed (age-matched control) at 0.1M MgClz 
(d) 
20% Protein fed (age-matched control) at 1.0M MgClz 
10 7 
Fig. 5.9 Critical electrolyte technique (continued) 
(e) 
4% Protein fed at 0.1M MgClz 
(f) 




































































































i) The similar serum sulphate contents of the 3 groups of 
animals and the fact that the malnourished animals have been shown 
to have the same total body water content as controls (Weinkove, 
Weinkove and Pimstone, 1976) suggests that when the same dose of 
Naz 3~S04 is administered per gram body weight, the cartilage in 
the different groups of animals is able to compete equally for the 
radioactive label. Differences in 35 so 4 uptake under these condi-
tions would be determined by intrinsic cartilage avidity and humeral 
factors which may influence this. The use of costal cartilage for 
quantitative work was necessitated by the difficulty in dissecting 
~ 
out epiphyseal growth pla~es free of bony contamination in an animal 
as small as the rat. The autoradiographic and histological fin-
dings however support the premise that costal and epiphyseal carti-
lage share many features. 
ii) The narrow epiphyseal plates confirmed the wark in human 
malnutrition and the radiographic findings in this animal model 
(le Reith and Pimstone, 1973). 
ral confirmed the narrowing, 
The histological findings in gene-
1 • 
inactivity and cellular changes pre-
viously described. They also showed no significant differences in 
the staining reactions but a decrease in the amount of the muco-
polysaccharides in the narrowed epiphyses of the malnourished ani-
mals. The oedema and hyalinisation described by Silberb~rg and 
Silberberg (1940) in female guinea pigs subjected to overall food 
restriction were not observed. 
iii) The growth, histology and 35 so 4 incorporation in vivo of 
cartilage are subject to hormonal influences. The histological 
features (Freud, Levie and Kroon, 1939; Ingalls and Hayes, 1941; 
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Ray, Evans and Becks, 1941) and autoradiographic features 
(Dziewiatkowski, 1964) of epiphyseal cartilage in hypophysectomised 
rats are not dissimilar to the findings in 4% protein fed rats and 
thus the study was extended to include some of the hormonal influe-
1 
nces on cartilage and the 35so4 incorporation by cartilage in vitro 
in the absence of hormonal influences. 
A 
CHAPTER SIX 
SERUM SOMATOME DI N ACTIVITY (SULPHATION 'FACTOR) 
IN EXPERI MENTAL PROTEIN MALNUTRITION IN THE RAT 
"Blood is a very speaiaZ juiae" Johann Wolfgang van Goethe 
Introduction 
1 1 0 
i) The growth failure and abnormal skeletal and cartilage 
morphology discussed in Chapters 4 and 5 have long suggested an ab-
normality of growth hormone in protein energy malnutrition. Bio-
assay of growth hormone in the pituitary glands of protein deprived 
or starved rats shows reduction; this has be en interpreted as 
being due to diminished production (Srebnik and Nelson, 1962) or 
increased secretion (Friedman and Reichlin, 1965) and popularised 
the use of the term pseudohypophysectomy, first used to describe 
the pituitary atrophy produced by malnutrition in animals (Mulinos 
and Pomerantz, 1940). Monckeberg, Donoso, Oxman, Pak and 
Meneghello (1963) have claimed that malnourished children failed to 
respond to refeeding without simultaneous growth hormone admini-
stration, suggesting a deficiency of growth hormone. However 
the general experience is that providing refeeding supplies ade-
quate protein and energy, catchup growth occurs (Ashworth, Bell, 
James and Waterlow, 1968) and that in untreated cases exogenous 
growth hormone is without effect (Hadden and Rutishauser, 1967). 
The similarity of metabolic responses in starvation and after 
growth hormone administration (Russell, 1957) and the abnormal glu-
cose tolerance in protein deprived animals (Heard and Turner, 1967) 
led . these investigators to predict that growth hormone might be 
elevated in these circumstances. 
ii) The accurate measurement of circulating growth hormone in 
man was made possible by radioimmunoassay and in children with 
1 1 1 
kwashiorkor and marasmic kwashiorkor, growth hormone was found to 
be elevated (Pimstone, Wittmann, Hansen and Murray, 1966; Pimstone, 
Barbezat, Hansen and Murray, 1967; Hadden, 1967; Graham, Cordano, 
Blizzard and Cheek, 1969; Milner, 1971a). In general, the ele-
vation of growth hormone in marasmus is lower than that occurring in 
kwashiorkor (Pimstone, Barbezat, Hansen and Murray, 1968). That 
elevated growth hormone resulted from a hypersecretion rather than 
reduced clearance was proven by the administration of somatostatin 
which directly inhibits pituitary growth hormone secretion. The 
half life of growth hormone disappearance after somatostatin in 
protein energy malnutrition is similar to that of exogenously ad-
ministered growth hormone in normal subjects (Pimstone, Becker, and 
Kronheim, 1975). In addition to being elevated, growth hormone 
is not suppressed by oral glucose (Pimstone, Barbezat, Hansen and 
Murray, 1967) or by carbohydrate feeding (Pimstone, Barbezat, 
Hansen and Murray, 1968). Oral mixed amino acids (Milner, 1971b) 
and milk protein feeding (Becker, Pimstone, Hansen and Hendricks, 
1971) rapidly drop the elevated growth hormone. The level of 
growth hormone elevation in protein energy malnutrition correlates 
best with the degree of protein deficiency, as reflected by the 
reduction in serum albumin. Below a plasma albumin of 25 to 30 g/1 
growth hormone tends to be elevated (Lunn, Whitehead, Hay and 
Barker, 1973). In spite of the inverse correlation between growth 
hormone and albumin and certain amino acids (especially alanine) 
in untreated protein energy malnutrition (Pimstone, Becker and 
Hansen, 1972), the growth hormone elevation does not appear to 
be causally related to the reduced albumin or amino acids in that 
intravenous infusions of albumin (Becker, Pimstone, Hansen and 
Hendricks, 1971), mixed amino acids (Becker, Pimstone and Hansen, 
1975) or alanine (Becker, Pimstone, Kronheim and Weinkove, 1975) 
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fail e d to reduce the elevated growth hormone. Thus the hypoalbu-
minaemia is a reflection of the the severity of protein deficit 
which results in elevation of growth hormone by an as yet unexplai-
ned mechanism. That energy intake is not causally related is 
suggested by the rapid return of growth hormone to normal (with 
normal glucose suppressibility) after protein rather than carbohy-
drate feeding (Pirnstone, Barbezat, Hansen and Murray, 1968; Becker, 
Pimstone, Hansen and Hendricks, 1971). 
iii) The apparent paradox of grossly elevated growth hormone in 
a condition associated with growth failure and narrow inactive grow-
th cartilages was resolved by the observation that bioassayable 
somatomedin (the putative mediator of growth hormone on skeletal 
tissueJ was greatly reduced in protein-energy malnutrition, retur-
ning progressively towards normal on refeeding as the growth hormone 
fell and serum albumin rose (Grant, Hambley, Becker and Pimstone, 
1973; Van den Brande and Du Caju, 1973; Hintz, Suskind, Amatayakul 
and Olsen, 1976). Thus impaired feedback of somatomedin may result 
in elevation of growth hormone, as has been suggested by Laron, 
Pertzelan, Karp, Kowadlo-Silbergeld and Daughaday (1971) in a form 
of familial dwarfism characterised by elevated growth hormone and 
reduced somatomedin. 
Not only was the bioassayable somatomedin reduced but frequent-
ly diluted in a dose response non-parallel to standard pooled normal 
serum (Grant, Hambley, Becker and Pimstone, 1973; Van den Brande 
and Du Caju, 1973). In the studies by Grant et al (1973) with an 
embryonic chick cartilage assay, mixing experiments failed to demo-
nstrate an inhibitor, while Van den Brande and Du Caju (1973) 
found a heat labile inhibitor. With refeeding, increasing serum 
albumin and normalis a tion of growth hormone, the non-parallel 
somatomedin dose response returned to normal. Non-parallel <lose 
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respons es have been reported in the very different nutritional con-
dition of acute sta rvation in the rat which resulted in the develop-
ment of an inhibitor which was not dialysable, antagonised the 
action of sulphation factor activity from normal fed rat serum, 
I 
inhibited basal 35so4 incorporation into cartilage in vitro and was 
inactivated by trypsin (Salmon, 1975). 
iv) At the time this study was initiated no data on somatornedin 
activity in protein malnourished experimental animals was available, 
in spite of the advantages, both practical and ethical, of animal 
models of protein-energy malnutrition outlined in Chapter 4. The 
obvious growth failure and abnormal epiphyseal morphology, histo-
chemistry and in vivo 35S04 incorporation strongly suggested th a t an 
abnormality of somatomedin activity was present in the Stead and 
Brock (1972) model. 
B Methodology 
i) Protein malnourished 4% protein fed rats, their well-
nourished, aged-matched 20% protein fed controls, and wellnouri-
shed, weight-matched controls (weanlings) were prepared as outlined 
in Chapter 4. 
ii) Blood samples were obtained by aortic puncture under light 
ether anaesthesia, allowed to clot at 4°C and the serum separated 
by centrifugation (3000g for 10 min at 4°C) and stored at -20°c 
until assayed. 
iii) Pooled serum from 60 rats fed a 20% protein diet, with 
a nominal potency ratio of 1.0 U/ml s erved as a reference standard. 
iv) Somatomedin activity in the serum was measured by a porcine 
costal cartilage bioassay modified from that of Van den Brande and 
Cu Caju (1974) as described in Chapter 3. Assays were performed at 
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four different dilutions of serum (5, 10, 20 and 40%). Potency 
ratios and pa rallelism were calculated using the computer programme 
of Phillips and Herington (1975). 
v) Mixing experiments based on those of I Phillips and Young 
(1976a)were performed; standard pooled rat serum was mixed in a 1:1 
ratio with pooled serum from 4 and 20% protein-fed rats or weanlings, 
and the stimulation of 35so4 incorporation into porcine cartilage 
discs determined at 10 and 40% dilutions. The stimulation of the 
standard, 4 and 20% protein-fed and weanling serum alone at the 
same concentrations was measured in the same assay. 
vi) The concentration of rat growth hormone was determined by 
radioimmunoassay (Birge, Peake, Mariz and Daughaday> 1967) with 
NIAMDD anti-rat GH serum 3, 1251-labelled (by the Chloramine-T 
method), NIAMDD rat GH 122 as tracer, NIAMDD rat GH RP1 as stan-
dard and a second antibody separation (rabbit antimonkey a globulin 
produced in our laboratory). The assay was performed in strict ad-
herence to the method recommended by the NIAMDD and is presented in 
detail in Appendix B. 
vii) Rat insulin was determined by radioimmunoassay (Weinkove, 
Weinkove, and Pimstone, 1974) using guinea pig anti-porcine insulin 
antibody (Burroughs Wellcome Ltd., U.K.) 125 1 labelled (by the 
Chloramine-T method), porcine monocomponent insulin (Novo) as 
tracer, crystalline rat insulin as standard (Novo) and a second 
antibody separation (rabbit anti guinea pig antiserum, Burroughs 
Wellcome Ltd., U.K.). 
appears in Appendix B. 
The detailed methodology of the assay 
viii) Administration of exogenous hormone. Human growth hor-
mone (Kabi, Stockholm; Crescormon) or bovine (NIAMDD BG-18) was 
1 1 5 
administered daily at a dose of 4 µg/g body weight by intraperito-
neal injection for 7 days (days 19-25 of diet) to six 4% protein-
fed rats. 
C Results 
i) The results of bioassay of serum somatomedin activity are 
shown in Fig. 6.1. In summary they show that serum somatomedin 
activity in rats fed a standard rat cube diet, a 20% protein diet 
and 21 day old weanlings did not differ significantly from each · 
other, but that after 4 days on the 4% protein diet there was a 
striking fall. The low level of serum somatomedin activity pre-
sent after 25 days of 4% protein diet did not alter significantly 
after 7 days of treatment with bovine or human growth hormone (days 
19-25 of special diet). 







Normal adult rats fed standard rat cubes 
(n = 20) 
Rats fed a 20% protein diet for 25 days 
(n = 20) 
Weanling rats (n = 20) 
Rats fed a 4% protein diet for 4 days 
(n = 6) 
Rats fed a 4% protein diet for 25 days 
(n = 20) 
Rats fed a 4% protein diet for 25 days 
and treated with human or bovine growth 
hormone (4 µg/g/day) for the last 7 days 
(n = 12) • 
Bars represent means and the vertical lines SEM. 
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ii) Mixing experiments failed to demonstrate an obvious inhi-
biting factor in the serum from protein malnourished rats (see Table 
6. 1) • 
TABLE 6.1 
MIXING EXPERIMENTS TO INVESTIGATE THE POSSIBLE INHIBITORY 
ACTION OF SERUM FROM PROTEIN MALNOURISHED RATS ON THE 
PORCINE COSTAL ASSAY FOR SOMATOMEDIN (Means+ SEM) 




Standard 1. 00 
Standard+ serum 
from rats fed 20% protein 1. 03 0.94 + 0.21 > 
Standard+ serum 





rat serum 0.99 0.92 + 0. 31 > a.so 
* Half (activity of standard+ previously assayed 
activity of test serum). Previously assayed 
pooled serum was mixed 1:1 with standard (potency 
defined as 1.00 U/ml) and the potency of the 
mixture compared with that calculated from the 
components of the mixture assayed separately. 
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iii) The failure of growth hormone to affect the morphological 
and biochemical features of protein energy malnutrition is shown 
in Tab.le 6.2. 
TABLE 6.2 
MORPHOLOGICAL AND BIOCHEMICAL FEATURES OF PROTEI N-DEFICIENT 
RATS WITH AND WITHOUT GROWTH HORMONE TREATMENT 
Weight (g) 
Total length (cm) 
Fatty liver (Oil red O) 
Serum protein (g/100 ml) 
Serum albumin (g/100 ml) 
Tibial epiphyseal width 
(µm) 
4% Protein Diet 
(n = 20) __ 
32 . 2 + 7.9 
20.4 + 1.3 
u Posi tive 
3.8 + 0.2 
2.1 + 0.1 
202 + 46 
4% Protein diet+ 
4 µg hGH or bGH g-1 
day-1 for 7 days* 
(n = 6 each) 
34.0 + 4.8 
20.8 + 1.8 
Positive 
3.9 + 0 . 2 
2.2 + 0.1 
216 + 50 
* As neither human nor bovine growth hormone had a signifi-
cant effect, the results are combined. 
iv) The hypoinsulinaemia previously observed in this model 
of protein malnutrition was confirmed (in the fasting state) and 
the rat growth hormone levels in the three groups of rats did not 
differ significantly from each other (see Table 6.3). 
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TABLE 6.3 
THE LEVELS OF rGH AND INSULIN (ng/ml) IN THE PLASMA OF PROTEIN-
DEFICIENT AND CONTROL RATS AFTER AN OVE~~IGHT FAST (Means+ SEM) 
A B C 
Weanlings 20% Protein Diet 4% Protein Diet 
(n = 8) (n = 8) (n = 8) 
Insulin 0.84 + 0.09 1. 03 + 0 . 11 1. 31 + o.o8*t 
rGH .I 78 26 89 + + 22 86 + 1 8 
Student's T (unpaired) 
*t p<0.001: Group A vs Group C and Group B vs Group C resp. 
p>0.500: Group A vs Group C ~nd Group B vs Group C. 
--..._ 
D Discussion 
i) Somatomedin activity in experimental protein malnutrition. 
We have shown in the Stead and Brock (1972) model of protein 
malnutrition t·hat there is reduced serum somatomedin activity simi-
lar to that occurring in human kwashiorkor except that non-parallel 
I 
dose response lines are infrequent (Shapiro and Pimstone, 1978). 
At the time this work was initiated there was no data available 
on serum somatomedin activity in protein malnourished animals. Re-
cently it has been reported in abstract that a diet low in protein 
is associated with lavserum somatomedin activity and that there is a 
positive correlation between serum somatomedin activity (and growt~ 
and dietary protein content (Reeves, Lee, Dickinson, Kilgore, 
Branham and Elders, 1977; Reeves, Dickinson, Lee, Kilgore, 
Branham and Elders, 1977). These workers also report a negative 
correlation between serum somatomedin activity and dietary fat con-
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tent. Somatomedin A measured by radioreceptor assay has been 
found to be reduced in animals fed a low protein diet (Takano, 
Hizuka and Shizume, 19 77, and Takano, personal communication, 
1977). There is thus a relationship between dietary composition 
and somatomedin activity which 1nay be at least one of the mediators 
of growth disturbance in protein malnutrition. 
ii) Somatomedin in acute starvation. 
The relationships between the changes in somatomedin (and other 
hormones) in protein malnutrition and those occurring in acute star-
vation of previously wellnourished animals, ar~ not yet clear. 
Decreased somatomedin activity was reported after a 48 hour fast 
(Daughaday and Kipnis, 1966). Phillips and Young (1976aj have shown 
that a significant fall in serum somatomedin activity occurred .with-
in 24 hours of the onset of an acute fast and reached hypopituitary 
levels after 72 hours. The fall was not prevented by exogenously 
administered bovine growth hormone but refeeding resulted in a sig-
nifitant increase in serum somatomedin activity within 6 hours which 
returned to normal within 24 hours. Mixing experiments failed to 
reveal an obvious inhibitor. Work in man and rats (Takano, 
Hizuka and Shizume, 1977) in which radioreceptor assayable rather 
than bioassayable somatomedin was found to be reduced in acute fas-
ting confirms that at least part of the reduced bioassayable somato-
medin activity is due to a true reduction in at least one component 
of total somatomedin activity (somatomedin A) . The return to nor-
mal of serum somatomedin activity after a 72 hour fast was directly 
proportional to the calorie intake provided and piotein was more 
effective than carbohydrate in stimulating this recovery (fat was 
still more stimulatory!) (Phi 11 ips and Oraws ki, 19 76) . In contrast 
to the findings of Phillips and Young (1976a), Salmon (1975) found 
evidence for an inhibitor of sornatomedin activity. It is possible 
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that an inhibitor present in low concentrations may net be detected 
by mixing experiments (Phillips and Young, 1976aj and thus the two 
groups of findings may not be irreconcilable. 
iii) The response of somatomedin activity ~o growth hormone in 
protein malnutrition . 
The failure of pharmacological doses of growth hormone (known 
to be biologically active in the rat) to have any effect on growth 
or somatomedin in the rat model of protein malnutrition studied is 
in keeping with its fatlure to increase somatomedin in acutely star-
ved animals (Phillips and Young, 1976a)and to stimulate lipolysis in 
human protein malnutrition (Hadden and Rutishauser, 1967) . 
iv) The relationship of somatomedin activity and growth hormone 
in experimental protein malnutrition in the rat . 
That the rat growth hormone in the protein malnourished rats 
was not elevated was somewhat different from the human syndrome, 
but there remained the dichotomy of low somatomedin activity in the 
face of normal growth hormone levels . The control and dynamics of 
growth hormone in the rat differs radically from that in man, stress, 
anaesthesia and hypoglycaemia suppressing growth hormone secretion 
(Martin, Durand, Gurd, Faille, Audet and Brazeau , 1978). H6wever 
growth hormone might be elevated in protein energy malnutrition rats 
if sampling were done frequently and basal and peak patterns asse-
ssed. To avoid such sampling error, chronic cannulation with very 
frequent sampling of fully conscious freely moving animals would be 
required (Dr. J. Martin, personal communication, 1977), a proce-
dure found to be quite impractical in malnourished rats weighing 
only 30-40g. The plasma rat growth hormone values in our experi-
ments were all from samples obtained between 09.30 and 10.30 (the 
usual time of the mid-morning growth hormone peak in the rat) under 
rapidly induced light anaesthesia and demonstrate that the protein 
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malnourished rat has at least growth hormone levels in the normal 
range and that the low serum sornatomedin activity cannot be ascribed 
to very low or absent growth hormone concentrations (a situation 
analogous to hypophysectomy). 
v) The relationship of somatomedin activity and insulin in 
experimental protein malnutrition in the rat. 
The hypoinsulinaemia occurring in protein malnutrition was con-
firmed in the overnight fasted state and is also known to be blunted 
in r e sponse to such stimuli as glucose (Weinkove, Weinkove and 
Pimstone, 1976). The role of insulin in somatomedin generation may 
be important in that insulin has been shown to increase body weight, 
length and epiphyseal cartilage width (Salter and Best, 1953) in 
hypophysectomised rats. Furthermore hypoinsulinaemic streptozoto-
cin induced diabetes resulted in reduced somatomedin activity nor-
malised by insulin administration (Phillips and Young, 1976b) and 
somatomedin is generated from isolated rat livers perfused with in-
sulin-containing medium (Daughaday, Phillips and Mueller, 1976). 
Insulin may also be a factor in some of the bizarre growth patterns 
reported post-operatively in patients with craniopharyngioma who 
may grow in spite of low or undetectable growth hormone and who 
have normal somatomedin levels (Finkelstein, Kream, Ludan and 
Hellman, 1972; Costin, Kogut, Phillips and Daughaday, 1976), those 
children who demonstrate increased appetite (occasionally to the 
point of pathological hyperphagia) with increased insulin levels 
being the ones who show "catch-up growth". 
The hypoinsulinaemia of protein malnutrition may thus be at 
least one factor for reduced somatomedin activity in serum in spite 
of normal (in rats) or elevated (in man) growth hormone. 
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CHAPTER SEVEN 
IN VITRO 35 so4 INCORPORATION INTO CARTILAGE 
"It is too bad that we cannot cut the patient in half in order 
to compare two regime ns of treatment" Bela Schick 
A Introduction 
Having demonstrated in the protein malnourished rat, growth 
35 failure, narrow epiphyses, reduced so4 incorporation into carti-
lage in vivo and reduced serum somatomedin activity, an in vitro 
study of the 35 so4 incorporation into the costal cartilages of mal-
nourished and wellnourished control rats was undertaken to study 
the role of the end-organ. The 35 so4 incorporation in vitro in 
the ' absence of serum was taken as a measure of intrinsic cartilage 
activity, while the stimuiation of 35 S04 incorporation by serum 
was taken as a measure of responsiveness to somatomedin. As the 
response to sera from normally nourished and malnourished animals 
was studied this provided, in effect, another bioassay system for 
the somatomedin activity of malnourished serum. 
B Methodology 
i) Dissection of tissue 
Under light ether anaesthesia malnourished and wellnourished 
(age and weight matched controls) rats were positioned on their 
backs on a dissecting board, the fur on the ventral surface was 
trimmed with an electric hair clipper and the whole ventral surface 
was vigorously swabbed with 95% ethanol. The skin was incised from 
jaw to groin with sterile scissors and the skin displaced laterally 
by blunt dissection. Using a new set of sterile instruments the 
abdomen was opened, the abdominal aorta exposed and the animal 
killed by exsanguination via a 21 gauge needle and sterile syringe. 
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The blood was allowed to clot at 4°c and the serum separated by cen-
trifugation at 4°c and the pooled serum (equal volumes from each 
animal within each group) stored at -20°C for future use. 
The entire anterior chest wall, including all the sternally 
attached costal cartilages, was removed as a single block and p~a-
ced between two sterile gauze swabs moistened with 0.9% sterile sa-
line in a sterile stainless steel dissecting tray. Using yet ano-
ther set of sterile instruments and gloves the costal cartilages 
from the 3rd to the 7th ribs were excised, with the exception of 
the most lateral 2 mm including the costochondral junction, strip-
ped free of muscle and perichondrium and diced into pieces 2-3 mm 
long. The lateral 2 mm of the costal cartilages 3 to 7 including 
the costochondral junctions were dissected out, pooled separately, 
preincubated and incubated as for the cartilage fragments. These 
cartilage fragments were then placed in an Erlenmeyer flask with 75 
ml of supplemented phosphosaline buffer (composition as described in 
Appendix B). In all, cartilage fragments from 5 animals of each 
type were dissected and pooled on four occasions. 
ii) Pre incubation 
The three flasks containing the pooled cartilage fragments or 
costochondral junctions from the three different groups of animals 
were "preincubated" at 37°c in air with occasional gentle agitation 
for 18 hours. 
iii) Unstimulated and serum stimulated 35 so4 uptake 
Pooled cartilage fragments from 4% protein-fed malnourished 
rats and their 20% protein-fed age matched and weanling weight mat-
ched controls were incubated with two concentrations of pooled serum 
from each type of animal. 
Under sterile conditions groups of cartilage fragments (8-10/ 
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tube) were placed in plastic test tubes (12 x 75 mm) containing 1 ml 
of supplemented phosphaline buffer, a 10% or 40% dilution of pooled 
serum from each type of animal, each in triplicate. Sterile car-
rier-free Na2 35 so4 (Radiochemical Centre, Amersham, U.K.) was added 
in a volume of 20 µl by "Repette" (Hemel Hempstead, U.K.) to give a 
final concentration of 2 µCi/ml. 
After 20 hours incubation in air at 37°c the incubation medium 
was aspirated and the cartilage killed by boiling water. The tops 
of the tubes were covered with nylon mesh held in place with rubber 
bands and repeatedly rinsed with cold tap water. 
35S04 was 1 d bl · h h no anger etecta e int e was water, 
20 rinses were carried out. 
c-' iv) 35so4 determination 
After 10 rinses 
but an additional 
After rinsing, the cartilage fragments in their tubes were 
dried at 80°C for 24 hours and after cooling weighed by microtortion 
balance, dissolved in 23M formic acid in Packard Scintillation 
vials (80°C for 1 hr) and after cooling, 35 so 4 determined by liquid 
scintillation counting in 10 ml of Instagel (Packard). 
C Results 
1) This experiment was performed 4 times (i.e. 20 animals of 
each type) (The results are shown in Table 7. 1, Table 7. 2, Fig . . 
7~1 and Table 7.3). 
ii) In summary the results were:-
(a) Cartilage from 4% protein-fed rats in the absence of serum 
. , 3SS . d incorporatea 04 i entically to . that from 20% protein-
fed rats of the same age. Cartilage from the younger 
weanlings, under the same conditions had a higher incor-











































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































IN VITRO RESPONSE OF CARTiLAGE 














35 In vitro uptake of so4 by pooled costal 
cartilage fragments from rats fed a 4% 
protein diet (hatched bars), 20% protein 
diet (small stippled bars) or weanlings 
(large stippled bars), incubated in the 
absence of serum or with 40% serum from 
controls (20% protein fed age-matched 
controls or weanling weight-matched controls) 
or protein malnourished rats (4% protein fed). 
Results are means+ SEM of three experiments 



































































































































































































































































































































































































































































(b) Cartilage from 4% protein-fed rats and 20% protein-fed 
rats was equa lly stimulated to incorporate 35 S04 by 
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pooled norma l human se rum while weanling cartilage was 
greater and the dose respons e steeper. Serum from hypo-
pituitary humans was only about 1;s as stimulating as nor-
mal serum (Table 7.3). 
(c) Pooled serum from 20 % protein-fed ~r weanling rats was 
11 t . 1 t t th . t· f 35 S04 by b.oth equa y s 1mu a ory o e 1ncorpora ion o 
20% protein-fed rat cartilage and 4% protein-fed rat car-
tilage, with parallel dose response curves when studied 
at two dilutions (10 and 40%). The stimulation of 35 S04 
by weanling cartilage was even greater and the dose res-
ponse steeper. 
(d) In contrast ~oled serum from 4% protein- f ed rats was only 
poorly stimulatory to all three types of cartilage but 
dose responses were still parallel to those of 20% protein-
fed an~ weanling rat serum (Fig. 7 . 1) . 
(e) The behaviour of the costochondral junctions was essen-
tially like that of the rest of the costal cartilage but 
the incorporation was greater under all circumstances . As 
there were fewer costochondral junction fragments only 3-5 
could be placed in each tube for incubation in triplicate. 
(Table 7. 2). 
D Discussion 
i) Although it is a highly artificial system, the in vitro 
incubation of cartilage fragments has been Kidely used to study the 
behaviour of cartilage in a variety of conditions in the rat, namely 
starvation and refeeding (Phillips and Young, 1976a), streptozoto-
cin diabetes (Phillips and Young, 1976b), cortisone-induced growth 
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arrest (Mosier, Jansons, Hill and Dearden, 1976), propylthiouracil-
induced hypothyroidism (Mosier,Dearden, Jansons and Hill, 1977) and 
the effect of ageing (Heins, Garland and Daughaday, 1970; Beaton, 
1976). Such systems have the advantage of permitting the manipu-
1 
lation of variables acting on cartilage in a manner impossible in 
vivo. As with the above studies, costal cartilages were chosen 
because of the ease of dissection and the adequate amount of tissue 
obtained and 35 so4 incorporation used as an indication of cartilage 
growth activity. The dissection of epiphyseal growth plate proved 
impractical in terms of the tissue required, the amount of carti-
lage obtained and the inaccuracy of the dissection. Costal carti-
lage has been widely used as being representative of growth carti-
lage in general and the results of in vivo 35 so4 labelling experi-
ments (Chapter 4) showed costal and epiphyseal cartilage to have be-
haved in a qualitatively similar way. 
(iia) The system utilized in this study differed from those 
previously described in that all cartilage was subjected to an ini-
tial serum-free preincubation in an attempt to minimize the "carry-
over" of the in vivo somatomedin and other humoral effects. That 
such carryover occurs is exemplified in the porcine costal cartilage 
bioassay for somatomedin (Van den Brande and Du Caju, 1974) in which 
the cartilage fragments are subjected to a preincubation step and in 
which the incubation with 35so4 follows the incubation with serum, 
but 35so4 incorporation is related to the somatomedin stimulus of 
the preceeding serum incubation. There is some evidence for the 
"carryover" of somatomedin effect in vivo to in vitro cartilage in-
cubation with 35 so4 (Phillips and Young, 1976a). The reduced serum 
somatomedin activity which occurs in acute starvation in the rat is 
paralleled by decreased 35 S04 incorporation into cartilage from 
starved animals incubated in a serum-free in vitro system. Such 
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cartilage was however still sensitive to stimulation of 
35
S04 incor-
poration by normal rat serum. 
(iib) The incorporation of 35S04 in this system was proven to 
be active in that boiled cartilage failed to incorporate 35S04. 
(iic) The incorporation of 35 so4 in this system was shown to 
be somatomedin dependent by the experiment in which stimulation of 
incorporation by panhypopituitary human serum was~ 20% that of 
normal .serum. Human hypopituitary serum was used because of the 
non-availability of hypophysectomised rat serum and came from patie-
nts without detectable growth hormone and who were on full replace-
ment therapy (thyroxine, cortisone, androgens or oestrogens). 
(iii) Cartilage from 20% protein-fed and 4% protein-fed rats 
" 
behaved similarly in that in the absence of serum they incorporated 
35 S04 d d d 11 t 1 d f 20° t . f d an respon e equa y o poo e serum rom o pro e1n- e 
and weanling rats. The response to pooled 4% protein-fed rat serum 
was less than that to normally nourished serum but was similar with 
both types of cartilage. Thus as in acute starvation (Phillips 
and Young, 1976a), in experimental protein malnutrition in the rat, 
the cartilagenous end-organ was normally responsive to serum soma-
tomedin activity and the reduced serum somatomedin in experimental 
protein malnutrition is probably the major factor in the reduced 
35so4 labelling in vivo and reduced skeletal growth. 
(iv) The cartilage of weanling rats had a higher serum-free 
35 S04 incorporation and showed a steeper dose response to serum 
containing somatomedin than 20% protein-fed and 4% protein-fed rat 
cartilage (Fig. 7. 1). This is in keeping with the fact that age 
appears to be the most important single factor determining cartilage 
responsiveness to soma tome din a.cti vi ty (He ins, Garland and Daughaday, 
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1970; Beaton, 1976). The response to 4% protein-fed rat serum 
was once again less than that to normally nourished serum. 
(v) The heterogeneity of the costal cartilage is well recog-
nised (Herbai, 1970), the costochondral junction area having the 
greatest 35so 4 incorporation. In the protein malnourished rats and 
their age and weight matched wellnourished controls this also proved 
to be the case but the response to different sera showed the same 
pattern as the costal cartilage itself. 
E Conclusions 
i) Experimental protein malnutrition does not alter the in-
trinsic ability of the cartilage to incorporate 35 so 4 , 
whether unstimulated or stimulated by serum. 
ii) The age of the animal appears to be the major determinant 
f 35so · · · · 1 · h · o . 4 incorporation into cart1 age, 1n tat unstimu-
lated and stimulated incorporation is greatest in wean-
lings and the slope of the dose response to serum is also 
steeper. 
iii) Serum from protein malnourished rats is poorly stimula-
tory to all types of cartilage, demonstrating the anti-
cipated low somatomedin activity. 
iv) Thus the poor 
35 so4 incorporation (and presumptively the 
growth) of cartilage in the protein malnourished rat in 
vivo is primarily due to a disturbance of the humeral 
factors acting on cartilage. 
CHAPTER EIGHT 
SOMATOMEDIN ACTIVITY GENERATION BY THE ISOLATED PERfUSED 
LIVER IN EXPERIMENTAL PROTEIN ENERGY MALNUTRITION 
"He looked in th e liver" Ezeki elf 21. 21. 
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In Section I of this chapter the evidence for the liver being 
a major site of somatomedin activity and the validation of a liver 
perfusion technique will be presented, while in Section II, the 
generation of somatomedin activity by· protein malnourished and con-
trol livers will be considered. 
SECTION I 
A The role of the liver in somatomedin generation 
Evidence for the liver as a major site of somatomedin genera-
tion is based on four groups of observations: 
i) Uthne and Uthne (1972) noted that partial hepatectomy in 
the rat resulted in a rapid fall of serum somatomedin activity which 
rose with hepatic regeneration. The entire phenomenon may have 
been a non-specific response to a severe traumatic insult and bio-
chemical derangement and the return to normal of somatomedin activi-
ty with liver regeneration the recovery from that insult. 
ii) In chronic liver disease serum somatomedin activity is re-
duced in spite of normal or elevated growth hormone (Wu, Grant, 
Hambley and Levi, 1974; Giordano, Foppiani, Minute, Ferroni and 
DiCicco, 1975). Similarly NSILA is reduced in patients with cirr-
hosis (Samaan, Stillman and Fraser, 1962). 
iii) A trans-hepatic gradient of somatomedin activity has been 
shown in the dog, the levels in the hepatic vein being significan-
tly higher than the portal vein (or femoral vein or artery) 
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(Schimpf£, Donnadieu, Glasinovic, Warnet and Girard, 1976). 
iv) Generation of somatomedin activity has been demonstrated 
by a variety of in vitro liver preparations: 
a) A crude microsomal fraction of rat liver in the pre-
sence of growth hormone and co~factors (Hall and 
Uthne, 1 9 71) . 
b) Isolated perfused rat liver preparations in response 
to growth hormone (McConaghey and Sledge, 1970; 
McConaghey, 1972; Williams and Hughes, 1974; Ash 
and Francis, 1975; Francis and Hill, 1975; Phillips, 
Herington, Karl and Daughaday, 1976; Daughaday, 
Phillips and Mueller, 1976; Wondergem, Gaspard, 
Hamamdzic and Klitgaard, 1977). 
c} Isolated perfused liver preparations in response to 
prolactin (Francis and Hill, 1975; Hill, 1977) and 
insulin (Daughaday, Phillips and Mueller, 1976). In 
addition NSILA has been generated in such systems 
in response to growth hormone (Schalch, Heinrich, 
Johnson, Koch and Miller, 1977; Heinrich, Schaich, 
Miller and Johnson, 1977). 
d) Superfused rat liver slices in response to growth 
hormone (Hintz, Clemmons and Van Wyk, 19 72). 
e) Incubated rat liver slices in response to growth 
hormone (McConaghey, 1972). 
B Methodology of liver perfusion 
i) Choice of experimental animals: In the preceeding chap-
ters, the protein malnourished rat was studied using a wellnouri-
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shed (20% protein fed) age-matched control and a wellnourished wean-
ling weight-matched control. The weanling controls were especial-
ly valuable in the study of cartilage behaviour (in vivo and in 
vitro) because of their known rapid growth and highly active carti-
lage. The weanlings were shown to have serum somatomedin activi-
ties si'milar to those of 20% protein fed and standard diet fed rats, 
thus in attempting to study liver somatomedin generation by the iso-
lated perfused livers of protein malnourished rats, 20% protein 
fed rats and standard diet fed rats were used as controls as the 
small friable vasculature and livers of the weanlings made perfu-
sion technically difficult. The standard diet fed rats had the 
additional advantage of being readily available .and were especially 
valuable in establishing techniques and in pilot studies for which 
the rats fed a special diet could not be spared. 
ii) The liver perfusion circuitry: The apparatus used per-
mitted recycling perfusion by the method of Hems, Ross, Berry and 
Krebs (1966). The liver, left in situ in the animal, was perfu-
sed via the cannulated portal vein and the perfusate returned to 
the reservoir via a cannula from the inferior vena cava. The 
bile duct was cannulated where possible and the hepatic artery liga-· 
ted (~ee section iv below for detailed operative technique). 
The perfusate was pumped from the reservoir by a peristaltic 
pump (initially a SARNS model 5500, Ann Arbor, Michigan, U.S.A. 
and later a Gilson Minipuls, France) and flowed down the inside of 
the glass "lung", which had a large dimpled surf ace and a counter-
current gas flow of 95% Oz/5% COz at 3 1/min. This provided pOz 
in the inflowing perfusate of 300-475 mmHg. An overflow from the 
lower end of the lung to ' the reservoir provided a constant pressure 
head. The reservoir was gently stirred by a magnetic stirrer and 
gassed with 95% 02/5% COz. Some livers were perfused with a con-
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stant set flow rate by means of a second peristaltic pump (Gilson 
Minipuls) interposed between the lung outflow and the liver. Flow 
rates were adjusted to provide sufficient oxygen for the maintena-
nce of liver viability (as confirmed by the tests detailed below) 
I 
for 2 hours by alteration of lung height above liver and adjustment 
I 
of valve V (see Fig. 8.1) or by direct setting of flow in the 
second pump. 
The entire circuitry except for the peristaltic pumps was 
housed in a perspex fronted, asbestos board cabinet provided with 
fluorescent lighting. The environment in which the experiments 
were conducted was maintained at 38°C by a thermostatically con-
trolled heater, high humidity was maintained by a steam inlet from 
an electrically heated evaporator, the air in the cabinet was cir-
culated by an electric fan. Liver temperatures of 37°-38°C were 
confirmed by a telethermometer probe (Simpson Electrical Co., 
Chicago, U.S.A.) placed between adjacent liver lobes. The liver 
itself was further protected against surface drying by covering 
with a gauze swab moistened with warm Plasmalyte B (Saphar Labora-
tories, South Africa). 
iii) Preparation of perfusate: The perfusate was a semisyn-
thetic medium containing aged human erythrocytes to increase oxygen 
carrying capacity. 
a) Outdated human donor blood was obtained from the 
Western Province Blood Transfusion Service. This 
blood was 4-5 weeks old and had been anticoagulated 
in the standard way with acid-citrate-dextrose and 
stored at 4°C. After centrifugation at 2000g for 
S min at 4°c, plasma and buffy coat were removed 
by aspiration. The erythrocytes were then washed 
with three times their own volume of chilled Krebs 
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Fig. 8.1 Liver perfusion apparatus 
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Fig. 8.1 Liver perfusion apparatus 
B Bile collection 
F Fan 
H Heater 
IC Inflow cannula (in portal vein) 
M Manometer 
MS Magnetic stirrer 
0 Oxygenator 
OC Outflow cannula (in inferior vena cava) 
OF Overflow 
OH Humidifier for oxygen/carbon dioxide 
P Primary pump (reservoir to oxygenator) 
P~ Secondary pump (oxygenator to liver -
not used in all experiments) 
PF Perfusate filter 
T Thermostat 
T~ Thermometer (for cabinet temperature) 
TT Telethermometer (connected to thermo-
sistor under lobe of liver) 
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Henseleit bicarbonate buffer (KHB). The wash was 
removed by centrifugation and aspiration as before. 
In all, three washes were performed. The final 
erythrocyte pellet was r ese rved and kept at 4°c 
until use (within 1 hour). 
b) Krebs Hense lei t bicarbonate buffer (KHB), gassed 
with 95% Oz:5% CO2 for 10 minutes at room temperature 
(20-22°C) was mixed with 2.Sg/100 ml bovine serum 
albumin (BSA) (fraction V) (Miles, Biochemicals, 
Cape Town) and 90 mg/100 ml D (+) glucose and the 
pH adjusted to 7.4 with a few drops of 1M NaOH. 
Glucose was omitted in those experiments to test the 
gluconeogenic capacity of the livers. 
c) The erythrocyte pellet and KHB-BSA mixture were 
mixed in a ratio of 1:9 to give a final haematocrit 
of 8-10%. The addition of another 0.7-1 .0 ml 1M 
N aHC03 was required to bring the final pe rfus ate pH 
to 7.38-7.50 after equilibration through the appara-
tus for 20 minutes at 37°C. 
I 
d) This provided an easily prepared, uniformly repro-
ducible perfusate, the characteristics of which 
are summarised in Table 8.1. 
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TABLE 8. 1 
PERFUSATE COMPOSITION (MEAN OF 10) 
Whole perfusate 
Haemoglobin (g/100 ml) 
Haematocrit (%) 
Glucose (mg/100 ml) 
added (standard) 
not added (gluconeogenic 
experiments) 
Supe rna tan t 
Free haemoglobin (g/100 ml) 
Albumin ( g/ 10 0 ml) 
Lactate (mMol/1) 
2.8 + 0.5 
8 + 1 
85 + 6 
< 2.5 
< 0.005 











iv) The operative technique of liver perfustion: Anaesthe-
sia was induced with 20% diethylether (Natal Cane Byproducts Ltd., 
Natal) in 95% Oz:5% CO2 from an ether dispenser, flow rate 3-5 L/ 
min. Once surgical anaesthesia was achieved, this was maintained 
using 5-10% ethylether in the same gas mixture and flow rate. 
I 
The rat was positioned on its back with its head away from the ope-
rator and the limbs gently abducted by elastic bands from the feet 
to pins on the operating board. The abdominal cavity was opened 
by a midline incision from pubis to xiphoid process and extended 
laterally on each side just below the costal margin. Care was 
exercised to avoid excessive haemorrhage from the internal mammary 
arteries or damage to the liver and diaphragm. The abdominal vis-
cera were displaced to the left of the animal and enclosed in a 
layer of gauze moistened with "Plasmalyte B" (Na+ 130, K+ 4, Mg++ 
1.5, Cl-109 and HC0- 3 28mM in sterile water). This allowed easy 
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access to the portal vein, bile duct, inferior vena cava and 
right kidney. Better display of the portal vein and bile duct was 
obtained by gentle traction applied by "mosquito" forceps on the 
pyloroduodenal junction, the duodenal wall at the level of the 
ampulla of Vater and the descending colon. 
The bile duct was opened with fine scissors and cannulated 
with fine polyethylene tubing OD 0.75mm (Portex Ltd., U.K.) with a 
sharp point and made rigid by placing in crushed ice and secured 
with one 4-0 silk suture. The fine strands of connective tissue 
between the right lobe of the liver and the inferior vena cava were 
divided and a loose linen ligature (A) placed around the vena cava 
above the level of the right renal vein with dissecting forceps. 
A _loose 4-0 silk suture (B) was inserted under the portal vein 4mm 
from the point where the main trunk divides into the branches ente-
ring . the different lobes of the liver. Another suture (C) was in-
serted under the portal vein 6mm distal to suture B. 
tied. 
Suture C was 
The portal vein was opened with fine scissors and a cannula 
introduced. The cannula was connected to an intravenous giving 
set and a bottle of "Plasmalyte B" warmed to 36-37°C. Great care 
was taken to exclude air bubbles from the system. Cannulae were 
constructed from 8-inch infant feeding tubes (Pharmaseal Inc., 
U.S.A.) with a tip of polyethylene tubing, Size C PE190 (Clay Adalffi 
Inc., N.J., U.S.A.) for rats in the weight range 90-130g. For 
protein malnourished rats (weights 27-40g) the cannulae had tips of 
polyethylene tubing, size B, PE60. The portal vein cannula was 
secured by tying suture B, the cannula tip thus lying well below 
the point whete the main portal trunk divides. The long ends of 
suture C were also tied around the cannula to ensure firm position-
ing. 
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The "Plasmalyte B" was allowed to flow at 2-4 ml/min and the 
/ 
liver checked for non-perfused areas (which remained the normal red-
brown colour while perfused segments we re yellow-brown). If the 
cannulation was satisfactory, the diaphragm was opened along the 
I 
costal margin taking care not to damage the intrathoracic inferior 
vena cava or liver. The anterior chest wall was widely removed to 
give adequate exposure of the thoracic viscera. The thymus was 
excised. A loose linen ligature (D) was passed under the inferior 
vena cava above the diaphragm. The inflow of "Plasmalyte B" was 
briefly increased to 4-8 ml/min to distend the vena cava and right 
heart chambers but distension of the liver itself was avoided. 
The right atrium was incised and a second cannula introduced into 
the inferior vena cava and secured in place by tying ligature D. 
Flow-rate was restored to 2-4 ml/min. The abdominal inferior vena 
cava was ligated by tying ligature A. 
Blood was swabbed from the body cavity with a moist gauze swab 
and the animal transferred to a glass platform which was then fitted 
into the top of the perfusate reservoir (later cannulations were 
performed directly on the platform). The portal venous cannula 
was disconnected from the intravenous giving set and connected to 
lung outflow without the introduction of air bubbles. The initial 
volume of effluent was drained into a measuring cylinder. After 
this initial "washout" phase the out-flow cannula was inserted into 
the reservoir. The vertical distance from the liver to the end of 
the out-flow cannula was kept at 3-4 cm. The bile duct cannula 
was placed in a tube (volume 1 ml graduated in 10 µl divisions). 
The liver was covered with a gauze swab moistened with warm "Plasma-
lyte B". Flow rate was adjusted by altering the lung outflow 
valve, the lung height or the secondary pump. Care was exercised 






---=------- Portal vein 
I 





The total procedure took 10-14 minutes, of which the "ischaemic 
time" was 3.5-4.S minutes (i.e. the time from portal vein ligature 
to establishment of perfusate flow). 
v) 
I Assessment of liver function and viability: In all per-
fusions the following were assessed: 
a) Macroscopic liver appearance: Only perfusions in which livers 
were uniformly perfus ed, showing a normal reddish-brown appearance 
with no swelling, distension or exudation from the surface were 
considered satisfactory. 
b) Bile volume: Bile was collected during the perfusion (except 
as discussed under operative technique in the very small protein 
malnourished rats). Mean bile production from 20% protein fed and 
normal diet fed rats was 63-66 µ1/hr/g wet liver weight. Although 
bile flow has been frequently cited as a criterion for liver func-
tion in perfused livers, it is an insensitive index (Ross, 1972). 
Mechanical problems such as twisting and curling of the bile duct 
can give falsely low bile flow rates and are very difficult to cor-
rect once perfusion has commenced. 
c) Flow rate: Flow rate was measured by timing the initial 100 ml 
perfusate (in the case of 20% protein fed and normal diet rats) or 
30 ml (in the case of 4% protein fed rats) through the liver. 
Throughout the perfusion the flow rate was monitored by counting the 
drop rate from the cannula in the inferior vena cava at frequent in-
tervals. (The drop volume of perfusate from such cannulae had been 
shown to be very uniform). Just before the termination of the ex-
periment another timed collection of 15 ml was made. A constant 
flow rate was maintained, the adjustments described in Section I. B 












































































































































































































































































































































































































































































































































































































d) ' Oxygen consumption: Specimens of perfusate were drawn into 
2 ml syringes via 21 gauge needles inserted into the portal vein 
and inferior vena cava cannulae and immediately analysed for pOz by 
the method described in Appendix B. Such sampling was conducted 
at 30 minute intervals over the 2 hour perfusion. With knowledge 
of flow rate, perfusate haemoglobin content c~ 2.8 g/100 ml) and 
the portal/hepatic p02 difference, the oxygen consumption could be 
calculated. (See Table 8.2). 
e) Wet/dry liver weight ratio: Livers were excised and weighed 
immediately after perfusion (a sample then being removed for histo-
logy in some cases) and dried to constant weight at 100°C. The 
wet/dry weight ratios were then calculated, taking the weight of 
the histological sample into account if necessary. The ratio did 
not differ significantly from those of unperfused livers (see Table 
8.2 
f) Histology: A total of 70 livers were examined histologically 
by means of 7 µ fixed paraffin embedded sections stained with haema-
toxylin and eosin (see Appendix A for method). The histological 
appearance of the perfused livers did not differ from that of un-
perfused livers described in Chapter 4. 
g) Glucagon-induced glycogenolysis. Using the identical appara-
tus, perfusate and techniques but livers from fed normal animals, 
Sacks, Waligora, Matthews, Pimstone (1977) found a glucagon concen-
tration of 6 x 10- 11 M sufficient to produce detectable glycogenoly-
sis. The maximal rate of glycogenolysis was achieved with 2.4 x 
-9 -10 10 Mand the! max with 1.2 x 10 M. These results represent a 
glucagon responsiveness close to the physiological range. 
h) Maximal rate of lactate gluconeogenesis: While all the indi-
ces described above are important measures of liver function in the 
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perfused liver, all are relatively insensitive. A far more sensi-
tive and satisfactory index of metabolic function in the perfused 
liver is the examination of a biosynthetic process as recommended 
by Hems, Ross, Berry and Krebs (1966). Maximal rates of urea, 
protein and glucose synthesis may all be used (Ross, 1972f). 
The choice of maximal rate of gluconeogenesis from lactate. 
The maximal rate of glucose synthesis from media containing 10mM 
(a saturating concentration) was chosen because this reaction is 
more sensitive than urea synthesis in that it requires 30% more ATP, 
mol per mol, and requires a longer chain of enzyme catalysed reac-
tions (Ross, 1972f). Hepatic protein synthesis (usually albumin) 
requires the use of labelled amino acids, the radioactivity of 
which would have contaminated the apparatus, or sensitive assays 
for other liver proteins (e.g. fibrinogen). The rate of albumin 
(Kelman, Saunders, Wich t, Fri th, Corrigan, Ki rs ch and Terb lanche, 
1972) and urea (Schimke, 1964) synthesis by the livers of protein 
depleted rats, is known to be diminished. This fact in itself 
need not be an objection to their use, providing the rate of the 
reaction remains constant over the period of the experiment (Sacks, 
1977a). 
The determination of lactate gluconeogenesis was performed in 
experiments separate from those for somatomedin generation. Ani-
mals from all three nutritional groups were studied: 
1) The following protocol was observed: time O min was 
taken as the moment that perfusate flow was achieved, the 
circuit was primed with 67 ml of glucose free medium, at 
28 min 1 .0 ml of 0.7M neutral L(+) Lactate (700µmol) was 
added to the reservoir. By 30 min the lactate concentra-
tion of the medium was~ 10mM. 
2) Lactate sampling at O, 30, 60, 90 and 120 minutes. 
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0.6 ml of perfusate was aspirated from the reservoir and de-
proteinised by the addition of 0.2 ml of ice cold 12% perchlo-
ric acid, centrifuged and the supernatant frozen until analy-
sed for lactate (see Appendix B). 
3) Glucose sampling at O, 10, 20, 30, 45, 60, 75, 90 and 120 
minutes. 0.6 ml of perfusate was aspirated from the reser-
voir for glucose analyses (see Appendix B). 
4) Perfusate volume was determined at the end of perfusion 
by allowing the perfusate to drain from the liver and the 
circuit pumped dry (1 ml was left behind). Thus the initial 
volume (ml) = volume drained+ volume of samples taken+ 1. 
The volume at each time of sampling could be calculated. 
Total perfusate glucose and lactate at each time point= per-
fusate volume x concentration. Total glucose and lactate 
were plotted against time and rates of glucose formation and 
lactate removal were obtained from the gradients of the plots 
and expressed as µmol/min/g wet or dry liver weight. 
5) Results: The plots from a representative experiment 
are shown graphically in Fig. 8.3. Glucose appearing in the 
medium during the initial 30 minute perfusion represented 
glucose formed from residual liver glycogen by glycogenolysis 
(Hems, Ross, Berry and Krebs, 196 6) . When no lactate was 
added at 30 minutes there was only a slight increase in glu-
cose due to endogenous gluconeogenic substrate in the liver 
(the glycogenolytic substrate now having been depleted) (Hems, 
Ross, Berry and Krebs, 1966). When lactate was added (10mM) 
there was a linear increase of glucose with a reciprocal 
linear fall in lactate. A delay of up to 15 minutes after 
the addition of lactate sometimes occurred as previously des-
cribed (Hems, Ross, Berry and Krebs, 1966). In the case of 
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Time course of glucose generation ( T) and 
lactate clearance ( +) by a perfused normal 
rat liver. The generation of glucose ( b) 
from another liver in the absence of added 
lactate is also shown. 



























of larger livers from well-nourished anima ls, the glucose 
production diminished between 90 and 120 minutes, at this 
stage the perfusate lactate had fallen to 4mM (n = 6) and 
linear glucose output could be restored by the further addi-
tion of lactate. In the case of the smaller protein-malnou-
rished livers, glucose output was linear until 120 minutes 
at which stage the lactate concentration was 9mM (n = 6). 
These results show that the flattening of glucose output from 
larger livers was due to substrate depletion and not deterio-
rating liver function. The maximal rates of gluconeogenesis 
from lactate are shown in Table 8 . 2 and Table 8.3. The rates 
in all 3 nutritional groups were similar, whether expressed 
in terms of wet or dry liver weight and resemble those of 
Hems, Ross, Berry and Krebs (1966) (1.0 ~ 0.06 µmol/min/g 
wet weight), Exton and Park (1967) (1 . 0 ~ 0 . 3 µmol/min/g 
wet weight) and Sacks (1977b) (normal rats 0 . 85 ~ 0 . 05 µmol/ 
min/g wet weight, protein-depleted rats 0.75 + 0 . 08 µmol/min/g 
wet weight). 
vi) Summary of tests of hepatic viability (Table 8.2): 
Table 8.2 summarises the results of the experiments which were used 
to determine the adequacy of liver function during perfusions of 2 
hours. No single test is an adequate test of viability but with 
satisfactory performance by 8 criteria, especially those of meta-
bolic synthetic function and hormone sensitivity, the livers were 
considered adequately viable for further experiments on somatomedin 
generation. 
C Discussion 
i) The choice of perfusion as a technique to study somato-




























































































































































































































































































ration by the liver in protein malnutrition include homogenates, 
subcellular fractions enriched with microsomes, isolated hepato-
cytes, liver slices (incubated or perifused) or the intact perfu-
sed liver. The isolated in situ liver perfusion technique was 
chosen and the advantages and disadvantages are compared to some of 
the techniques previously used to study somatomedin generation. 
a) When the isolated organ is perfused, the macroscopic and 
microscopic morphology remain intact, thus the architec-
tural relationships of cells to each other and of intra-
cellular organelles within cells are preserved. Simi-
larly the so-called physiological compartments of the 
intravascular, interstitial and intracellular spaces are 
preserved. Cell membranes which are vital permeability 
barriers maintaining gradients between cells and the 
interstitial compartment and between organelles within 
cells are not disrupted as is the case in homogenates 
and subcellular fractionations of homogenates such as 
those used by Hall and Uthne (1971). 
b) The nutrient and oxygen-carrying med1um circulates 
through the vascular space as it would in life. In the 
case of liver slices, exchange of nutrients, gases and 
metabolic substrates is by diffusion across the whole 
tissue for distances of 0.5 to 0.2 mm. 
ii) The choice of the in situ perfusion technique of Hems, 
Ross, Berry and Krebs (1966): The advantages included: 
a) Simple operative technique. The entire procedure could 
be conducted by a single operator without assistance and 
the difficult transfer of the isolated liver to an organ-
bath is eliminated. 
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b) Once cannulation and connection to the circuit was com-
pleted v e ry little supervision was required and the flow 
r~te rema ined remarkably constant as the positions of the 
cannulae were maintained throughout. 
I 
c) The liver itself was hardly handled at all, and this 
atraumatic method has been shown to be important in at 
least certain effects of insulin on the liver (Haft and 
Miller, 1958). 
d) Should the bile duct not be cannulated there is free flow 
of bile into the duodenum. In isolated liver perfusions 
the bile duct must be cannulated to prevent bile flowing 
into the medium where it may have untoward effects. Al-
ternatively the bile duct may be ligated (Abraham, Dawson, 
Grasso and Goldberg, 1968) with resultant unphysiological 
cholestasis. 
e) Because of the advantages listed ab~ve, Ross (1972b) 
recommends the in situ technique except where frequent 
liver tissue samples or liver surface measurements are 
the primary aim of the perfusion. 
' iii) How physiological is perfusion via the portal vein alone?: 
Perfusion via the portal vein alone is not entirely physiological in 
that in life the portal vein supplies 80% and the hepatic artery 
'\, 20% of the liver's blood supply. The portal circulation is low 
pressure (12-14 cm blood), non-pulsatile and relatively deoxygena-
ted (Ross, 1972c). Of especial interest is the observation that 
liquid media injected via the portal vein (silicone rubber) did not 
enter the hepatic arterial system, while injection into the hepa-
tic artery does fill part of the portal venous system and central 
sinusoids (Hase and Brim, 1966). Most authors agree that perfusion 
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via the portal vein alone is adequate to provide liver oxygen re-
quirements and that in the rat at least the hepatic arterial supply 
is not required for normal biochemical function (Ross, 1972d). 
There are liver perfusion circuits by means of which both circula-
tions may be perfused (Powis, 1970) but these were not considered 
because their complexity outweighed the theoretical advantages. 
iv) The choice of a semisynthetic red cell containing medium: 
To date somatomedin generation has been studied from livers perfu-
sed with synthetic media, usually Waymouth's MB 752/1 with bovine 
serum albumin (BSA) 0.5-1.0% (See Table 8.5). The reason for the 
use of a complex tissue culture medium is that it will support the 
cartilage of the somatomedin bioassay after perfusion (Ross, 1972g). 
We however chose a semisynthetic medium (KRB, 2.5% BSA), aged 
human red cells to a final haematocrit of~ 8%) for the following 
reasons: 
a) The higher concentration of BSA was much closer to that 
in vivo and provided a more physiological colloid osmotic 
pressure for the medium -which prevented the liver becom-
ing oedematous (confirmed by wet/dry weight ratios). 
b) The aged human red cells greatly increased the oxygen 
carriage of the medium, ensuring adequate oxygenation 
of the tissue without the problems of very high flow 
rates. Aged red cells are unable to glycolyse and do 
not influence the glucose in the medium in experiments 
studying gluconeogenesis (Hems, Ross, Berry and Krebs, 
1966). 
c) The amino acids, other nutrients and antibiotics requi-
red to maintain the cartilage fragments in the bioassay 
were all added to the medium post perfusion after the 
centrifugation of the red cells. The addition of these 
substances preperfusion, as is usually the case, may 
result in their loss by catabolism during perfusion (es-
157 
pecially gluconeogenic amino acids). In addition it was 
found in preliminary experiments using Waymouth's medium, 
that bile flow was very poor. Although the mechanism of 
this phenomenon was never elucidated it was decided to use 
a semisynthetic medium in the place of Waymouth's medium. 
v) Assessment of viability: The perfused livers were judged 
as being satisfactory by 8 criteria: macroscopic appearance, 
histology, wet/dry weight ratio, perfusate flow rate, bile flow, 
oxygen consumption, lactate gluconeogenesis, glucagon induced 
glycogenolysis, as discussed earlier in this chapter. 
In much of the previously published work on the generation of 
· somatomedin by perfused livers there is no reference to the viabi-
lity of the preparation (see Tables 8.4 and 8.5). Only in the 
cases of Daughaday, Phillips and Mueller (1976), Phillips, Hering-
ton, Karl and Daughaday (1976) and Hill, Francis, Conroy and Ashton 
(1977), where normal lactate/pyruvate ratios were demonstrated, 
and Heinrich, Schalch, Miller and Johnson (1977), where the syn-
thesis of 5 plasma proteins was measured, has there been biochemi-
cal proof of viability. 
In earlier work there is only reference to flow rate (in some 
cases); these were 3,5-5.0 ml/min (see Table 8.5). For a red 
cell free medium gassed at atmospheric pressure with 95% Oz:5% COz, 
such flow rates are at best marginally adequate in providing oxyge-
nation. The flow rates described by Daughaday, Phillips and 
Mueller (1976), Phillips, Herington, Karl and Daughaday (1976) and 
Hill, Francis, Conroy and Ashton (1977) are three times greater than 
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AVAILABLE DATA ON SOMATCHOIN C[N[AATION BY TH[ PERFUSED LIVER (OR . KIDNEY) 
Perfusate 
Waymouth 's ,e 
752/1 
0. 51 BSA 
penici 11 in 
100 u/ml. 
streptomycin 
100 ug/11! . 
Waymouth's ,e 
752/1 








0 . 5\ B.S.A. 
penici 11 in 
100 u/ml. 
streptomycin 





0 . 51 BSA 
(froction V) 
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with honnone- 5 ml/min. 
free medi I.ft. 





100 11! washout 
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free med i um . 
100 ml bGH 
containing 
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3. 5 - 4 . S 
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hblt8,5 (continutd) AVAILABLE DATA ON SOMATOMEOIN GENERATION BY THE PERFUSED LIVE~ (OR KIOIIEY) 
Tests Duration 
Perfusion of and flow 
Author ~~ Perfuute Ho,..,,,.s Assay sys tea Yhblllty Voh•s ratts 
Francis & Non111l Nit Wa)100uth' s "8 bGH (NIH·GH-817) Centrl fugatlon, In situ lher 100 al washout 
Hill (197S) Spragut· 752/1 0. 1, 1.0, 10.0 •ill lport perfusion with horwone-
Naturt 255 : 167 Dawlty rots O. S1 8,5.A . ug/al . Ovlnt fl ltrat ion and fret aedfia. 
(Wt.220• {fraction V) prohctin (Sigma frozen. 100 al horaone 
260 9). or NIH·SIO) Assayed for cont,tnfng 
s.o, so, soo sulphatfon acdl .. rt· 
ng/al. factor by cfrcullt£d 
nonul rat thrice. 
cos ta 1 
cartilage assay 
(I point). 
Phillips, Nonul Mlo Wa)100uth' s "8 bGH (NlH·GH-817) Mf llfport Ex situ lher Lactate/Pyru,ate 40 111 changed 3 hours 
Herington, Spr1gut· 7S2/1 in ,ltro ff ltratlon perfusion ratio 13.S e.ery 30 •in 15-16 
Karl & Dawlty 11 8 . S.A. 2S ug/al . and frozen. for 3 hours. al/11in. 
Daugh1day r1ts (fr,ctfon V) In •ivo to Assayed for 
( 1976) (Wt . 85-lSOg) hypox. rats sulphatfon 
Endocrinol. Hypox. Nlt S00 ug SJ, 29 hctor by 
98 : 606 . rats 1nd 6 hours hypox. rat 
(Wt.8S·110g) Ip btfort costa 1 






addtd bt fore 
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Daughaday, Hypox.Nlt Way,oouth' s "8 bGH (HlH·GH- 817) Assayed for Ex situ 11,-.r L1ttatt/PyruV1te 40 al changed 3 hours Phillips & Sprogue- 752/I 0.2S ug/ml sulpha t1on I\Jt 1 ltr Dawlty 11 8.S.A . 2S .0 ug/al 
perfusion ratio every 30 min IS-16 
( 1976) f1etor by for 3 hours. al/ain. rats (fraction V) Insulin (Lilly) · hypox. rot Endocrine 1. (Wt.8S-110g) 100 uU/•1 costal 98 : 1214 1000 uU/al cartilage 
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sulph1t ion factor. 
Scha 1 ch, Non111l rots. GH Assayed for Ptrfustd 1i Yer 
Heinrich, Hypox. rots. TJ NSILA by 12 hours 
Johnson, Hypox . rots Cortisol COlll)Otitf.e 
Koch I prttruted Insulin protein 
Miller (1977) with GH, binding asuy . 
Clin . Res . T3, cortisol 
2S : 399A and insulin. 
twfnrich, No .... 1 rots . GH Assayed for Perfused liver Synthesis or s Schaich, Hypox . rats. T3 NSILA by different 12 hours Miller I Hypox. rats Cortisol Coq>t tit 1 ye plasN protein Johnson prttrt1ted Insulin protein 
(1977) with GH, binding uuy. Acta Endocrin . T3, cortisol 













































































































































































































































































































































































































































































































































































































































































































































































































































A Somatomediti gene~atidn by th~ isdl~ted "iti situ perftised liver 
Somatomedin activity generation by the isolated perfused livers 
of 4% protein fed, 20% protein fed and standard diet fed rats were 
studied under five hormonal conditions. (The rats fed standard rat 
cubes were a pilot study conducted before animals fed special diets 
were studied): 
1. No added hormones 
2. Human or bovine growth hormone 10 µg/ml 
3. Porcine insulin 1000 µU/ml 
4. Porcine insulin 1000 µU/ml + bovine growth hormone 10 µg/rnl. 
B Methodology 
i) The perfusate was prepared and the liver prepared for per-
fusion as already described. 
ii) In the case of 20% protein fed and standard diet fed rats 
the liver was subjected to an initial "once through washout" of 100 
ml of hormone-free perfusate which required about 10 minutes and 
which was collected in a measuring cylinder rather than being re-
turned to the reservoir. With 4% protein fed rats a similar pro-
cedure was carried out with 30 ml of hormone-free perfusate which 
also required about 10 minutes and was equivalent on a liver weight 
basis. 
iii) At the end of the "washout" phase the outflow cannula was 
inserted into the reservoir and the perfusion circuit thus conver-
ted from a straight through to a recycling system. 
iv) In those perfusions in which hormonal additions were made, 
these were to the reservoir and the remaining 35 ml of perfusate. 
In the case of growth hormone a single addition was made directly 
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after the "washout" phase; with insulin the first addition was 
directly after the "washout" phase and smaller additional amounts of 
insulin were added at 30 minute intervals to compensate for the 
rapid clearance of insulin. Th e amounts of insulin added to com-
pensa te for liver clearance were derived from the work of Sacks 
(1977c). 
v) A sample of uncirculated medium from the same batch with 
the same hormonal supplement was reserved and at the end of the 
perfusion period (2 hours) a sample of circulated medium was collec-
ted for radioimmunoassay of the hormone infused, to confirm the 
levels, and for bioass ay of somatomedin. Samples were prepared 
as follows: red cells were removed by centrifugation (2000g for 
10 minutes) and the supernatant decanted, rapidly frozen and sto-
red at -20°C until assay. 
vi) Preparation of samples for assay of somatomedin activity. 
Samples were thawed and filtered into sterile tubes through (EG 0.2 
µm) millipore filters. Circulated and uncirculated media from the 
same batch were always dealt with in the same assay. The sterile 
perfusate was then pipetted into the incubation rack at a concentra-
tion of 80%, the volume being made up by a supplement of amino 
acids and antibiotics which gave amino acid and antibiotic concen-
trations identical to those of the bioassay medium described in 
Chapter 3 and Appendix B. The amino acids and antibiotics were 
themselves dissolved in the KHB-BSA medium of the perfusate. 
Some samples were subjected to assay (after supplementation as 
above) at dilutions in assay buffer of 80, 40, 20 and 10% against 
a pooled rat serum standard of arbitrary (normal) potency 1 U/ml. 
All perfusates were assayed in triplicate by measuring the 
35S04 uptake into porcine costal cartilage discs as described in 
Chapter 3. In the case of the "single point" assay the amount of 
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35 so4 incorporated with uncirculated medium from a given p~rfusion 
was taken as a nominal 100% and the 35 S04 incorporation occurring 
with the circulated medium expressed in terms of this. 
C Results 
The 35 so4 incorporation into porcine costal cartilage discs 
stimulated by circulated perfusate (relative to uncirculated perfu-
sate) from the livers of protein malnourished and control animals is 
shown in Table 8.6. In dilution samples were parallel to standard. 
TABLE 8. 6 
STIMULATION OF 35 S04 INCORPORATION INTO PORCINE COSTAL 
CARTILAGE DISCS BY PERFUSATES AT AN 80% CONCENTRATION, 
WITH AMINO ACID AND ANTIBIOTIC SUPPLEMENT 




GH ( 1 0 µ g / m 1) 
Insulin (1000 
108.5.:i:_ 4.9(11) 124.1+ 5.6(12) 
158.8+11.2 (9)§ 0 243.3+ 9.7(12)t 
148.6~12.1 (6) 
214.8~11.8(14)t 
µU/ml) 147.3~11.0(10)§ 0 211.5~10.4(10)t¢ 
159.9+10.7 (8)§ 0 251.2+11.9 (8)t 
+ 223.0+11.9 (6)+ 
GH + insulin 
1. as bGH and hGH were not significantly different from 
each other they are presented combined 
2. unperfused medium= 100 
3. Mean+ SEM (number) 
4. Student's unpaired t test 
* p < 0.05 4% Protein diet vs 20% Protein dieter Standard diet 
§ p < 0.005 4% Protein diet vs 20% Protein diet or Standard diet 
t p < 0.001 hormonal addition vs hormone free (20%) or Standard 
diet 
t p < 0.002 hormonal addition vs hormone free Standard diet 
o p < 0.005 hormonal addition vs hormone free (4%) 





The genera tion of somatomedin activity by the isolated perfu-
sed liver of protein ma lnourished and control rats. 
i) Hormonal stimuli previously shown t d stimulate somato-
medin generation . Human arid bovine growth hormone at 10 µU/ml 
are concentrations previously shown to stimulate somatomedin gene-
ration in perfused liver systems (McConaghey and Sledge, 1970; 
Daughaday, Phillips and Mueller, 1976). The range of growth hor-
mone concentrations used has been 0.1 to 100 µg/ml (McConaghey, 
1972) with the majority of workers using 10 or 25 µg/ml (see Tables 
8.4 and 8.5). The lowest level of growth hormone producing detec-
table somatomedin activity generation is 1 µg/ml (McConaghey, 1972; 
Francis and Hill, 1975). The somatomedin activity generation dose 
response relationship ·with growth hormone remains incompletely ex-
plored but at present pharmacological or maximum physiological 
doses of growth hormone are required to produce detectable somato-
medin activity. (In the rat , growth hormone peaks as high as 1 
µg/ml can occur (J . Martin, personal communication , 1977) . To 
date, only insulin at the pharmacological dose of 1000 µU/ml , has 
produced somatomedin activity generation by the perfused liver 
(Daughaday, Phillips and Mueller, 1976) . 
The subject of interactions between growth hormone and insulin 
has only been partly explored (Daughaday , Phillips and Mueller, 
1976) but a synergistic action is suggested by the fact that doses 
of growth hormone (0 . 25 µg/ml) and insulin (100 µU/ml) neither of 
which produced significant somatomedin activity generation alone 
together resulted in significant generation of somatomedin activi-
ty. At the high insulin concentration (1000 µU/ml) the suboptimal 
growth hormone concentration (0.25 µg/ml) had no additive effect 
probably because the response to insulin was already maximal . To 
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study the interaction between the somatomedin activity generation 
dose response relationships to insulin and growth hormone is an 
immensely complex and laborious task and has not as yet been attem-
pted. 
Ovine prolactin at concentrations as low as 50 ng/ml has been 
shown to result in significant generation of somatomedin activity 
by the isolated perfused liver (Francis and Hill, 1975). This phe-
nomenon also has a circadian variability in that more somatomedin 
is generated at 1100 hours than at 1500 hours (Francis and Hill, 
1975) and may be related to the circadian variation in glucocorti-
coids (Hill, Francis, Conroy and Ashton, 1977) although the rele-
vance of ovine prolactin (structurally similar to growth hormone) 
and the use of cortisone in the rat, whose physiological gluco-
corticoid is corticosterone, may be questioned. 
ii) Hormones used to study somatomedin generation by protein-
malnourished livers. The hormones used were selected to seek an 
answer for the finding of low serum somatomedin activity with nor-
mal growth hormone and low insulin in experimental protein malnu-
trition. Would the malnourished liver respond in vitro to pharma-
cological levels of growth hormone (when the intact animal failed to 
do so) and what role did the hypoinsulinaemia play? 
The method of hormone addition. Only a single dose of growth 
hormone was added to the perfusate to give an initial concentration 
of 10 µg/ml; this is in keeping with the work of others (see 
Tables 8.4 and 8.5) and the relatively slow clearance of growth 
hormone by perfused livers in this system (Sacks, 1977, personal 
communication). The addition of supplementary insulin at 30 
minute intervals using the insulin clearance by normal and malnou-
rished livers studied in an identical system (Sacks, 1977c) compen-
sates for the relatively rapid clearance of insulin. This corres-
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ponds in some ways to the intermittent changes of insulin containing 
medium by Daugha<lay, Phillips and Mueller (1976). Haemolysis is a 
major cause of insulin degradation in perfusion systems using red 
cell-containing media, in all experiments great care was taken to 
( 
prevent haemolysis and that which occurred was within the range 
shown not to cause excessive insulin degradation (Sacks, 1977c). 
The high albumin content of the perfusate prevented excessive ad-
sorbance of hormone to glass. 
iii) The "washout" phase of perfusion. This served to remove 
residual blood and thus any already extracellular somatomedin acti-
vity trapped in the liver and is a widely practised technique 
(Table 8.4). The volume used in the 20% protein fed and standard 
diet fed rats was comparable with those used by other investigators 
for animals of approximately similar weight. The lesser volume 
used for the 4% protein fed rats provided a similar volume washout 
on a gm liver weight basis and required a similar time c~ 10 minu-
tes) . 
iv) The period of perfusion, volumes of perfusate and expre-
ssion of results. In work published to date two approaches have 
been used; following a washout phase a small volume (40 ml) was 
recirculated and changed every 30 minutes for three hours which 
allows for the study of the time-course of somatomedin activity 
generated (Phillips, Herington, Karl and Daughaday, 1976; 
Daughaday, Phillips and Mueller, 1976) or larger volumes (100 ml) 
were recirculated three times through the liver, multiple recircu-
lation being required before a significant generation of somato-
medin activity could be demonstrated (see Table 8.5). 
The approach in studying the malnourished rats and their con-
trols was somewhat different, a smaller volume of perfusate (35 ml) 
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was recirculated through the liver for 2 hours. The multiple re-
circulation of a small volume was to maximise changes in somatomedin 
activity generated. The time period of 2 hours was one in which 
variability of the liver preparation was proven. 
A comparison between the somatomedin activity generated in 
such a system by livers with such different weights and flow rates 
is difficult. The following factors may influence apparent soma-
tomedin activity generation: 
a) Perfusate volume (constant in this system) 
b) Duration of perfusion (constant in this system) 
c) Washout phase (adequate and equal on a liver weight 
basis in this system) 
d) Perfusate flow rate (approximately equal in the different 
livers on a liver weight basis in this system) 
e) Mass of liver tissue (a major difference which was partly 
compensated for in some of the factors above). 
Thus values were expressed per liver wet weight. Corrections 
for flow rate, while somewhat altering values, did not cause 
major overall changes. Previous workers have not taken liver or 
animal weight, variations in flow rate into account, even where 
animals of different weights (e.g. hypophysectomised and control 
rats) were used (Phillips, Herington, Karl and Daughaday, 1976). 
Only in the case of Schalch, Heinrich, Johnson, Koch and Miller 
(1977) was body surface area taken into account in a study of 
NSILA generation. 
v) The preparation of samples for assay. Centrifugation of 
red cells, storage at -2o 0 c and sterilisation by millipore filtra-
tion are standard techniques in studying somatomedin activity gene-
ration in incubation, perifusion and perfusion systems. Micro-
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biologica l contamination of the sample may result in degradation of 
hormones in it or may interfere with the cartilage fragment incuba-
tion which is vital to the somatomedin bioassay. Antibiotics were 
added to the medium post perfusion for the same reason. Most wor-
kers add antibiotics to the medium pre-perfusion (except Daughaday, 
Phillips a nd Mueller, 1976) and this may result in alteration in 
antibiotic concent r a tion and possibly adversely affect the quality 
of the liver preparation. It was impossible to sterilise the per-
fusion apparatus but it was at all times kept meticulously clean, 
and with millipore filtration and antibiotic addition, frequent 
microbiological surveillance showed contamination by microorganisms 
not to be a problem. 
The addition of the amino acids to the perfusate post perfusion 
provided known and adequate concentrations, which may have been 
altered by processes such as gluconeogenesis, if such amino acids 
had been added before perfusion. Waymouth's medium 752/1 also does 
not contain optimal concentrations of serine and glutamine for 
somatomedin bioassay and the release of these amino acids may con-
tribute to the low molecule weight c~ Daltons) somatomedin activity 
described in liver perfusates by Dehnel, McConaghey and Francis, 
(1974). 
vi) The assay of somatomedin activity in perfusates. 
a) Because of the large numbers of perfusate samples genera-
ted by the perfusion programme, all samples were initially assayed 
for somatomedin activity by a simplified assay at only one concen-
tration (80%) in triplicate. The incorporation of 35 S04 occurring 
with uncirculated perfusate was given a nominal value of 100 and 
circulated perfusate of the same batch compared with this in the 
same assay. 
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Results were expressed as: 
CPM 35 S04 incorporated/mg cartilage/g wet liver weight= 100 for un-
circulated perfusate 
or 
CPM 35so4 incorporated/mg cartilage/g wet liver weight/flow rate 
(ml/min) = 100 for uncirculated perfusate 
A similar approach has been used by the majority of investiga-
tors to date (Tables 8.4 and 8.5) and is probably a satisfactory 
method of estimating somatomedin activity of perfusates. 
Assay in serial dilutions of perfusates against a standard of 
pooled rat serum was carried out on a limited number of perfusates 
selected at random--and in all cases parallelism of perfusate to 
serum standard was found in keeping with the findings of Wondergem, 
Gaspard, Hamamdzic and Klitgaard (1977) and Williams and Hughes 
(1974). 
b) 35 The majority of workers have used S04 incorporation into 
rat costal cartilage as a bioassay, using either hypophysectomised 
rats or immature intact rats (see Tables 8.4 and 8.5). Only 
Wondergem, Gaspard, . Hamamdzic and Klitgaard have used the chick 
cartilage sulphation assay and Ash and Francis (1975) a rabbit 
chondrocyte assay examining 35 so4 and tritiated thymidine incorpora-
tion. The porcine costal cartilage assay has not been used by 
others to date. It has an additional advantage in that the S04 
content of the medium, which may change during perfusion (Phillips, 
Herington, Karl and Daughaday, 1976) does not influence the assay if 
the 3 5 S 04 s t age f l · f d · h h ' o t 1e assay is per orme in t e IICommunity Bat. . 
NSILA has been measured using a competitive binding protein assay 
(Heinrich, Schalch, Miller and Johnson, 1977). 
vi) Somatomedin activity gene ration by protein malnourished 
and control animals: 
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a) The livers of 20% protein fed and standard diet fed rats 
l perfused with a hormone free medium showed a significant generation 
of somatomedin activity over two hours. In- time-course experimen-
ts, Phillips, Herington, Karl and Daughaday (1976) have shown the 
major fraction of somatomedin generated in a hormone-free perfusion 
to occur early (up to 90 min). Schalch, Heinrich, Johnson, Koch 
and Miller (1977) reported similar results for the generation of 
NSILA. This probably represents a carryover of the growth hormone 
and other hormonal factors present in vivo in that they showed re-
duced somatomedin generation from the livers of hypophysectomised 
rats which could be restored to normal by pretreatment in vivo with 
growth hormone. Thus the somatomedin activity generated by hor-
mane-free perfusions may be taken as an indication of the in vivo 
stimulatory milieu for somatomedin generation and the liver's capa-
city to respond to this. In contrast to the significant generation 
of somatomedin activity by control livers in a hormone-free perfu-
sion, that generated by the livers of protein malnourished animals 
was less and only just detectable. This observation may indicate 
that the low serum somatornedin activity observed in protein malnou-
rished rats is due to reduced hepatic generation. Earlier workers 
were unable to show sornatornedin activity generation from hormone-
free perfusions (e.g. McConaghey and Sledge, 1970) but the explana-
tion for this offered by Phillips, Herington, Karl and Daughaday 
(1976), namely that due to low flow rate the preparation was sub-
optimally oxygenated, seems valid. 
b) Human and bovine growth hormones, both known to be bio-
active in the rat, caused significant and similar stimulation of 
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somatomedin generation in 20% and standard diet fed control animals, 
and while a response occurred in the 4% protein fed rat livers per-
fused with these hormones, it was significantly smaller than that 
of the control animals. This observation is consistent with the 
failure of protein malno~rished rats to grow or their serum somato-
medin to increase after high dose exogenous growth hormone admini-
stration. It represents an end-organ resistance at liver level to 
an action of growth hormone in protein malnutrition. The only 
similar resistance of the perfused liver to a stimulus for somato-
medin generation is that produced by cortisol on prolactin-induced 
somatomedin generation (Hill, Francis, Conroy and Ashton, 1977). 
c) The perfusion of well nourished control livers with insu-
lin (1000 µU/ml) resulted in a generation of somatomedin activity 
significantly less than that achieved with growth hormone but not 
out of keeping with the findings of Phillips, Herington, Karl and 
Daughaday (1976). As with growth hormone, the response of the 
protein malnourished livers to insulin was less than that of well 
nourished controls but unlike the controls the responses to growth 
hormone and insulin were of equal magnitude - this may represent 
a relatively greater sensitivity to insulin of the malnourished 
livers (possibly a result of the in vivo hypoinsulinaemia in these 
animals). 
d) The combination of growth hormone (10 µg/ml) and insulin 
(1000 µU/ml) was equal to growth hormone alone in stimulating 
somatomedin activity generation from well nourished and protein 
malnourished livers. The failure to obtain an additive effect 
was probably due to the high concentrations of hormones used, each 
already giving maximal stimulation and was in keeping with the 
findings of Daug~aday, Phillips and Mueller (1976). 
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e) The mechanism for the reduced somatomedin generation by 
protein malnourished livers may be: 
Specific, as a homeostatic response to protein malnutrition by 
which the rapid direct metabolic effects of growth hormone may be 
dissociated from the effects of somatomedins which growth hormone 
usually induces. Somatic growth may be seen as non-adaptive in a 
time of restricted substrates as occurs in protein energy malnutri-
tion. Insulin, and possibly other hormones (e.g. glucocorticoids) 
may be amongst the factors operative. 
Due to a generalised depletion of amino acid substrates for 
hormone synthesis. If this was the case then it was not due to 
differences in the circulating amino acids because all livers were 
perfused with an essentially amino acid free perfusate. However a 
depletion of the intracellular utilisable amino acid pool is proba-
bly present, but as the requirement for hormonal synthesis is such 
a minute fraction of hepatic protein synthesis, simple substrate 
deficiency seems a superficial explanation. In human protein ener-
gy malnutrition elevated growth hormone levels (and the low somato-
medins associated with them) are inversely correlated to certain 
amino acids and infusions of these amino acids do not lower the 
growth hormones (Pimstone, Becker and Hansen, 1973). 
Non-specific as a response to the deranged liver function 
which is a consequence of protein malnutrition. The livers were 
macroscopically fatty, had increased extractable lipid and the 
characteristic abnormal histology. 
f) The term somatomedin activity generation has been used 
because the presence of somatomedin activity in the perfusates from 
stimulated or unstimulated livers may be due to release from pre-
existent stores or de novo synthesis. To date no work with inhibi-
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tors of protein synthesis has been performed to elucidate this. 
Some worke rs (Williams and Hughes, 1974) have extrapolated somato-
medin activity generation by perfused livers to synthetic rates and 
compared these to that obtained from the T1 of somatomedin in the 
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rat. This requires considerable assumptions and as the T! of 
somatomedin in the malnourished rat may differ from normal, no 
such extrapolations were made. 
g) The nature of somatomedin activity in liver perfusates. 
The somatomedin activity of liver perfusates shares many characte-
ristics with serum somatomedin (see Table 8.5). 
It stimulates 35 S04 incorporation into hypophysectomised and 
normal rat cartilage, chick cartilage and as demonstrated here, 
into porcine cartilage. Thymidine uptake into rat cartilage has 
also been demonstrated~ 
In those cases where multiple point bioassay has been conducted 
dose response curves of liver perfusate and rat serum are parallel 
(Wondergem, Gaspard, Hamamdzic and Klitgaard, 1977; Williams and 
Hughes, 19 7 4) . The non-parallelism discussed by Hintz, Clemmons 
and Van Wyk (1972) refers to fractions from chromatography only. 
Liver perfusate somatomedin activity competes for binding on 
placental membranes similarly to serum somatomedin (Daughaday, 
Phillips and Mueller, 1976) and perfusate NSILA binds to specific 
NSILA binding protein (Heinrich, Schalch, Miller and Johnson, 1977). 
Preliminary characterisation by Sephadex chromatography. 
(Hintz, Clemmons and Van Wyk, 1972; Wondergem, Gaspard, Hamamdzic 
and Klitgaard, 1977) and by Amicon molecular ·filters (Dehnel, 
McConaghey and Francis, 1974) shows a pattern not dissimilar from 
that found in serum. 
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E Conclusions 
With a well validated in situ isolated perfused liver system 
significant stimulation of somatomedin activity generation was 
a&ieved with growth hormone, insulin and the two hormones in com-
bination in normal rats. 
In protein malnourished rats the somatomedin generation was 
reduced in hormone-free and growth hormone and insulin stimulated 
perfusions. These observations suggest that the reduced serum 
somatomedin activity of protein malnourished rats may be due to 
decreased hepatic generation. The mechanism for reduced somato-
medin generation may thus in part be due to. the hypoinsulinaemia 
of protein malnutrition. 
CHAPTER NINE 
SUMMARY OF CONCLUSIONS 
"I gnorabimus, dubi temus" 
be cautious) 
(Where we do not know, Zet us 
Etiz DuBois-Reymond 
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A satisfactory assay for the measurement of somatomedin acti-
vity in rat serum was established and its specificity, sensitivity 
and reproducibility documented. 
A model of protein-energy malnutrition in the rat was chosen 
which has in common with the human syndrome, growth failure, hypo-
proteinaemia, hypoalbuminaemia and fatty infiltration of the liver. 
This model was found to have narrow, histologically inactive epi-
physeal growth cartilage, the matrix of which did not differ histo-
35 chemically from wellno.urished controls, and reduced so4 incorpo-
ration into cartilage (as shown by autoradiography of sections of 
long bones and by liquid scintillation counting of dissolved costal 
cartilage). Exogenously administered growth hormone (known to be 
biologically active in the rat) failed to cause weight gain, in-
crease in length or increase in tibial epiphyseal width. 
Serum somatomedin activity was reduced in the protein malnou-
rished rats, no obvious inhibitor could be demonstrated either by 
non-parallelism of dose-response compared to wellnourished standard 
or by mixing experiments. Low serum somatomedin activity was pre-
sent in the face of normal growth hormone levels. Exogenously ad-
ministered growth hormone failed to stimulate serum somatomedin 
levels in the protein malnourished animals. Insulin levels were 
low and this may be in part responsible for low somatomedin activity. 
The cartilage of protein malnourished animals was found in vivo 
to incorporate 35so4 similarly to that of age-matched controls both 
basally and in response to normal rat serum while malnourished rat 
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serum hardly stimulated either type of cartilage, suggesting that 
cartilagenous end-organ resistance to somatomedin was not a major 
factor in the reduced growth rate of protein-energy malnutrition. 
A method of isolated in situ liver perfusion was validated for 
protein malnourished and control animals in which the somatomedin 
activity generated by the livers of protein malnourished animals was 
less than controls either in the absence of hormonal stimuli, with 
growth hormone, with insulin and a combination of insulin and grow-
th hormone. A slightly greater relative sensitivity of the mal-
nourished animal's livers to insulin may reflect the importance of 
insulin as a factor in the maintenance of normal somatomedin activi-
ty. Reduced liver generation of somatomedin activity is postulated 
as being a possible cause for the reduced somatomedin activity of 
serum in protein-energy malnutrition, this may be either a non-
specific reflection of deranged liver function or may represent an 
adaptive homeostatic mechanism whereby the direct actions of growth 
hormone might be permitted at a time that stimulation of growth is 
disadvantageous. 
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APPENDIX A: HISTOLOGICAL AND HISTOCHEMICAL TECHNIQUES 
A. Routine staining with haemalum and eosin 181 
B. Metachromatic staining with toluidine blue 181 
C. Sweet's resorcin-crystal violet and picro-fuchsin stain 182 
D. Alcian blue (pH 1.0) for sulphate groups of mucopoly-
saccharides 
E. Alcian blue (pH 2.5) for acid groups (COOH and OS03H) 
of mucopolysaccharides 




Digestion with testicular hyaluronidase 
Oil Red O stain for fat 





Measurement of serum and perfusate albumin 
Measurement of total se~um protein 
Measurement of perfusate glucose 
Determination of extractable liver lipid 








Measurement of perfusate lactate 
Determination of serum sulphate 
Measurement of perfusate p02 
Programming of Packard Tricarb 2650 for the counting 
of 35 S04 
Preparation of incubation medium 






























HISTOLOGICAL AND HISTOCHEM ICAL TECHNIQUES 
(A) Routine staining with haemalum and eosin (Culling, 1974). 
1. Mayer's haemalum was prepared after ;the method of 
Culling (1974)_. 
2. Dewaxed sections were brought to water through graded 
alcohols. 
3. Stained in Mayer's haemalum for 15 minutes. 
4. Washed in tap water until blue. 
5. Differentiated in 1% HCl in ethanol (about 10 secs). 
6. Again washed in tap water until blue. 
7. Counterstained with 1% aqueous eosin for 3 minutes. 
8. Washed in tap water for 3 minutes. 
9. Dehydrated in graded alcohols, cleared in xylol and 
mounted in Depex (Gurr, England). 
(B) Metachromatic staining with toluidine blue (Culling, 1974). 
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Reagents A: Toluidine blue (BDH, Poole, England) 0.25g in 
100 ml Michaelis' Veronal acetate - hydrochloric 
acid buffer pH 4.5. 
B: Veronal acetate solution 
Sodium acetate 1.943g 
Sodium barbiturate 2.943g 
Distilled water to 100 ml 
C: For pH 4.5 Michaelis' Veronal acetate - hydro-
chloric acid buffer 
5 ml veronalacetate solution 
11 ml 0.1N hydrochloric acid 
9 ml distilled water 
Method: 




Stained in solution A for 10 seconds!" 
Rinsed in distilled water. 
4. Blotted dry with fluffless blotting paper, then air 
dried. 
5. Dehydrated in graded alcohols, cleared in xylol and 
mounted in Depex (Gurr, England). 
Results: 
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Metachromatic substances red, pink or purple. Nuclei blue. 
(C) Sweet's resorcin-crystal violet - and picro-fuchsin stain 
(Sweet, 1968). 
Reagents A: Harris' haematoxylin (Gurr, England) prepared 
according to the method of Culling (1974). 
B: Crystal violet (BDH, 3043960, Poole, England) 
1g, resorcin (Hopkins and Williams Ltd., England), 
distilled water 60 ml were all boiled for 3 min 
with constant stirring after which 30 ml of a 
30% w/v solution of FeCl3 was added and boiling 
continued for another 3 min. The solution was 
filtered and the filtrate reserved, the precipi-
tate was washed with 50 ml distilled water and 
100 ml of absolute alcohol was added to the 
second filtrate. Both filtrates were combined 
and boiled for 5 min, filtered again and the 
precipitate discarded, finally 2 ml of concen-
trated (32% w/w) HCl was added to the filtrate 
which was cooled before use. 
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C: Van Gieson's picro-fuchsin. 100 ml saturated 
aqueous picric acid was mixed with 10 ml 1% acid 











Dewaxed sections were brought to water through graded 
alcohols. 
Stained in solution A for 5 min. 
Washed in tap water until blue. 
Stained in solution B for 1 hour. 
Briefly washed in tap water (about 30 secs). 
Stained in solution C for 2 min. 
Graded alcohols served to differentiate and dehydrate 
the section. 
Cleared in xylol and mounted in Depex (Gurr, England). 
Epiphyseal cartilage stained blue and articular cartilage pink. 
The deepest layer of the articular cartilage may contain 
scanty pericellular blue staining material. 
(D) Alcian blue (pH 1.0) for sulphate groups of mucopolysacchari-
des (Culling, 1974). 
Reagents A: Alcian blue 8GX (Gurr, England) 1% w/v in 0.1N HCl. 
Method: 
1. 
B: 0. 1N HCl. 
Dewaxed sections were brought to water through graded 
alcohols. 
2. Stained in solution A for 30 min. 
3. Rinsed in O. 1 N HCl for 10 secs. 
4. Blotted dry, dehydrated in graded alcohols, cleared 
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in xylol and mounted in Depex (Gurr, England). 
Results: 
Sulphated mucopolysaccharides stained blue. 
(E) Alcian blue (pH 2.5) for acid groups (COOH and OS03H) of muco-
polysaccharides (Culling, 1974). 
Reagents A: Alcian blue 8GX (Gurr, England) 1% w/v in 3% v/v 
acetic acid (pH 2.5). 
Method: 
1. Dewaxed sections were brought to water through graded 
alcohols. 
2. Stained in solution A for 30 min. 
3. Rinsed in distilled water for 30 secs. 
4. Dehydrated in graded alcohols, cleared in xylol and 
mounted in Depex (Gurr, England). 
Results: 
Acid mucopolysaccharides stained blue. 
(F) Alcian blue: critical electrolyte concentration technique 
(Quintarelli, Scott, Dellovo, 1964; Culling, 1974). 
I 
' 
Reagents A: Alcian blue 8GX 0.1% w/v in 0.05M sodium acetate 
buffer (pH 5.7). 
Method: 
B: MgCl2 was added to aliquots of solution A to give 
final molar concentrations of 0.1, 0.7 and 1.0M. 
1. Dewaxed sections were brought to water through graded 
alcohols. 
2. Serial sections were each stained with one of the four 
solutions described above for 30 min. 
3. Rinsed in tap water for 30 secs. 
V\, 
4. Dehydrated in graded alcohols, cleared in xylol and 
mounted in Depex (Gurr, England). 
Results: 
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Sulphated mucopolysaccharides stained blue at all concentra-
tions of MgCl2 while carboxylated mucopolysaccharides did not 
at MgCl2 concentrations of 0.7 and 1.0M. 





Ovine testicular hyaluronidase EC 3.2.1.35 
(Boehringer, Mannheim 15005). Solution: SO mg/ 
100 ml 0.1M sodium acetate buffer pH 6.0. 
Sodium acetate buffer, 0.1M pH 6.0. 
Alcian blue 8GX 1.0% w/v in 0.1N HCl. 
1. Dewaxed sections were brought to water through graded 
alcohols. 
2. Sections were covered with solution A, prewarmed to 
37°c, and incubated for 6 hours at 37°C. 
3. Control sections were similarly incubated in solution B. 
4. Slides were rinsed in ~olution Band then tap water (1 
min each). 
S. Stained. with solution C as described above. 
6. Dehydrated in graded alcohols, cleared in xylol and 
mounted in Depex (Gurr, England). 
Results: 
Loss of blue staining (relative to buffer control) indicated 
removal of hyaluronic acid and/or chondroitin sulphates A 
and/or B. 
(H) Oil Red O stain for fat (Lillie and Ashburn, 1943) 




B: Solution A was diluted 6:4 with distilled water, 
allowed to stand for , 10 mins and filtered. The 
filtrate must be used within 1-2 hours. 
C: 60% Alcohol. 
D: Mayer's haemalum (Gurr, England). 
Tissue was fixed for 24 hours in phosphate buffered 
formalin. 
2. Frozen sections, 10 µm thick, were cut on an Oxford 
freezing microtome and fixed to gelatinised slides. 
3. Sections were stained in solution B for 10 mins. 
4. Differentiated in solution C for 15 sec. 
5. Counterstained in solution D for 3 min. 
6. Blued in tap water. 
7. Mounted in glycerine jelly. 
Results: 




CHEMICAL AND BIOCH EMICAL ME THODS 
(A) Measurement of serum and perfusate albumin (Doumas, Watson and 
I 
Biggs, 1971). I 
Principle: The dye bromocresol green binds specifically to albumin 
without reacting with globulins. 
Reagents A: A commercial preparation, Albustrate (Warner-
Lambert Co., U.S.A.) of bromocresol green, sur-
face autoreagent, buffer and preservative. 
B: Commercial serum standards of known albumin con-
centration were used (Calibrate, Warner-Lambert 
Co. , U.S.A. ) . 
Method: All assays were carried out in duplicate as follows: 
1. 0.5 ml Albustrate reagent. 
2. 2.0 ml Distilled water. 
3. 5 ml Sample or Standard. 
4. Absorbance was read after 30 min at 630 nm by means of a 
Zeiss PMZD spectrophotometer. 
Results: 
Absorbance was linear over the working range (1.5-4.6 g/100 ml). 
Reproducibility: 
Interassay coefficient of variation was 1.8% (n = 8 ). 
(B) Measurement of total serum proteins (Lowry, Rosebrough, Farr 
and Randall, 1951). 
Principle: The Folin-Ciocalteu reagent was used which reacts with 
tyrosine and tryptophan residues in proteins. 
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B: 0.5% w/v CuS04·S HzO in 1% w/v potassium sodium 
tartrate. 
C: Before use 50 ml of solution A was mixed with 
1 ml of reagent B. 
D: Folin-Ciocalteu reagent (Merck, Darmstadt) 
diluted 1:1 with distilled water. 
E: 0.9% w/v NaCl in distilled water. 
F: Standard was as for albumin (Calibrate, Warner-
Lambert Co., U.S.A.). 
All assays were carried out in duplicate as follows: 
5 µ1 Standard or Sample. 
1 ml 0.9% Na:Cl. 
.5 ml of Lowry reagent C. 
After 10 min 0.5 ml of the diluted Folin-Ciocalteu 
_J 
reagent (solution D) was added and thoroughly mixed. 
5. After standing at room temperature for 30 min absorbance 
was read at 500 nm by means of a Zeiss PMZD spectro-
photometer. 
Results: 
Absorbance was linear over the working range (2.46-7.4 g/100nl) 
Reproducibility: 
Interassay coefficient of variation was 2.1% (n = 8). 
(C) Measurement of perfusate glucose. 
Principle: The sample was deproteinised with perchloric acid and 
the glucose content of the supernatant determined by 
the glucose oxidase/peroxidase/0-dianisidine reagent 
of Lavine, Chick, Like and Makdisi (1971). 
Reagents A: 2% Perchloric acid (Merck, Darmstadt). 
B: 1% w/v 0-dianisidine dihydrochloride (Sigma, 
U.S.A.). 
C: i) 0.2M Potassium phosphate buffer (34.836g 
K2U2P04 g/L, KHzP04 27.200 g/L adjusted to 
· pH 7. 0) • 
ii) Horseradish peroxidase EC 1.11.1.7 (Sigma, 
U.S.A.) 10 mg in 500 ml phosphate buffer. 
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iii) Glucose oxidase, EC 1.1.3.4 activity 15,000 
µ/g (Sigma, U.S.A.) 133.3 mg in 500 ml phos-
phate buffer. 
Method: 
D: Glucose Standard: 20 mg D (+) glucose (BDH, 
Poole, England) was made up with double dis-
tilled water to a volume of 10 ml (= 200 mg/100 
With double distilled water secondary 
standards were made up (200, 150, 100, SO, 25 mg 
100 ml- 1). 
· 1. 60 µl of sample or standard was added to 460 µl cold 2% 
HCl04 and the protein-free supernatant separated by 
centrifugation at 1000g for 10 min. 
2. 100 µl supernatant was added to 1 ml reagent. 
3. Incubated for 30 min at 30°c. 
4. Absorbance was read at 436 nm against a reagent block 
by means of a Zeiss PMZN spectrophotometer. 
Results: 
-1 Ab ~orbance was linear over the range 0-200 mg 100 ml • 
Reproducibility: 
Interassay coefficient of variation was 1% (n = 8). 
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(D) Determination of extractable liver lipid (Hazlewood and Nichols 
(1969). 
Principle: Lipids were extracted from liver by petroleum ether. 
Method: 
1. Three samplesof liver (300-500 mg) were taken from each 
liver and immediately weighed in glass-stoppered centri-
fuge tubes and again after 8 days drying (open) at 110°c. 
2. The dry tissue was then extracted with 10 ml of petroleum 
ether (BP 40°-6o 0 c BDH Chemicals Ltd., Cape Town) for 
24 hours, while being shaken mechanically (60 cycles/min, 
S cm oscillation). 
3. This extraction procedure was repeated twice after which 
the tissue was freed of residual petroleum ether by 
drying at 37°C for 24 hours and again weighed. 
4. The lipid content was expressed as:-
(Dry weight) - (Extracted weight) x 100 
Dry Weight 
(E) Measurement of haemoglobin and haematocrit in perfusates. 
a) Perfusate total haemoglobin content was measured by the 
cyanmethaemoglobin method, and the "free" haemoglobin 
in the perfusate supernatant by the benzidene method 
(both as described by Dacie and Lewis, 1963). These 
analyses were performed by the Cape Provincial Blood 
Transfusion Laboratory, Cape Town. 
b) Perfusate haematocrit was measured in heparinised capilla-
ry tubes after centrifugation at 12,000 rpm for 3 min in 
a high speed microhaematocrit centrifuge (Hawksley, 
England). 
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(F) Measurement of perfusate lactate. 
Principle: Perfusate lactate concentrations were determined 
enzymatically using lactate dehydrogenase by the 
method of Hohorst (1964) in the enzyme catalyses 
the reaction: 
Lactate+ NAD -+ + Pyruvate + NADH 
Under the chosen conditions of incubation the 
equilibrium is directed towards pyruvate and NADH. 
The NADH is thus formed in direct proportion to the 
lactate concentration. 
Reagents A: Glycine buffers: This was prepared from two 
stock solutions (i) and (ii) in a ratio of 
approximately 1:1 to give a pH of 9.4-9.5, 
just before assay. 
Method: 
Solution (i) 2N NaOH 
Solution (ii) 20.8g Hydrazine Sulphate in 200ml 




B: Lactate standard solution, 1 mM (Boeh ringer, 
Mannheim) • 
C: NAD (Miles Laboratories, U.K.) 1% w/v in double 
distilled water. 
D: Lactate dehydrogenase EC 1.1.1.27 (32,000 U/10 ml) 
Miles, Laboratories, U.K.). The required con-
centration of 36,000 U/ml was obtained by adding 
1.125 ml of the stock enzyme solution to 10 ml 
double distilled water. 
1. Perfusate was deproteinised by the addition of perchloric 
acid (2% w/v) and centrifugation of the precipitared 
proteins. 
2. The resulting supernatant was neutralised by adding a 
known volume of 0.1N KOH containing a trace of BDH 
universal indicator. 
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3. Assays were performed at 20-22°C in clean 3.0 ml cuvettes 
and the absorbance read at 340 nm with air as reference 
I • by means of a Un1cam SP 1700 spectrophotometer. 
4. The experiment was set up as follows: 








Sample or Standard 
LDH 
1. 10 or 
0.05 or 
0.10 
1. 20 1. 30 
0.20 
0. 10 
Total I'\, 3.00 I'\, 3.00 
S. The reaction was started by the addition of 0.01 ml 
LDH solution. 
6. The absorbance was read every 10- min until stable. The 
optical density change (60D) at 340 nm of the blanks was 
subtracted from those of samples or standards. Where 
high lactate concentrations were anticipated(> 2nM) 
0.05 ml of sample was used, whereas for those with low 
concentrations 0.20 ml was used. 
Calculations: The cuvette having a volume of 3 ml and a 1 cm 
light path, the expected 60D produced by 0.05, 
0.10 and 0.20 ml of 1 mM lactate are directly pro-
portional to each other. 
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Thus 0.05 ml 1mM Lactate produces 60D 0.1305 absorbance units 
0.10 ml 1mM Lactate produces 60D 0.207 absorbance units 
0.20 ml 1mM Lactate produces 60D 0.414 absorbance units 
then with 0.05 ml Sample 
Lactate (mM) = 60D Sample - 60D Blank 
0. 10 35 
with 0.10 ml Sample 
Lactate (mM) = 60D Sample - 60D Blank 
0.207 
and with 0.20 ml Sample 
Lactate (mM) = 60D Sample - 60D Blank 
0.414 
The concentration of lactate in each sample before neutralisation 
was then calculated 
% Recovery= 60D 0.05 ml Standard - 60D Blank x 100 
0. 10 35 
on this basis; mean+ SEM recovery was 95 + 2% (n = 10) 
(G) Determination of Serum Sulphate. 
Principle: Serum sulphate was determined by a modification (Henry, 
i 
1964) of the method of Kleeman, Taborsky and Epstein 
(1956). 
Serum was deproteinized with uranyl acetate, which 
simultaneously removed inorganic phosphate. The sul-
phate in the filtrate is precipitated as benzidene 
sulphate and the benzidene quantitated by photometric 
measurement after reaction with S naphthoquinone-4-
sulphonate. 
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Reagents A: 1% Benzidene (BDH, Poole, England) w/v ethanol 
was prepared freshly on the day of assay from 




B: 0.4% w/v aqueous uranyl acetate (Merck, Darmstadt). 
C: 1% w/v Sodium borate in 0.1N NaOH (must be stbred 
in polyethylene bottle). 
D: 2:1 v/v ethanol, diethylether wash reagent. 
E~ Sodium S naphthoquinone-4-sulphonate, 15 mg in 
10 ml double distilled water was prepared on the 
day of assay. 
F: Stock sulphate standard 1.090g K2S04/L double 
distilled water. 
G: Working sulphate standard 1:10 dilution of stock 
standard. Contains 20 µg S/ml. 
H: Powdered glass. Pyrex glass was ground to a fine 
powder with a mortar and pestle, washed twice 
with hot, dilute HN03 and repeatedly washed with 
distilled water and then dried. 
0.5 ml serum was added to 1.5 ml of reagent B, mixed 
and then precipitated by centrifugation (2000g for 5 min). 
In 8 ml glass stoppered centrifuge tubes the following 
were made up: 
,. 
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· Blank Sta·ndard Unknown 
Water 0.25 ml 
Standard (5 µg S) 0.25 ml 
Sample (Supernatant) 
Uranyl acetate solution 
Glacial acetic acid 
Benzidene solution 

















I\, 5 mg 
3. Tubes were stoppered and stood upright at 4°C for 18 hours. 
4. After centrifugation (2000g/5 min) the supernatant was 
aspirated and the tubes drained by inversion on absorbent 
paper for 3 min. 
5. The inside of the tube was rinsed with 1 ml of absolute 
alcohol without disturbing the precipitate, centrifuged 
and aspirated as before. 
6. 8 ml of alcohol-ether wash was added, the tube stoppered 
and vigorously shaken, centrifuged and aspirated. 
7. 0.5 ml of alcohol was added without disturbing the pre-
cipitate, centrifuged and aspirated. 
8. 0.25 Sodium borate solution was added and the tubes 
heated to 60°C in a waterbath for 10 min. 
9. After cooling, 0.25 ml double distilled water and 0.25 
ml 8 naphthaquinone-4-sulphonate solution were added, 
mixed and incubated for exactly 5 min then 0.5 ml acetone 
was added, mixed and the tubes centrifuged as before. 
10. The supernatant was t r ansferred to clean tubes and the 
absorbance read by means of a Zeiss PMZN spectrophoto-
meter at 485 nM. 
'U' 
Calculation: 
mg Sulphate/ 10 0 = Abs orbance unknown - abs·orb'ance blank x 6 
Absorbance of standard - absorbance of blank 
Absorbance was linear over the range 1 ·· mg/ 100 ml. 
Reproducibility: 
Interassay coefficient of variation was 6.9% (n = 5). 
Comment: 
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In view of the known carcinogenicity of benzidene and the 
radioactivity or uranylacetate, the greatest care was exer-
cised with this assay, gloves and apron being worn at all 
times and in addition a mask was worn during the weighing of 
benzidene. All glassware was used only for this assay and 
was separately and specially cleaned. 
(H) Measurement of Perfusate p02. 
1. Perfusate p02 was measured by means of a Radiometer 
(Copenhagen) p02 electrode Type E 5046, pH meter Type 
PHM27 and gas monitor PHA 927. The instrument was 
calibrated against Radiometer S4150 pOz zero solution 
and distilled water equilibrated with room air. The 
scale 0-1200 mmHg was used for high p02 perfusates 
leaving the oxygenator and the scale 0-120 mmHg for 
low p02 perfusates leaving the liver. 
2. All samples were drawn into plastic syringes and 
analysed within 5 min. 
(I) Programming of Packard Tricarb 2650 for the counting of 35 so4 
1 cycle/tray 
1st vial is a background 
Lower limit reject (Red, green) o, 0 
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Lower limit discriminator (Red, green) so, 50 
Upper limit discriminator (Red, green) 1000, 1000 
% Gain (Red, green) 4.5, 4.5 
Count mode ES 
Calibration No 
Curve 1D CPM 
Count/Sample 1 
Divide constant 1. 00 
Reset time (Red, green) 5 min, 5 min 
Preset counts (Red, green) 8 X 10 6 , 8 X 10 6 
(J) Preparation of incubation medium (Daughaday and Reeder, 1966) 
400 ml required (preincubation 75 ml, dilution of samples 150 ml, 
isotope incubation 175 ml). 
Method: 
1. Glucose 800 mg. 
2. Phosphate buffer (5 x final concentration) 80.0 ml 
15775g Na2HP04 dissolved in 850 ml double distilled 
water 
1N HCl to pH 7.4 
Double distilled water to 1000 ml 
Frozen in aliquots of 81 ml 




Double distilled water to 1000 ml 
Frozen in aliquots of 21 ml 
4. Amino acid solution (10 x final concentration) 40.0 ml 
L glutamine 833.5 mg L Valine 293.0 mg 
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L Lysine 292.5 mg L Arginine 173.5 mg 
L Leucine 1 70. 0 mg Glycine 157.5 mg 
L Threonine 142.5 mg L Histidine 124.0 mg 
L Cystine 120.0 mg L Tyrosine 108.5 mg 
L Tryptophan 102.0 mg L Isoleucine 92.0 mg 
L Phenylalanine 44.5 mg L Methionine 82.5 mg 
Cystine and methionine were dissolved in 300 ml of double distilled 
water with heating, the phenylalanine and tyrosine were added 
while the solution was hot and after cooling the remaining amino 
acids were added and the volume made up to 1000 ml with double 
distilled water and the resultant solution frozen in aliquots of 
41 ml. 
5. Buffered Na penicillin 40,000u (Novo Industries 
(Pharmaceuticals) (Pty) Ltd., South Africa. 
6. Streptomycin S04 40 mg ( Glaxo Al lenburys (S. A.) (Pty) 
Ltd., South Africa. 
7. Kanamycin 40 mg (Novo Industries (Pharmaceuticals) (Pty) 
Ltd., South Africa. 
8. Double distilled water to 400 ml. 
9. The resulting solution was sterilized by filtration 
through a 0.2µ Millipore filter (EGWP02500). 
Dextrose and salts AR grade BDH, Poole, England. 
Amino acids, Grade I, Sigma Biochemicals, U.S.A. 
(K) Radioimmunoassays of rat growth hormone and insulin. 
(a) General principle of radioimmunoassay (Yalow and Berson, 
1964). 
Such assays depend on an antibody directed against and specifi-
cally binding to the hormone to be measured. A fixed amount of 
radioactively labelled hormone competes with unlabelled hormone 
.J 
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(either Standard or unknown) for binding sites on a limited amount 
·of antibody. 
The amount of labelled hormone bound to antibody diminishes 
with increasing amounts of unlabelled hormone. Separation of the 
labelled hormone bound to antibody from that unbound ("free") is 
possible by a variety of processes, in these instances a double 
antibody precipitated the first along with the hormone bound to it. 
The concentration of hormone in the unknown is determined by 
comparing the displace~ent of labelled hormone produced by the un-
known with that produced by a series of known concentrations of pure 
hormone standard in a dose-response curve. 
(b) Radioimmunoassay of rat insulin. 
The method of Weinkove, Weinkove and Pimstone (1974) was used. 
Bound labelled insulin was separated from free labelled hormone by 




Assay buffer. O.OSM Veronal buffer pH 8.6 
containing 0.25% w/v crystalline bovine serum 
albumin (BDH, Poole, England) was used to dilute 
reagents, standards and if necessary, serum 
samples. In the case of precipitating second 
antibody and guinea pig carrier plasma the buffer 
also contained 0.01M EDTA. 
Standards. Crystalline rat insulin biopotency 
2114/mg, separated from proinsulin and related 
substances Cb-component) by Sephadex chromatogra-
phy by the manufacturers, Novo Research Institute, 
Denmark (lot number R171). 
125 I labelled insulin. Porcine monocomponent 
insulin (Novo, lot number S823058) was labelled 
by the method of Hunter and Greenwood (1962) to a 
Method: 
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specific activity of 250-300 µCi/µg. 
D: Guinea pig antiporcine insulin antibody (Burroughs 
Wellcome Ltd., U.K., Lot number K2357). 
E: Rabbit anti-guinea pig antiserum. Made by Pentex 
U.K., was used as second precipitating antibody. 
F: Carrier plasma was obtained from healthy 3 month 
old guinea pigs. 
The assay was carried out at 4°c in 400 µl Beckman microfuge 
tubes. The optimal concentrations of antibodies and carrier plasma 
and the time required to reach steady-state binding at 4°C were all 
determined before using the assay for determining insulin content of 
unknown sera. 
After addition of each reagent, tubes were closed and centri-
fuged in a Beckman microfuge in order to mix them. 
1. Preincubation of standards and unknowns with insulin anti-
2 . 
3. 
body. S µl of serum sample or standards (40, 20, 10, S, 
2.5, 1.25, 0.625 ng/ml) were pipetted into the tubes 
followed by SO µl of guinea pig anti-insulin antibody 
(K2357) diluted 1/100,000. 
4°C for 24 hours. 
Add . . f 125! . 1· ition o -insu in. 
Incubation was conducted at 
20 125 r . 1· . so 1 pg -insu in in µ 
buffer(~ 8000 cpm) was added, mixed and incubated at 
4°c for 24 hours. 
S t . f b d f f 125 r · 1· epara ion o oun rom ree -insu in. SO µl of 
rabbit anti-guinea pig precipitation serum diluted 1/8 
and SO µl of guinea pig plasma, diluted 1/5000 were 
added to the tubes, mixed and incubated at 4°c for 48 
hours. 
4. Centrifugation in the Beckman microfuge for S min 
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(17,SOOOg) produced a firmly adherent precipitate. The 
supernatant was "flicked" out of the tube and drainage 
completed by being left inverted for 1 hour at 4°C. 
S. The tip containing the precipitate was cut off with shears 
f 
and placed in a counting vial and counted for a minimum of 
10,000 counts or 20 minutes in a Packard autogamma scinti-
llation spectrometer (efficiency 56%). 
Calculation: 
1. Total counts added, 6 tubes containing labelled hormone 
alone were counted. The mean being taken as the 
total counts for the purpose of calculation. 
2. "Non-specific" b indin'g or blank. This reflects the label 
adsorbed onto the tube and trapped in the precipitate in 
the absence of the specific binding of the anti-insulin 
antiserum and was estimated from tubes containing all the 
reagents detailed above except that buffer replaced anti-
body in Step 1 of the method. 
of the total counts added. 
The blank counts were 1-2% 
3. Bound counts (B) = counts in sample or standard-counts in 
blank. 
4. Free counts (F) = Total counts - B. 
S. B/F ratio was plotted semilogarithmically as a function of 
the concentration of insulin standards to generate a 
standard curve .(see Fig. B.1). Serum insulin concentra-
tions were determined from this curve. 
Sensitivity: This was 0.5 ng/ml. 
Reproducibility: 
Intra-assay coefficient of variation= 8% in the midrange (n = 6) 
Interassay coefficient of variation, low concentration 24% (n=1~ 
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(c) Radioimmunoassay of rat growth hormone. 
This assay made use of reagents kindly don ated by the National 
Institute for Arthritis, Metabolism and Digestive Diseases of the 
National Institutes of Health (U.S.A.) Rat Pituitary Hormone Distri-
bution Program. 
Reagents A: Assay buffer 0.025M EDTA phosphosaline buffer 
containing 1% w/v crystalline bovine serum 
albumin (BDH, Poole, England) and. 0.1% w/v sodium 




Standard: Rat growth hormone reference prepara-
tion for radioimmunoassay (NIAMDD-Rat GH-RP-1). 
Biological potency= 0.6 International units 
(Bovine GH) per mg. 
125 I labelled rat growth hormone. Purified rat 
rat growth hormone (NIAMDD-rat GH-1-3). The 
lyophilised powder was dissolved in 0.01M NaHC03 
and 25 µ1 aliquots (concentration 1 mg/ml) stored 
at -20°C until iodination. 
D: Monkey antiserum to rat growth hormone NIAMDD-
E: 
anti-Rat GH-Serum-3). The lyophilized antiserum 
was diluted 1/1000 in the assay buffer and frozen 
in 100 µ1 aliquots. 
Rabbit anti-monkey gamma globulin serum. A 
serum with high affinity was prepared in our 
laboratory and was used as a second precipitating 
antibody. 
F: Carrier plasma was obtained from heal thy Rhesus 
monkeys. 
1. Radioiodination: 125 I-NaI (The Radiochemical Centre, / 
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Arnersham, U.K. Specific activity mCi/mg). 
O.SM NaH2P04 buffer pH 7.6. 
Chloramine-T, a solution of 35 mg in 10 ml O.OSM 
NaH2P04 buffer was prepared immediately before use. 
Sephadex G-50, equilibrated with 0.05 barbital buffer, 
pH 8.6 was packed into a 0.9 x 20 cm column, coated 
with a few drops of 5% bovine serum albumin and washed 
with barbital buffer before use. 
2. Labelling procedure: In a reaction tube 100 µl O.SM 
phosphate buffer, 2 mCi 125 1, 20 µl of NIAMDD-Rat GH-1-3 
(1 mg/ml) and 10-20 µl chloramine-T solution were added in 
this sequence. 45 seconds after the addition of the 
chloramine-T, the reaction mixture was placed on the 
Sephadex column and eluted with O.OSM barbital buffer 
3. 
pH 8. 6. Fractions of 0.5 ml were collected into bovine 
serum albumin coated plastic tubes. 
Results: Two distinct peaks were obtained, the first 
radioactiye peak contained the labelled hormone and was 
diluted in 1% BSA-phosphaline buffer pH 7.6, aliquoted 
and stored at -20°c until use. The second peak con-
tained the free iodine and was discarded. On the day 
of assay a portion of the labelled hormone was repurified 
on a Sephadex G-100 column 1.5 x SO cm equilibrated in 
O.OSM barbital buffer pH 8.6 1 x 10 6 cpm was applied to 
the column which was then eluted with barbital buffer 
and 2 ml fractions collected. Three radioactive peaks 
were obtained, the first being aggregated poorly immuno-
reactive material, the second being the labelled hormone 
used in the assay, and the third small molecules. The 
first and third peaks were discarded. 
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4. Radioimmunoassay procedure: 
i) 300 µl of buffer, 100 µl of standards in duplicate 
(at 0.1, 0.25, 0.5, 0.75, 1.0, 2.5, 5.0 ng/100 µl) or 
0.05 and 0.025 ml of unknown serum sample (the 0.025 
ml sample being made up to 0.05 ml with buffer) were 
added to 10 x 75 mm disposable test tubes in that 
sequence. 
ii) 100 µl of the repurified labelled rat growth hormone 
was added such that each tube received 5000 to 8000 
cpm. 
iii) 100 µl of monkey anti-rat growth hormone serum 
diluted 1:20,000 was added to all but 3 non-specific 
binding tubes which received 100 µ1 of assay buffer 
in its place. 
iv) The mixture was incubated for 72 hours at 4°c. 
v) 25 µ1 Sodium heparin (1000 USP units/ml), 100 µl 
carrier plasma diluted 1:1600 and 100 µl of rabbit 
anti-monkey precipitating serum were added in that 
sequence and the incubation continued for 24 hours 
at 4°c. 
vi) The precipitate was separated by centrifugation for 
30 min at 1000g at 4°c and the supernatant discarded, 
the radioactivity in the precipitate was counted in 
a Packard automatic gamma scintillation spe~trometer 
(efficiency 56%) for a minimum of 10,000 counts or 
20 minutes. 
Calculations: These were as for the rat insulin radioimmunoassay. 
Sensitivity: This was 2-5 ng. 
Reproducibility: 
(Midrange) Intra-assay coefficient variation 5% (n = 7) 
Interassay coefficient variation 13% (n = 8) . 
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. APPENDIX . C 
STATISTICAL METHODS 
20 7 
"A Judicious man looks at statistics not to get knowledge but to 
save himself from havinr irmorance foisted on 'h·im" Thomas Carlyle. 
All statistical analysis of data was performed using the 
appropriate programme for a Hewlett-Packard computer, model 9830A. 
(A) Parametric tests: 
a) The mean, - 1 x = - Ex n 
where n = number of observations 
b) Standard Deviation, S.D. = IE(x _ x)Z 
n-1 
where n < 30 
c) Standard error of the mean, SEM = S.D. 
~ 
d) Coefficient of Variation,= S.D. x 100 
-X 
e) Least Square Regression Line 
a line y =a+ bx was fitted to pairs of data (x1Y1, 
xzyz, XnYn) 
when a= ~(Ex2)-(Ex) (Exy) 
nEx2 - (Ex)2 
b = nExy (Ex) (Ey) 
nEx2 - (Ex)Z 
f) Correlation Coefficient 
r = nExy - (Ex) (Ey) 
nEy2-(Ey)2 
g) "Student's" t test: 
To compare the means x and x of 2 small samples 
n and n from normal populations (with unknown 
variances which are assumed to be equal) 
- -
X - X 
t = ./ 
1 + 1 
s n n 
where Sis an estimate of the standard deviation 
based on both samples together 
sz = 1 
n+n - 2 n n 
Degrees of freedom= n+n - 2 
h) Levels of significance 
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Values of p were determined from the appropriate tables 
fort tests and correlation coefficients. 
Two-tailed tests were used in the determination of p, 
where p exceeded 0.05 (p > 0.05) the differences between sample 
means were regarded as non-significant. 
(B) Bioassay Statistics: 
a) Data from the somatomedin bioassay was subjected to 
analysis by means of a computer programme designed by Phillips and 
Herington (1975) and a Hewlett-Packard 9810 (model 10) desk top 
computer with the following options: 001 (111 data-storage regis-
ters), 003 (2036 programme steps), 004(printer), read only memory 
(ROM) plug-in instruction blocks 11214A (statistics), 11261A 
(plotter printer alpha), 11262A (peripheral control cassette 
memory), 9862A (calculator plotter), 2748B (punch tape reader) 
and 9865A (cassette memory). 
The programme was entered on magnetic cards. Data could be 
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entered manually or by means of paper tape and the dose responses 
automatically plotted. The programme accepted dose-response lines 
made up of up to 30 points at up to S concentrations (the number of 
points for each concentration must be constant). 
The automatic plotting of dose-response lines allowed easy 
examination and rapid selection of the appropriate portions for 
analysis, which could then proceed without re-entry of the raw data. 
Data was processed with the response represented in the form: 
z = K1K2 (x-K3) 
y 
where K1 = specific activity 
K2 = the dilution factor 
K3 = the background CPM 
X = the uncorrected response CPM 
y = the cartilage weight 
Error was minimised by specific instructions prior to the 
entry of each datum or option. Assay number, date, estimated 
maximal and minimal responses, background CPM and standard CPM, 
total µgS04/tube (a constant), dilution factor (to convert specific 
activity to the chosen units), options for variable or constant 
cartilage weight and log-log or semi-log transformation, maximum 
t value for fiducial limits calculations ·(for minimum n and chosen 
probability), the number of points per group (a constant) and the 
potency of the standard. 
Data for each sample were then entered in sequence. The line 
number and total number of points entered manually, followed by the 
uncorrected CPM entered in sequence, either manually or read from 
paper tape. Concentrations for each sample were entered manually 
in sequence. The full dose response lines were then plotted and 
the means and standard errors of the means printed out. If parallel 
.. 
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line analysis was required, the standard line was entered first. 
After inspection of the whole dose reponse lines, concentra-
tions were chosen for a trial pair of standard and test lines, those 
portions appearing linear and parallel being selected. If a test 
line was obviously unsatisfactory, analysis was omitted entirely 
and a new test sample requested. If a trial comparison was unsatis-
factory, analysis with different concentrations was performed until 
the best possible comparison was obtained, after which the next 
test line was analysed as before. 
The schematic flow chart of the programme is represented in 
Fig. C.1. 
b) Equations 
i) General form of data Z = K1Kz (x-K3) 
y 
where K1 = specific activity 
Kz = dilution factor 
K3 = background CPM 
X = uncorrected response CPM 
y = cartilage weight 
ii) Specifically for the somatomedin bioassay 
Incorporated S04 (as µg/100 mg cartilage) = 
CPMi - BKgd x total µg S04 X conversion factor 
CPMsA -BKgd 
where total µg S04 = 
(tube volume x Sample concentration(%) x Sample S04 cone. (µg/ml) 
100 
(tube volume x 100-Sample concentration(%) x Buffer so4 cone.) 
100 
Wti may be constant or vary for each CPMi 
Fig. Cl Program Flow Chart (Phillips & Herington, 1975) 
Request: Assay No. 
Date 
Maximum y 
Minimum y ! 
I 
Draw axes 
Lable y axis 
Print assay no. and date on graph 
Store scaling factor 
I 
Request: Background CPM 
Standard CPM 
D·i 1 ut ion factor 
µg S04 tube 
Store: Background, specific activity 
I 
Request, Store: Wt if constant 
0 if not 
1 if 1 og-1 og 
0 if semi-log 




Request, Store: Line number (LN) 
Yes--e--No 
I I 
assign location J 
of std line 
assign location 
of test line 
__.L-:-----
r-------------'----·------------, 
Request, Store: Points/line 
CPM in sequence 
Set FLAG for tape reader 
Yes--_, ---No 
I / I I Enter CPM by tape I I Enter CPM bt hand I 
Yes /Wt>o) Np 
Di vi de by Enter and divide 
constant ~Jt by Wts in sequence 
Store as µg S04/lOO mg cartilage 
= t S04 
2 1 1 
Recall analysis code 
Take log of 










Request, store as ·109: 
concentrations in sequence 
Print group means and SEMs 






Code location of Std t S04 values 
Request concentration numbers for Std line (B) 
Enter O for test line, when done, set FLAG 
(C) Yes (D)Line analysis 
212 
Yes Recall location code >----...a...::.;=----1 
No 
Recall concentration 
corresponding to number 





(E) Use previous Std line 
Request test concentration 
numbers 
(A) Request new line 
213 
( D) Recall location code 
tes t cS code 
Std code 
Store: number, slope, intercept 
I - - 2 s2Es X' y' 0 X5, 
Print I 
I 
Print: Slope, intercept, correlation 
F linearity, df, t slope, df, 
t parallelity, df, potency, FL 
I 
Recall location code 
test ~ Std 
code y code I (E) 
Code location of test t S04 values 
Request concentration numbers for test line 
Enter O for new line. : When done set FLAG 
I 
(C) 
Set . FLAG for new line 
Omit FLAG for repeat analysis 
_L 




(A) (B) (C) (D) (E) denote imprirtant locations in the program 
( 
214 
BKgd, CPMsA, conversion factor are all constant 
Total µgS04 depends on relative volumes and S04 
concentrations of sample and buffer (or buffer only 
if the 35so4 incubation follows the serum incubation 
as in the method of Van den Brande and Du Caju (1974). 
iii) Dose response lines 
Each dose reponse line was designated a line number to distin-· 
guish standard (=O) and unknown test sample line (tO). 
Each line would consist of several concentrations, each with 
a series of associated data points. 
constant. 
The number of data points was 
• The standard had a constant potency. The potency of the un-
known test sample was expressed in terms of the standard ("potency 
ratio") . 
The appropriate portions of standard and unknown test sample 
dose response lines were selected for derivation of potency ratios. 
All concentrations were subjected to logarithmic transformation 
(semi-log): y =blog x + a. Responses (data points) could be 
transformed logarithmically if this provided a more linear dose 
response line (log-log): logy= blog x + a. 
iv) Least-squares analysis 
1. Intercept= a= Yi - bxi 
2. Slope= b = {EXiYi - (Exi) (Eyi/n} 
. {LXiz - (Exi)2/n} 
n-1 
n-1 
S. Residua l me an square for each line= sE2 
= ·.{ay2 - b2ax2}(n-1) 
(n-2) 
6. Significance of b for any lline (t-tes t) 
I 
t = b 
n - 1 ) } 
with (n-2) degrees of freedom (df) 
7. F-test for linearity of any line= F 
F = Sz2 with df Sz2 : K-2; S32 n-K 
where n = total number of points and K = 
number of groups. 
n - K 
= (~Yi)2 for each group of size n· J 
Sz2 = {(n-1)ay2-(n-K)S 32-(n-1)ax2} 
K - 2 
8. Correlation coefficient for any line= r 
r = b ay 
ax 
9. Index of precision=! 
! = SE (for standard line only) 
b 
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v) Comparison of Standard and test lines 
1. Pooled slope bsr = Cbs + br) 
2 
where bs = slope of standard line 
br = slope of test line 
2. · Potency ratio 
bsr 
3. Pooled sEZ = sp2 
4. 
spZ = {(ns-Z)s2Es+Cnr-2)S2ET} 
"{ns+nr-4} 
Pooled variance of x = sZ xp 
5. Finney's g = {t2.s2p} 
. {bsrz .sz } 
Xp 
where tis chosen for appropriate limits for 
(ns+nr-2) degrees of freedom and pre-
selected degree of confidence usually 
I\, 2 
6. Parallelity t 
t = 1bs br 1 
Sp {1/ (ns-1)axs 2} + {1/ (nr-1)axr2} 
degrees of freedom= ns + nr-4 
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7. Test potency= Standard potency•antilog M. 
8. Fiducial limits= 
Standard potency•antilog xs-xT+ (m-xs+xT) + (t • Sp) 
i 
( 1 - g) bsT (1-g) 
·{(1-g)(l + l) + (rn-xs+xT)2}} 
ns nT 
(C) The Bioassay Computer Programme 
1) Plotter options 
Steps 0000-0331 
1. Set up plotter first, with lower left and upper right 
chosen. 
2. Card was entered. 
3. The programme- requested assay number, date, expected 
minimum and maximum value. 
4. Axes were then drawn and labelled, ordinates divided 
into 20 parts and abscissa incremented. 
S. The computer automatically started for entry of assay 
programme. 
ii) Assay programme 
Steps 0000-1974 
1. Data was requested and analysed as described above. 
iii) Plotter option listing (magnetic card 1). 
iv) Assay programme listing (magnetic card 2). 
v) Important steps in somatomedin assay programme 
1 Set decimal 
2 Request background 
30 Store background 
21 7 
34 Request standard CPM (CPMsA) 
63 Request total S04 
84 Request dilution factor 
105 Store specific activity 
109 Request weight of constant 
146 Store weight or 0 
150 Request 1 if Log-Log 
184 Store 1 or 0 
188 Request maximum t for fiducial limits 
209 Store t 
213 Request points per group 
230 Store 
234 Request potency for standard line 
251 Store 
255 Request line number 
273 Store 
218 
277 Determine location of CPM for standard or test S/R (a) 
292 Request number of points 
310 Store 
319 Request CPM, FLAG for tape reader 
I 
356 Correct CPM for background 
361 Convert CPM to µg S04 
373 Store as µg 
384 Reset location 
392 Test for constant weight 
403 If not, request individual weights 
425 . µg S04 by weight, store 
444 . µg S04 by weight, store 
486 Test for Log-Log 
492 If Log-Log, take log of each µg/100mg S/R (xto) 
497 Request concentrations 
514 Determine location 
562 Store concentration 
573 Redetermine location of µg/100mg 
626 Form sums for groups 
641 Print mean 
650 Scale mean for plot 
661 Increment x coordinate 
675 Test for first group 
696 Pen down to mean if not first 
709 Pen up to mean if first 
731 Standard error 
749 Determine location for line number plot 
773 Pen up to location 
784 Print line number 












Request concentration numbers for standard 
Determine location of µg/100mg 
Calculate sum for linearity 
Test if line number= 0 (Standard) 
Test for FLAG 
Where to store concentration number 
Form regression sums 
Test: if Standard or test line 
Store for Standard: n, a1, ao, xs, Ys, a2xs 
Calculate (n-2)SE2 S/R(1/x) 
Calculate !l 
1093 Slope, intercept, correlation 
























Calculate F for linearity and degrees of freedom 




Calculate t parallelity 
Calculate mean slope 
Store 
Calculate M-is + it 
Store 
Calculate M (potency ratio) and somatomedin 
SM value 
Calculate ( 1-g) 
Store 
Calculate 2nd term for fiducial limits 
Store 
Calculate 1st term for fiducial limits 
Fiducial limits 
Upper limit calculation 
Lower limit calculation 
Test: Standard or test line 
1748 Request concentration numbers for test line 
1821 Choose new line or repeat analysis 
1880 Set location for test values 
1887 Tape reader instruction (here - 2nd of 3) 
1928 Take log of each µg/100mg 
1952 Calculate (n-2)s2E 
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